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ABSTRACT
The intestine is the largest lymphoid organ in the body, challenged constantly by
an enormous quantity and diversity of antigens. Distinct from peripheral lymphocytes
intestinal lymphocytes have evolved unique mechanisms of tolerance and appear to
govern mucosal processes such as "chronic physiologic inflammation" and oral tolerance.
Failure of mucosal tolerance has been implicated in the pathogenesis of several diseases
including inflammatory bowel disease, celiac disease, and even autoimmune diabetes.
One population of intestinal lymphocytes, intraepithelial lymphocytes (IELs), exists
within the intestinal epithelium itself and remains poorly characterized. IELs respond to
unique activation signals and appear to be in part responsible for the maintenance of
epithelial integrty and mucosal tolerance.
Type 1 diabetes is one of the most common chronic childhood ilnesses and
causes significant morbidity and mortality. Type 1 diabetes melltus is an autoimmune
disease that results from immune-mediated destrction of insulin-producing pancreatic
beta cells and is characterized by an absolute insulin deficiency. Several animal models
are used to study the immunopathogenesis of tye 1 diabetes, including the BB rat and
NOD mouse. BBDP rats spontaneously develop autoimmune diabetes mellitus and are
severely deficient in peripheral T cells. BBDR rats do not spontaneously develop
autoimmune diabetes, have normal numbers of peripheral T cells , and can be induced to
become diabetic by injections of a cytotoxic anti-ART2a mAb and low doses of poly I:C.
The cause of autoimmune diabetes in BB rats and humans is stil unkown, but both
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genetic and environmental factors appear to paricipate. I hypothesize that one important
class of environmental factors--iet and enteromicrobial agents-participates in this
pathogenic process through the mediation of the gut immune system.
In this disserttion, I report a new method for the isolation of rat IELs that is
based on the selective removal of intestinal epithelial cells under conditions that leave the
basement membrane undistubed. The yield of rat IELs using this method is 5-10 fold
greater than that reported for other methods. Morphological and phenotyic analyses
demonstrate that the purfied cell population is comprised of IELs and is not
contaminated with lamina propria or Peyer s patch lymphocytes. Phenotyic analysis
reveals 5 major subsets of IELs, including populations of yo T and natual kiler (N)
cells present at levels not previously detected.
I also report that rat intraepithelial NK (IENK) and peripheral NK cells are similar
in morphology, in their ability to lyse NK-sensitive targets, and in their ability to suppress
a one-way mixed lymphocyte cultue. In contrast, IENK cells differ from splenic NK
cells phenotyically, and a substantial fraction of IENK cells appear to spontaneously
secrete IL-4 and/or IFN-y. I conclude that rat IELs harbor a large population of NK-
PIA+ CDT cells that function as NK cells but display an activated phenotye and
unusual cytokine profie that clearly distinguish them from splenic NK cells. Their
phenotyic and fuctional characteristics suggest that these distinctive intraepithelial NK
cells may participate in the regulation of mucosal immunity.
I next demonstrate that, prior to diabetes, both BBDP and ART2a-depleted BBDR
rats have a reduced total number of IELs and exhibit a selective deficiency of IENK cell
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number and fuction as compared to control BBDR rats. The deficiency of BBDP rat
IELs can be corrected by engraftent of bone marow from histocompatible WF donors.
These results suggest 1) that the peripheral lymphopenia in BBDP rats extends to the IEL
compartment, particularly to IENK cells, 2) that in BBDR rats the diabetes-inducing
treatment depletes IELs , particularly IENK cells, and 3) that the defect in BBDP rat IELs
is intrnsic to hematopoietic cells , not intestinal stromal cells.
I also establish that, unlike BBDR and WF rats , BBDP rats are also deficient in
yoTCR + IELs, a population of T cells that may playa role in normal mucosal tolerance.
In addition, I report preliminary data supporting the hypothesis that systemic
autoreactivity may be initiated in the intestine; peripheral autoreactive lymphocyte
populations appear to emanate first from mesenteric lymph nodes that drain the intestine
and such cells may initiate a tye 2 autoimmune phenomenon driven by IL-
Collectively, my findings support the hypothesis that a failure of mucosal
tolerance in BBDP rats, perhaps secondary to deficiencies in one or more IEL
subpopulations, paricipates in the pathogenesis of autoimmune diabetes in these animals
by activating peripheral autoreactive T cells. The nature of the autoimmune response in
BB rats (drven by IL-4) appears to be distinct from that of NOD mice. Despite the
differences between these two well-accepted animal models of autoimmune diabetes
until more is known about the pathogenesis of tye 1 DM in humans, lessons learned
from both the BB rat and NOD mouse continue to be of tremendous benefit to our
understanding of human disease.
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CHAPTER I
COMPREHENSIVE INTRODUCTION
Chapter I, Section 1 - General Background to Introduction
Diabetes melltus: Definitions and classifications
Diabetes melltus (DM), the most common endocrine disease, afficts approxi-
mately 5% of Americans (1). It is a leading cause of morbidity and mortality in the
United States and accounts for a disproportionately high fraction of U.S. health care ex-
penses, costing $105 bilion dollars (14.6% of health care expenses) in 1992 (2). The
term diabetes mellitus actually includes several endocrine disorders. Type 2 diabetes
mellitus , by far the most prevalent tye of DM, is a collection of disease states that have
in common the feature of "hyperglycemia resulting from defects in insulin secretion, in-
sulin action, or both" (3). Type 1 DM, the focus of this dissertation, is an autoimmune
disease that results from immune-mediated destruction of insulin-producing pancreatic
beta cells and is characterized by an absolute insulin deficiency (1 ;3;4). Type 1 DM tyi-
cally presents in children and young adults and accounts for approximately 10% of cases
of DM (1). Type 1 DM has been known formerly as insulin-dependent DM (IDDM) and
juvenile-onset diabetes mellitus (3).
Clinical rationale: Why study pathogenesis of type 1 diabetes melltus?
The absolute insulin deficiency associated with untreated tye 1 DM results in de-
fects of carbohydrate, lipid, and protein metabolism that contrbute to hyperglycemia
electrolyte abnormalities, and ketoacidosis (5). Acutely, hyperglycemia promotes an os-
motic diuresis that depletes the body of water and electrolytes. Untreated, these events
culminate in coma and death. Given appropriate insulin treatment, patients with tye 
DM can avoid the metabolic distubances associated with an absolute insulin deficiency.
Unless blood sugar is strctly controlled, however, patients are stil at risk for complica-
tions of chronic hyperglycemia such as blindness, renal failure , amputations, infection
and cardiovascular disease (5).
Individuals afflicted with tye 1 DM face a lifetime of insulin injections, and
children therefore experience a prolonged period over which morbidity may develop. A
cure for tye 1 DM is clearly necessary. Currently, restoration of beta cell function
through transplantation of functional pancreatic tissue is being investigated as a curative
therapy for tye 1 DM. This modality is limited, however, by a lack of donor organs and
immunologic barrers of transplantation and recurent autoimmunity (6). Such considera-
tions underscore the importance of preventing in addition to curng tye 1 DM. Before
we can successfully attempt to prevent this devastating disease in humans, however, a
greater understanding of the immunopathogenesis of tye 1 DM is necessary.
-. 
Experimental tools: Animal models in the study of type 1 diabetes
Several limitations hinder one s ability to study the immunopathogenesis of tye
1 DM in humans. These include the relative inaccessibility of the pancreas, the genetic
heterogeneity of human beings, and ethical considerations regarding experimentation in
humans (4;7). The use of animal models overcomes these limitations, and fortately
there exist several animal models of human tye 1 DM. Two rodent models, the
BioBreeding Diabetes-Prone (BBDP) rat and the Non-Obese Diabetic (NOD) mouse
spontaneously develop autoimmune diabetes that in many ways resembles human dis-
ease. In addition, autoimmune diabetes can be induced in BioBreeding Diabetes-Resistant
(BBDR) rats and in streptozotocin-treated rats. The immunopathogenesis of autoimmune
diabetes has been studied extensively in all of these models and has provided much in-
sight into human disease (7).
Overview of this dissertation
The comprehensive goal of this dissertation is to increase our understanding of the
immunopathogenesis of autoimmune diabetes in BioBreeding (BB) rats, with the hope
that information uncovered by this work may eventually contrbute to the prevention 
tye 1 DM in humans. Specifically, these studies focus on intestinal intraepitheliallym-
phocytes (IELs), a large yet poorly understood compartment of the gut-associated lym-
phoid tissue (GALT) that lines the entire gastrointestinal tract. As wil be discussed 
greater detail below, environmental factors clearly influence the expression of autoim-
mune diabetes in humans and rodents, and intestinal lymphocytes are among the first
cells of the immune system that encounter potential environmental trggers of autoimmu-
nity (8;9). This dissertation characterizes the phenotye and function of IELs in normal
and diabetic rats and postulates a mechanism whereby deficiencies in one or more IEL
populations contrbute to the earliest immunopathogenesis of autoimmune diabetes.
Overview of Chapter I
The objective of this introductory chapter is to acquaint the reader to background
material as it pertains to the remainder of this dissertation. Section 2 of this chapter pro-
vides an overview of the immune system and describes characteristics and functions of
peripheral T and natural kiler (N) lymphocytes as they relate to this dissertation. Sec-
tion 3 presents evidence supporting the concept that tye 1 DM in humans is an autoim-
mune disorder. Section 4 describes in detail our curent understanding of the immunopa-
thogenesis of autoimmune diabetes in the BB rat. Section 5 introduces the intestinal im-
mune system, paricularly intraepitheliallymphocytes. Finally, Section 6 states the aims
and goals of this disserttion.
Chapter I, Section 2 - The Immune System
To study the autoimmune pathogenesis of diabetes mellitus in humans or animal
models , a working knowledge of the immune system is necessary. This section of the in-
troduction presents a general overview of the immune system and then details two popu-
lations of peripheral lymphocytes, T and NK cells, as they pertain to this dissertation.
General overview of the immune system
Mammals and other multi-cellular organisms have evolved an elaborate immune
system to identify and eliminate pathogenic agents such as microorganisms, viruses
toxins, and neoplasms. An immune response must therefore be selective for the offending
pathogen yet limit damage to healthy tissue. The immune system is often divided fuc-
tionally into innate (natual) and acquired (adaptive) immunity, and each of these divi-
sions is comprised of humoral (plasma-borne) and cellular elements (10). Cells of the
immune system (immunocytes) exist in peripheral blood, lymph, and lymphoid organs
such as the spleen, lymph nodes , and intestine (10).
The innate immune system
The innate immune system responds rapidly to injur or infection. Stimuli for in-
nate immunity include highly conserved and distinctly foreign molecules like lipopoly-
saccharide (LPS), a component in the outer cell wall of gram-negative bacteria (11).
Limitations of the innate immune system include 1) a lack of pathogen specificity thus
allowing for bystander damage, 2) a restrcted repertoire of trggering antigens , and 3) a
failure to generate memory, as described below. Humoral components of innate immu-
nity include proteolytic cascades (e.g. complement), locally acting lytic enzes (e.
defensin), and secreted pattern-recognition receptors (e.g. mannan-binding lectin) (11).
Cellular components of innate immunity include NK cells, phagocytes (neutrophils , eo-
sinophils and macrophages), and antigen presenting cells (APCs) such as dendrtic cells
(DCs), activated macrophages, and activated B cells (10;11). Recognition ofLPS by cells
of the innate immune system is mediated in part by a family of surace-bound pattern-
recognition receptors termed toll-like receptors (11).
The acquired immune system
Directed by Band T cells, the acquired immune system evolved to compensate
for limitations of innate immunity. Acquired immunity generates an antigen-specific im-
mune response , responds to a diversity of antigens , and allows for memory through the
creation of memory cells. The clonal selection theory states that antigen-specific immune
responses are mediated by selective proliferation and differentiation of antigen-specific
lymphocytes that recognize antigen by cell surface receptors (12). In a primary immune
response, however, this process takes time (days to weeks), and an organism is therefore
dependent upon innate immunity to contain pathogens in the interim. Diversity of the ac-
quired immune response is accomplished through random rearrangement of genes coding
for antigen-specific receptors (13;14). Memory is the phenomenon whereby, following a
primary encounter with an antigen, memory cells are generated that allow for a rapid re-
sponse by the acquired immune system in the event of subsequent exposures to the same
pathogen. The principle humoral component of acquired immunity is immunoglobulin
(Ig) secreted by plasma cells (differentiated B cells). Cellular components of acquired
immunity include both B and T cells.
Primary and secondary lymphoid organs
Lymphocytes (B , T, and NK cells) are of hematopoietic lineage and derived from
plurpotent stem cells in the fetal liver and bone marow. The majority of T cells undergo
additional matuation in the thymus (described below). These organs in which lympho-
cytes originate and mature are referred to collectively as primar lymphoid organs (10).
Matue lymphocytes are found in peripheral blood, lymph, and designated secon-
dary lymphoid organs (spleen, lymph nodes, and mucosal suraces). The spleen and
lymph nodes contain large numbers of peripheral (circulating) lymphocytes (10). Muco-
sal suraces such the gastrointestinal , respiratory, urinary, and reproductive tracts harbor
vast numbers of lymphocytes that are distinct from peripheral lymphocytes and referred
to collectively as mucosa-associated lymphoid tissue (MALT) (15; 16). One mucosal
comparent, the gut-associated lymphoid tissue, is comprised of three lymphoid popu-
lations: Peyer s patch lymphocytes (PPLs), lamina propria lymphocytes (LPLs) and in-
traepithelial lymphocytes. The GALT, particularly IELs, is a focus of this dissertation
and is discussed in Section 5 of this chapter. Figure 1 ilustrates the various pathways by
which T lymphocytes migrate to secondary lymphoid organs.
Overview of peripheral T cells
T cell receptor
The antigen receptor clonally expressed by mature T cells is termed T cell receptor
(TCR). TCR includes either a and ~ or y and '6 chains and is the product of a successful
genomic rearrangement of TCR-encoding genes (14). The vast majority of peripheral T
cells express TCR comprised of a and ~ chains (a~TCR). Antigens specifically recog-
nized by a~TCR are almost always short peptides presented in the peptide-binding
groove of class I or class II major histocompatibilty complex (MHC) molecules ex-

Figure 1: Normal T cell lymphopoiesis. All T lymphocytes are of hematopoietic lineage
and in adults are derived from pluripotent stem cells in the bone marrow (steps and 2).
A majority of T cells mature further in the thymus before entering circulation and seeding
secondary lymphoid tissues like the spleen, lymph nodes, and mucosal surfaces (step 3).
In normal circumstances , a small percentage of recent thymic emigrants undergo apopto-
sis in the liver. T cells that localize to the intestine contrbute to the Gut-Associated Lym-
phoid Tissue (GALT) that includes Peyer s patch lymphocytes (PPLs), lamina propria
lymphocytes (LPLs), and intraepitheliallymphocytes (IELs). Although the majority of
PPLs and LPLs are thymus- derived (green), IELs appear to be of both thymus-dependent
(green) and thymus- independent (blue) ontogeny.
pressed on the surace of target cells or APCs , respectively (17). Only a low percentage
of peripheral T cells express TCR comprised ofy and 0 chains (yoTCR). These yo T cells
for the most part localize to mucosal surfaces (18; 19) and are discussed further in Section
5 of this chapter.
Phenotype of peripheral T cells
In addition to TCR, T cells express many other surace molecules that allow them
to interact with their environment. Most of these molecules have been assigned to the
cluster of differentiation (CD) nomenclature. Such nomenclatue wil be followed
throughout this dissertation unless another more common name prevails in the literature.
All matue T cells co-express CD3 with TCR to form the TCR-CD3 complex
(20). Unlike TCR, the CD3 complex has substantial intracellular components that allow
for interactions with intracellular signaling molecules (20). Thus, upon specific engage-
ment of TCR by peptide plus MHC, CD3 initiates a signal that can activate the T cell
(20). Activated T cells synthesize interleukin- (IL-) 2 and IL-2 receptor (IL-2R) that drve
T cell proliferation and differentiation in an autocrine fashion (20).
Mature peripheral a~ T cells also express either CD8 or CD4 co-receptors (10).
CD8 , expressed on peripheral T cells as a heterodimer of a and ~ chains (21), enhances T
cell interaction with class I MHC , which is expressed by all nucleated cells and presents
endogenously synthesized peptides (17). In contrast, CD4 stabilizes T cell interaction
with class II MHC , which is expressed constitutively only by APCs and presents exoge-
nously derived peptides (17).
The majority of mature peripheral T cells are naive, meaning that they have yet to
encounter specific antigen. Most naive T cells express CD2 and CD28 but not CD25 (22).
CD2 , an accessory molecule to the TCR complex, adheres to CD58 on target cells or
APCs to strengthen cell-cell interaction (23). CD28 binds B7. 1 (CD80) or B7.2 (CD86)
molecules on APCs to provide a co-stimulatory signal to T cells that synergizes with the
CD3-driven activation signal (24). CD25 , the high affnity a chain ofIL- , is associated
mostly with T cell activation and therefore is not expressed by the majority of peripheral
T cells (20). In rats, a majority of matue peripheral T cells also express the glycosyl-
phosphatidylinositol- (GPI-) linked cell surface protein ADP-ribosyltransferase- (ART -)
(4;25;26). ART2 is addressed in greater detail in Section 4 of this chapter.
Function of peripheral T cells
Circulating through blood, lymphatics, and secondary lymphoid organs, naive pe-
ripheral T cells scour MHC-peptide complexes expressed on the surface of APCs or tar-
get cells (27). Successful engagement of TCR by a MHC-peptide complex signals the T
cell that it has encountered its specific antigen (20). In response to this CD3-drven signal
and other co-stimulatory signals, the T cell may proliferate and differentiate into an ef-
fector T cell (28). Activated CD8+ T cells differentiate into 1) memory cells; 2) Tc1 or
Tc2 cells that, analogous to Th1 and Th T helper cells , secrete tye 1 or tye 2 cytoki-
nes, respectively (see below); or 3) cytotoxic T lymphocytes (CTLs) that kill target cells
via secretion of membrane-disrupting molecules like perforins and granzyes (28). Acti-
1 A new nomenclature for the rat has been adopted. ART2 now replaces RT6; ART2a and ART2b, isofonn
of ART2, now replace RT6. 1 and RT6. , respectively (150).
vated CD4+ T cells differentiate into either memory T or T helper (Th) cells (28). It is
widely believed that the CD4+ Th cell is responsible for coordinating an immune re-
sponse (29). Th cells are critical for optimal antibody fuction, as isotye switching, so-
matic hypermutation, and B cell memory are absent in humans and rodents lacking T
cells (22;30). Th cells also support other immunocytes, including CTLs , macrophages
and NK cells (28).
The Th 1/Th2 model of immune responses
Based on numerous experiments, mostly conducted in mice, immune responses
can be divided into one of two major themes, termed tye 1 and tye 2 immunity (Figure
2) (29;31). Upon successful engagement ofTCR by a specific peptide-MHC complex-
plus a costimulation signal (often through CD28) - naive CD4+ T cells undergo IL-
drven proliferation and differentiation into effector Th1 or Th2 lymphocytes. Th1 lym-
phocytes direct tye 1 immune responses by recruiting CTLs, NK cells, macrophages
and antibody-producing B cells (IgG2a) (29). Th lymphocytes direct tye 2 responses
by recruiting eosinophils, mast cells, and antibody-producing B cells (IgG 1 , IgA, and
IgE) (29). Type 1 responses tend to be more effective against intracellular pathogens (vi-
ruses , neoplasms, intracellular bacteria, and intracellular protozoa), whereas tye 2 re-
sponses tend to be more effective against extracellular pathogens (bacterial toxins and
helminths) (29;31).
The nature of an immune response is determined by CD4+ Th cells through their
differential expression of cytokines. Th1 cells secrete IL- 12 and interferon- (IFN-) 
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Figure 2: Thl/Th2 model of immune responses. Upon successful engagement of TCR by
a specific peptide-MHC complex - plus a costimulation signal (often through CD28) -
naive CD4+ T cells undergo IL-2 drven proliferation and differentiation into effector Th1
or Th21ymphocytes. Prior to full differentiation, proliferating CD4+ Th cells pass through
a transient phase (termed ThO) in which they can commit to either Th1 or Th2 lineage
and theoretically secrete both IFN-y and IL-4. By secreting IL- 12 and IFN-y, Th1 lym-
phocytes direct tye 1 immune responses and recruit CTLs , NK cells, macrophages , and
antibody-producing B cells (IgG2a). By secreting IL-4 and IL- , Th2 cells direct tye 2
responses and recruit eosinophils, mast cells, and antibody-producing B cells (IgG 1 , IgA
and IgE).
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promote a tye 1 response, whereas Th2 cells secrete IL-4 and IL-10 to promote a tye 2
response (29;31). Before fully differentiating, CD4+ Th cells pass through a transient
phase (termed ThO) durng which they commit to either a Th1 or Th2 lineage. ThO cells
theoretically secrete both IFN-y and IL-4 (29). The exact mechanism that commits a ThO
cell to become either a Th 1 or a Th2 cell is unown, but it may be influenced by 1) the
nature of the antigen itself, 2) the tye of activation signal received by the T cell upon
antigen engagement, 3) properties of the Th cell itself, and 4) the cytokine milieu of the T
cell at the time of activation (29).
It has been postulated that, in normal circumstances, a balance exists between Th 
and Th2 immunity, and autoimmune diseases may result from overactive tye 1 or tye 2
immunity (29;31). In NOD mice, diabetes is associated with high levels of tye 1 cytoki-
nes and can be prevented by IL-4 driven restoration of the Th l/Th2 balance, a process
termed immune deviation (32-34). Other Th1-dominated diseases include experimental
autoimmune encephalomyelitis (EAE), autoimmune arthrtis, and Crohn' s disease (35).
Diseases associated with an overactive tye 2 response include food allergy, astha, and
ulcerative colitis (35). Applicability of this Thl/Th2 model to autoimmune diabetes in
rats and humans remains unclear and is addressed in Section 4 of this chapter.
Central tolerance
Genomic rearrangement of TCR genes generates tremendous diversity (14) but
also allows for the creation of non-functional or self-reactive T cells (35). Durng T cell
ontogeny, selection processes exist that delete non-fuctional or self-reactive T cells, a
process termed central tolerance (35). T cell progenitors originate in the bone marrow and
matue in the thymus, where they undergo two major checkpoints, positive and negative
selection (10;35). Positive selection deletes T cells that fail to recognize self-MHC , thus
eliminating non-functional TCR rearrangements (35). Negative selection deletes T cells
that recognize self-peptide in the context of self-MHC, thus eliminating self-reactive
(autoreactive) TCR rearrangements (35). Therefore, for a T cell to surive both positive
and negative selection, it must express TCR that recognizes foreign antigen (peptide) in
the context of self-MHC (35). Thymic selection is not a perfect process, however, as T
cells that express autoreactive TCR recognizing antigens synthesized extra-thymic ally
may escape negative selection and central tolerance (35). In these instances, additional
tolerance mechanisms are required peripherally to prevent autoreactivity (35).
Peripheral tolerance
Despite the highly selective nature ofT cell ontogeny, autoreactive T cells escape
the thymus and can be found in the periphery of disease-free individuals (36;37). Most
individuals do not manifest autoimmune disease, however, so mechanisms must exist pe-
ripherally to prevent the aberrant activation of autoreactive cells (35). These mechanisms
are referred to collectively as peripheral tolerance, and failure of peripheral tolerance ap-
pears to contrbute to autoimmunity. Immunologic ignorance is a mechanism of periph-
eral tolerance whereby auto antigens sequestered in immunologically privileged sites (e.
the central nervous system) are "invisible" to circulating T cells (38). Deletion, analogous
to thymic central tolerance, appears also to be a mechanism for peripheral tolerance
(39;40). Anergy, a hyporesponsiveness ofT cells to TCR stimulation (41-43), may be an
additional mechanism of peripheral tolerance, but anergy is curently only an in vitro
phenomenon and has yet to be convincingly demonstrated in vivo (35). A final mecha-
nism of peripheral tolerance may involve the down-regulation of autoreactive T cell re-
sponses by other lymphocytes, termed regulatory cells, which act to deviate an aberrant
immune response away from a destrctive phenotye (35). Multiple lines of study have
demonstrated that manipulation of peripheral tolerance in animal models of autoimmu-
nity modulates disease expression, and such modalities are curently being investigated
for the prevention and/or cure of human autoimmune diseases (35). Peripheral tolerance
mechanisms seem to be particularly relevant at mucosal surfaces and are discussed in
Section 5 of this chapter.
NK T cells
A candidate regulatory cell described recently is the NK T cell that, unlike most
peripheral T cells, also expresses the NK-P1 (CD161 , NK1.1) cell-surface antigen tyi-
cally expressed by NK cells (see below) (44;45). Mouse NK T cells are unique T cells in
that most express a TCR with a highly restrcted Va14-Ja281 variable region that recog-
nizes non-peptide antigens presented by non-classical MHC molecules like CD I (46).
Functionally, NK T cells have gained attention because of their differential secretion of
either IL-4 or IFN-y upon TCR or NK-P1 engagement, respectively (46). IL-4 secretion
is associated with regulatory activity in vivo (31), and NOD mice are deficient in NK T
cells (47;48). NK T cells have also been described in humans (49) and rats (50;51), but
their immunoregulatory role in these instances is unclear.
Overview of peripheral NK cells
Origin and phenotype of NK cells
Natural kiler cells , a component of innate immunity, are large granular lympho-
cytes derived from bone marrow precursors. They are abundant in the peripheral blood
and spleen but are rarely observed in lymph nodes (52). In rats, most peripheral NK cells
express CD2 and CD8 but not TCR or CD3 (51;53;54), thus distinguishing them pheno-
tyically from NK T cells (46). NK cells in the rat express a homodimeric CD8aa (21).
NK cells also express a number of distinct receptor families (e.g. NK-P1 and Ly-49)
that intimately relate to their cytotoxic function (44;45;55).
Function of NK cells in an immune response
NK cells kill virus-infected or neoplastic cells, an activity mediated by mem-
brane-disrupting perf orin molecules, serine proteases, and IFN-y (52;56). Antibody-
mediated cross-linkng of NK-P1 (or NK1.1 in the mouse) trggers phosphoinositide
turnover and arachnidonic acid production in NK cells that induces a rise of intracellular
Ca ++, provides an activation signal, and stimulates natual cytotoxicity (55;57-59). Re-
combinant NK-P1 binds synthetic carbohydrate, although in vivo ligands of NK-
have yet to be identified (55;60;61). A second class ofNK cell receptors, members of the
Ly49 family, binds to class I MHC on potential target cells and (along with so-called kil-
ler inhibitory receptors) provides an inhibitory signal that prevents NK cytotoxicity
(55;62;63). Healthy cells, which theoretically express ligands for both NK-P1 and Ly-
, avoid NK cytotoxicity, whereas virus-infected or neoplastic cells, which have often
down-regulated class I expression, are killed (55).
Function of NK cells in immune regulation
NK cells are traditionally considered a component of tye 1 immunity. A growing
pool of evidence, however, has also suggested that NK cells may act as regulatory cells 
vitro and in vivo (64-71). Mechanisms of NK cell regulation are stil unclear, but they
may involve secretion of inhibitory cytokines like transformation growth factor- (TGF-)
~ (66) or direct kiling of activated T cells or APCs (65).
Chapter I, Section 3 - Immunopathogenesis of Type Diabetes
Multiple lines of study in human subjects and animal models have suggested that
tye 1 DM results from an immune-mediated destrction of insulin-producing pancreatic
beta cells (1;72). Both genetics and environment clearly contrbute to disease immu-
nopathogenesis, a process whereby unkown environmental factors trgger an autoim-
mune destrction of beta cells in genetically susceptible individuals (1). Much of the
mechanism whereby genetics and environment precipitate disease expression remains
poorly characterized. This section of the introduction describes our curent understanding
of the autoimmune pathogenesis of tye 1 DM in humans and reviews genetic and envi-
ronmental factors that may contrbute to disease expression.
.. 
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Type 1 diabetes melltus as an autoimmune disease
Patients with tye 1 diabetes mellitus have a number of immunologic disturbances
suggesting that the pathogenesis of this disease involves an autoimmune process (Table
1) (1). These include the presence of mononuclear insulitis, the detection of islet cell
autoantibodies, an association of tye 1 DM with other autoimmune diseases, and the re-
currence of autoimmunity (memory). In addition, tye 1 DM is associated with human
histocompatibility leukocyte antigen (HLA) genes, and pharacological immunosuppres-
sion is effective in delaying the onset of overt diabetes in high-risk patients (1;4;7).
Insulitis in human type 1 diabetes melltus
In patients with recent-onset tye 1 DM, histologic analysis of pancreatic tissue
demonstrates in the islets a markedly reduced number of insulin-producing beta cells and
a striking mononuclear infitrate (1;73). Many of the infiltrating mononuclear cells are
CD4+ or CD8+ T cells , and similar findings have been observed in pre-diabetic BB rats
and NOD mice (74). Class I MHC is hyperexpressed on beta cells in the lesion (75).
Autoantibodies in human type 1 diabetes melltus
Antibodies specific for islet self-antigens are found in the serum of at least 70% of
patients with newly diagnosed tye 1 DM (76-78). Antigens recognized by these so-
called islet cell antibodies (ICA) include the 65 KDa glutamate decarboxylase (GAD)
(79), the tyosine phosphatase insulinoma-associated antigen-2 (IA-2) (SO), and insulin
itself (81). Although the contrbution of autoantibodies to the pathogenesis of tye 1 DM
TABLE 1
EVIDENCE FOR AUTOIMMUNITY IN TYPE 1 DIABETES MELLITUS
Evidence for autoimmunity
1. HLA associated
2. Preventable by immu-
noprophylaxis
3. Pancreatic insulititis
4. Islet cell antibodies
5. Association with other
autoimmune diseases
6. Recurrence of autoim-
munity
Legend to Table 1: Listed are attbutes of tye 1 diabetes mellitus in humans that suggest
that selective ~ cell destruction results from an autoimmune process.
remains unclear, ICA have been measured in at-risk individuals and used as a diagnostic
predictor for patients most likely to progress to clinical disease (1;72).
Association of human type 1 diabetes melltus with other autoimmune diseases
Type 1 DM is associated with a number of other organ-specific diseases that are
also believed to result from autoimmune disturbances. Approximately 10% of patients
with tye 1 DM have such affictions, which may include thyroiditis, Grave s disease
Addison s disease, or pernicious anemia (82-85). In addition, upwards of 5% of patients
with tye 1 DM exhibit evidence of celiac disease (86), an intestinal disorder character-
ized by hypersensitivity to dietary gluten (87;88).
Recurrence of autoimmunity
Sporadic case reports in humans provide perhaps the most compelling evidence
that tye 1 DM results from immunologic disturbances. There is a recurence of autoim-
munity in patients with tye 1 DM that receive a pancreas transplant from a discordant
monozygotic twin; despite identical MHC loci , donor ~ cells evoke a memory immune
response in the recipient and are selectively destroyed (89). In other cases, patients un-
dergoing bone marrow transplantation (BMT) for a hematopoietic disorder that receive
bone marrow from a donor with tye 1 DM have an increased risk of developing tye 
DM themselves (90).
Genetics and type 1 diabetes melltus
Genetics clearly influence the expression of tye 1 DM in humans. First-degree
relatives of patients with tye 1 DM have a 10-fold greater risk of developing the disease
versus persons with no family history (lifelong risks of -5% and -0.5%, respectively)
(1 ;72). Additional evidence for the role of genetics in disease expression comes from
twin studies , which have shown a disease concordance of 30-50% in monozygotic twins
versus 5% in dizygotic twins (72;91-93). Genetic studies in humans have mapped at least
four genes that confer susceptibilty to tye 1 DM (94). Underscoring the role of the im-
mune system in the pathogenesis of tye 1 DM , the strongest genetic association is in the
HLA locus that encodes for class II MHC molecules (94;95). For example , more than
90% of patients with tye 1 DM carr genes for HLA-DR3 , DQB1 *0201 or -DR4
DQB 1 *0302 (96). Such genotyes are only permissive for disease expression, however
since the majority of people that carr these genes do not develop tye 1 DM (97). Class
II genes that confer protection from tye 1 DM have also been identified (98- 100).
Environment and type 1 diabetes melltus
The fact that the concordance rate for tye 1 DM between monozygotic twins is
less than 100% (72;91-93) strongly suggests that environmental factors also contrbute to
disease expression (1). Indeed, both viruses and diet have been implicated in the patho-
genesis of tye 1 DM in humans (Table 2) (1;101). Epidemiological studies have identi-
fied an association between tye 1 DM and Coxsackie B4, mumps , and rubella viruses
TABLE 2
EVIDENCE FOR ENVIRONMENTAL ROLE IN
PATHOGENESIS OF TYPE 1 DIABETES MELLITUS
Environment and type diabetes
1. Discordance between mono-
zygous twins
2. Most genetically predisposed
individuals do not develop
tye 1 diabetes mellitus
3. Viruses?
4. Diet?
Legend to Table 2: Listed is evidence for the role of environmental factors in the immu-
nopathogenesis of tye 1 diabetes mellitus in humans.
(1; 102- 105), but the importance of viral infection as a precipitating event for disease ex-
pression remains uncertain (106; 1 07).
The role of dietary proteins and toxins in the expression of tye 1 DM has been
debated for many years and remains unclear. Several groups have suggested that dietary
cow s milk, when administered to genetically susceptible infants, is an environmental
risk factor for tye 1 DM (108- 110). The immunogenic component of cow s milk may be
bovine albumin (110), and antibodies to fragments of bovine albumin are found in greater
abundance in the serum of diabetic versus non-diabetic children (109). In contrast to
these findings, however, other studies have found little if any association between dietar
cow s milk proteins and tye 1 DM in humans (111; 112). Of importance to this disserta-
tion, it has recently been established that a correlation exists between tye 1 DM and ce-
liac disease (86), an intestinal disorder characterized by hypersensitivity to dietary gluten
(87;88). In addition, several studies document a relationship between smoked mutton
(which contains high levels ofN-nitroso compounds) and expression of tye I DM (113-
115). Clearly, the question of how environmental factors like viruses and diet contrbute
to the expression of tye 1 DM in humans requires further study.
Chapter I, Section 4 - The SS Rat Model of Type Diabetes
Due to ethical and moral considerations regarding experimentation in humans
animal systems have been used extensively to model human diseases, including tye 
diabetes melltus (7). One well-characterized animal model of human tye 1 DM, the BB
rat, is a major focus of this dissertation. This section 1) presents a general overview of the
BB rat; 2) describes clinical diabetes and immune cell defects in diabetes-prone BB rats;
3) describes diabetes induction in diabetes-resistant BB rats; 4) reviews evidence that
diabetes in BB rats is an autoimmune disease; 5) xplains the potential roles of ART2-
expressing T cells in the pathogenesis of diabetes in BB rats; 6) ilustrates the "Balance
Hypothesis" of diabetes in BB rats; 7) reviews environmental factors that influence dia-
betes expression in BB rats; and 8) summarizes the applicability of BB rats as a model of
human tye 1 DM.
General overview of the BB rat
Originally discovered in 1974 at the BioBreeding Laboratories in Ottawa, Canada
the spontaneously diabetic BB rat has received much attention as one of the few animal
models of human tye 1 diabetes melltus (4). Many subsequent breeding colonies of the
original diabetes prone BB rats have been established, including several inbred colonies
in Worcester, MA (4). Two of these inbred BB rat colonies have been maintained for 
generations and are referred to extensively in this dissertation: BBDP rats, which have
been bred for expression of spontaneous diabetes; and BBDR rats , which were derived
from BBDP forebears but have been bred for resistance to spontaneous diabetes (4). It is
important to note that, due to a combination of genetic drft and environmental variabil-
ity, individual colonies of BB rats have diverged from one another over time, giving rise
to significant genotyic and phenotyic heterogeneity among different colonies of BBDP
or BBDR rats (4).
Diabetes Prone BB rats: A model of spontaneous type 1 diabetes
Clinical characteristics of diabetes in BBDP rats
Greater than 85% of male and female BBDP rats spontaneously develop diabetes
between 55 and 120 days of age (rat adolescence) (4). Diabetes in these rats is similar to
human disease in that there is a period of insulitis , followed rapidly by selective beta cell
destrction, absolute insulin deficiency, hyperglycemia, and ketoacidosis if left untreated
by exogenous insulin (116). A number of environmental pertrbants (discussed below)
influence diabetes expression in BBDP rats.
Peripheral lymphocyte populations in BBDP rats
T eel/lymphopenia in BBDP rats
Unlike humans with tye 1 DM, BBDP rats exhibit a marked T cell lymphopenia
particularly of CD8+ (117) and ART2+ (118) peripheral T cells (116). The lymphopenia
maps to an autosomal recessive locus on chromosome 4 (iddml) (119) and is the result of
decreased thymic export of T cells (120) and increased frequency of intrahepatic T cell
apoptosis (121). The mechanism whereby homozygosity at iddml causes lymphopenia in
BBDP rats is not yet known. Discussed in more detail below, diabetes can be prevented
in BBDP rats via infusion of splenocytes from non-diabetic histocompatible rats provided
that ART2+ T cells engraft (122;123).
NK cells, B cells, and NK T cells in BBDP rats
The relative number and cytotoxicity of splenic NK cells is enhanced in BBDP
rats (53). Although the relative number of B cells is also increased in BBDP rats (124),
humoral immune responses to T cell dependent antigens appear to be defective in these
rats (4). In addition to the peripheral T cell lymphopenia, BBDP rats are also deficient in
splenic and intrahepatic NK T cell populations (51), although the significance of this ob-
servation is not yet known.
Diabetes Resistant SS rats: A model of inducible type 1 diabetes
BBDR rats never develop spontaneous diabetes in a viral antibody free (V AF) fa-
cility (4). Diabetes can be induced in these rats , however, by co-administration of a cy-
totoxic anti-ART2a monoclonal antibody (mAb) plus an immune stimulant like polyino-
sinic-polycytidylic acid (poly I:C) (125). This induction protocol depletes BBDR rats of
AR T2a + T cells and induces diabetes in :;90% of animals after -14 days of treatment
provided the animal is less than 30 days of age prior to initiation of the induction protocol
(4). Other immune stimulants such as Kilham s rat virus (KRV), a rat parvovirus , can
substitute for poly I:C (125;126). Clinically, the diabetes induced in BBDR rats is similar
to that of BBDP rats in that it is characterized by insulitis, selective beta cell destrction
an absolute insulin deficiency, hyperglycemia, and ketoacidosis if left untreated by ex-
ogenous insulin (4).
Diabetes in BB rats as an autoimmune disease
Like human tye 1 DM, numerous lines of evidence suggest that diabetes in both
spontaneously diabetic BBDP and diabetes-induced BBDR rats results from an immuno-
logical distubance, mostly likely an autoimmune disease. Evidence for autoimmunity
listed in Table 1 are equally applicable to BB rats. (4).
Immunoprophylaxis
Immunosuppressive agents such as radiation (4), cyclosporine (4), fusidic acid
(127), tacrolimus (128), and anti-lymphocyte serum (4) prevent spontaneous diabetes in
BBDP rats. Administration of anti-CD8 but not anti-NK-Pl cytotoxic mAbs also pre-
vents spontaneous diabetes in BBDP rats, presumably by deleting effector cells (4; 129).
HLA association
All diabetes-prone BB rats share the class II RTl rat MHC (4), which co-
localizes with the iddm2 diabetes-susceptibility gene to chromosome 20 of the rat
(4;116). Other RT1 -expressing rat strains , such as RTl PVG and RTl LEW.WRI rats
are also susceptible to diabetes induction (130; 131). R T 1 u is only permissive and not re-
quired for diabetes expression, however, as RTI U Wistar Furth (WF) rats never get dia-
betes (130; 131), and R TI PVG rats can be induced to become diabetic via a thymectomy
and irradiation protocol (132;133).
Insulitis
Insulitis resembling that of human tye 1 DM is present in newly diabetic BBDP
and BBDR rats (4;116;134). This lesion is characterized by mononuclear infiltrates of
CD4+ and CD8+ T cells , macrophages (135), NK cells, dendrtic cells (136), and B cells
(4). Cells infitrating the islet express messenger ribonucleic acid (mRA) for inflam-
matory cytokines such as tumor necrosis factor- (TN-) a, IL- , and IL-6 (137), and
mRA for Th1-associated cytokines like IFN-y and IL-12 (p40 chain) are also detected
in acutely inflamed islets (138). Hyperexpression of class I MHC (139) but not class II
MHC (140) also occurs on beta cells in diabetic BB rats.
Autoantibodies
Antibodies reactive against lymphocytes, gastrc parietal cells, smooth muscle
and thyroid colloid have been detected in the serum of BBDP rats (4). In contrast, the is-
let cell antibodies, including those specific for GAD (141), IA-2 (142;143), and insulin
(144), have not been convincingly documented in diabetic BBDP rats. The lack oflCA in
diabetic BBDP rats may reflect an impaired humoral response to T cell dependent anti-
gens (4).
Association with other autoimmune diseases
Both BBDP and diabetes-induced BBDR rats also show histologic evidence of
autoimmune thyroiditis (122;145) and sialadenitis (4). Thyroiditis in these animals is
similar to diabetes in that it can be prevented in BBDP rats by infusion of histocompat-
ible lymphocytes (122) and induced in BBDR rats (125).
Recurrence of autoimmunity
Both BBDP and BBDR rats harbor autoreactive T cells as shown using a number
of adoptive transfer models (4). Splenocytes isolated from spontaneously diabetic BBDP
rats can adoptively transfer diabetes to non-diabetic rats (146). Lymphocytes from dia-
betes-induced BBDR rats can likewise transfer diabetes to athymic recipients (147;148).
Adoptive transfer of thymocytes from BBDR rats also induces diabetes in athymic rats
but only if recipient rats are depleted of ART2+ T cells and administered poly I:C (4).
These findings suggest the presence of a defect in thymic selection in BB rats that allows
for the production of autoreactive T cells (4).
ART2: Surface protein expressed by regulatory cells in rats
Genetics and expression of ART2
First identified in the early 1970s, ART2 is expressed as a GPI-linked protein on
the surface of most mature, resting peripheral T cells in the rat. At least two ART2 alleles
(ART2 and ART2 ) that encode for ART2a and ART2b proteins, respectively, have been
reported in the rat (4). BB rats carr the ART2 allele, but BBDP rats are paricularly de-
ficient in peripheral ART2a+ T cells. Other lymphocyte populations in addition to resting
peripheral T cells also express ART2. Peripheral NK cells and activated T cells express
AR T2 , but only at very low levels, and IELs express -10 times more AR T2 than periph-
eral T cells (149;150). The significance ofthese observations is not yet known.
Adoptive transfer of ART2+ T cells protects BB rats from diabetes
Evidence for the existence of a regulatory population of lymphocytes that prevent
diabetes in BB rats has been shown in numerous adoptive transfer experiments
(122;123;146;148;151). Diabetes can be prevented in BBDP rats by administration of
ART2+ CD4+ T cells from non-diabetic histocompatible rats (116;122). In addition, the
diabetes induced in athymic rats that receive T lymphocytes from diabetes-induced
BBDR rats is prevented by co-administration of ART2+ T cells (148). T cells with an
ART2+ CD4+ phenotye have also been implicated as regulatory cells in another model
of autoimmune diabetes whereby diabetes is induced in PVG-RT1 U rats via thymectomy
and irradiation (133).
Mechanisms of regulation by ART2+ T cells
Several possible mechanisms may explain how AR T2+ T cells prevent diabetes in
BB rats (4). First, ART2 may simply be a marker of a regulatory T cell population that
acts to deviate the immune response away from a pro-destrctive inflammatory pheno-
tye , perhaps through differential expression of regulatory cytokines (31; 152). Second
the cell-signaling properties of ART2 (153) may allow ART2+ T cells to acquire regula-
tory activity. Third, the ability of ART2 to metabolize nicotinamide adenine dinucleotide
(154) may have immunoregulatory roles or allow ART2+ T cells to acquire regulatory
activity.
The "Balance Hypothesis" of autoimmunity in BB rats
The observation that both autoreactive and regulatory T cell populations can be
found in BB rats has led to the "Balance Hypothesis" that diabetes expression in BB rats
depends on a balance that exists between ARTT autoreactive T cells and ART2+ regula-
tory T cells (Figure 3) (4;155). In unmanipulated BBDR rats and in BBDP rats that have
received infusion of ART2+ regulatory T cells, a proper balance exists between regula-
tory and autoreactive T cells; diabetes is avoided (4). In contrast, spontaneously diabetic
BBDP rats and diabetes-induced BBDR rats are deficient in ART2+ regulatory T cells
secondar to iddml or ART2-depletion, respectively; the balance is tipped in favor of
autoreactive T cells and diabetes expression (4). It should be noted that, in BBDR rats
depletion of ART2+ T cells alone is insuffcient to induce diabetes (116;156), as some
sort of immune stimulation (poly I:C, KRV, etc.) is necessary for disease expression.
Whether a similar stimulation of the immune system is necessary for spontaneous diabe-
tes in BBDP rats is unown, however, as even gnotobiotic BBDP rats spontaneously
develop diabetes (157).
Environmental factors and diabetes expression in BB rats
Environmental factors clearly influence the expression of autoimmune diabetes in
BB rats. In BBDP rats, only -90% of animals ever become spontaneously diabetic
(-:100% disease concordance). Diabetes is modified in BB rats by cytokine-directed ther-
apy, viruses , and diet.
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Figure 3: Balance hypothesis of autoimmune diabetes in BB rats. Our laboratory has
proposed a teeter-totter model to ilustrate the balance that exists in BB rats between
ART2- autoreactive cells and ART2+ regulatory cells. In unmanipulated BBDR rats (up-
per- left) and in BBDP rats that have received infusions of ART2+ regulatory T cells (up-
per-right), a proper balance exists between regulatory and autoreactive T cells; ~ cell
mass (yellow) is preserved and diabetes is avoided. In contrast, spontaneously diabetic
BBDP rats (lower-right) and diabetes-induced BBDR rats (lower- left) are deficient in
ART2+ regulatory T cells secondary to iddml or ART2-depletion, respectively; the bal-
ance is tipped in favor of activated autoreactive T cells, ~ cell destrction, and diabetes
expressIOn.
Cytokine-directed therapy
Current dogma states that autoimmune diabetes results from an overactive Th 
immune response to beta cell antigens, and restoration of the ThllTh2 equilibrium pre-
vents diabetes (32;33). Data for this paradigm comes mostly from NOD mice, however
and is not necessarily applicable to BB rats. Administration of antibody specific for IFN-
y prevents or delays spontaneous diabetes in BBDP rats (158), but so does treatment with
recombinant IFN-y (159;160). Spontaneous diabetes in BBDP rats is also prevented or
delayed by recombinant TN-a (161) and IFN-a (162), but not IL-2 (163).
Viruses
As mentioned previously, viral infection with KRV induces diabetes in BBDR
rats (125;126), particularly when combined with depletion of ART2+ T cells (125;164).
KRV does not accelerate diabetes expression in BBDP rats (126), and lymphocytic cho-
riomeningitis virus actually prevents spontaneous diabetes in these animals (165). Poly
I:C , a synthetic double-stranded polyrbonucleotide that mimics viral ribonucleic acid (4)
induces diabetes in BBDR rats when used at high doses (10 g/g) alone (166) or at low
doses (5 g/g) in conjunction with ART2 T cell-depletion (125). In BBDP rats, spontane-
ous diabetes is accelerated by high doses of poly I:C (167;168) but actually prevented by
low doses of poly I:C (169).
Diet
Modification of dietary protein sources is associated with changes in spontaneous
diabetes in BBDP but not BBDR rats (4; 170). Diets in which proteins sources are com-
prised strctly of elemental I-amino acids, casein, or hydrolyzed casein are diabetes-
protective in BBDP rats (170- 174), and dietar wheat gluten or soy meal abrogate this
effect (170; 175). In diabetes-induced BBDR rats, however, diets of hydrolyzed casein do
not decrease disease incidence (172).
The effect of dietary cow s milk protein (bovine albumin) on diabetes expression
in BBDP rats is stil debated (4). Although some investigators have found variably-
diabetogenic effects of dietary cow s milk in BBDP rats (170), the elimination of dietary
cow s milk does not protect BBDP rats from spontaneous diabetes (172).
The mechanism whereby diabetogenic diets influence diabetes expreSSIOn II
BBDP rats may involve 1) changes in the beta cell itself and 2) deviation of the cytokine
profie of autoreactive cells (170). Neither the up-regulation of class I by beta cells nor
the dominance of IFN-y in the acutely inflamed islet are observed in BBDP rats fed a
diabetes-protective hydrolyzed casein diet (176; 177).
Changes in dietary carbohydrate or fat sources do not normally modify the inci-
dence of spontaneous diabetes in BBDP rats (170). An exception to this is the low essen-
tial fatt acids (LEF A) diet, which is diabetes-protective (178). The mechanism of pro-
tection for the LEFA diet may involve decreased macrophage migration and fuction (4).
It has also been claimed in a single study that oral nicotinamide delayed and prevented
spontaneous diabetes in BBDP rats, but this observation has yet to be confirmed (179).
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BB rats as a model of type 1 diabetes melltus
The pathogenesis of autoimmune diabetes in BB rats resembles that of human
tye 1 DM in that both diseases are associated with insulitis, immune-mediated destrc-
tion of beta cell , absolute insulin deficiency, and hyperglycemia. Both diseases are also
associated with MHC genes, autoantibodies, bone marrow-derived cells, and other
autoimmune disorders. Additionally, environmental factors like infection and diet that
clearly influence diabetes in BB rats may also contrbute to the expression of tye 1 
in humans. Limitations of using the inbred BB rat as a model of human tye 1 DM are
apparent when one is reminded of the lymphopenia of BBDP rats and the genetic hetero-
geneity of human beings. These similarities and differences between rat and human
autoimmune diabetes must therefore be considered whenever the BB rat is used to model
human tye I DM (7).
Chapter I, Section 5 - The Intestine as an Immune Organ
An introduction to the intestinal immune system is necessary in order to address
the role that environmental trggers may play in the immunopathogenesis of diabetes in
BB rats. The intestinal immune system is considered distinct from the peripheral immune
system; much of the dogma surrounding peripheral lymphocytes is inapplicable to intes-
tinal lymphocytes, which are constantly confronted with foreign antigens from sources
that are not tyically pathogenic (e.g. the diet and commensal flora). This section of the
introduction 1) reviews the strctue/fuction relationships in the intestine, 2) addresses
barrer fuction of the intestinal epithelium, 3) describes the different compartents of
the gut-associated lymphoid tissue, particularly intrepithelial lymphocytes, and 4) de-
fines curent concepts of mucosal tolerance, the state whereby intestinal lymphocytes re-
main tolerant to foreign antigens from sources that are not tyically pathogenic.
Anatomy of the small intestine: A structure/function relationship
The gastrointestinal tract is a collection of organs primarily concerned with the
digestion and absorption of dietary nutrents. One of these organs , the small intestine has
evolved anatomically from a relatively simple tube in primitive organisms into a highly
sophisticated tube in mammals. The terms "outer" or "superfcial" refer to lumenal as-
pects of the intestine, and this nomenclatue wil be used here.
From superfcial to deep, the small intestine is divided histologically into four
layers: the mucosa, the submucosa, the muscularis, and the adventitia. The mucosa
which consists of many fingerlike projections called villi, is further subdivided into
epithelial and lamina propria layers (Figure 4). The epithelium, which lines the entire lu-
menal surace of the small intestine, is primarily responsible for nutrent absorption and 
just a single cell-layer thick. It is separated from the lamina propria by a basement mem-
brane composed mostly of tye IV collagen, laminin (a glycoprotein), and heparin sulfate
(a proteoglycan) (180).
Barrier function of intestinal epithelial cells
The primary fuction of intestinal epithelial cells (IECs) is nutrent absorption
but IECs also subserve several fuctions in the intestinal immune system. First, the epi-
thelium presents a physical barrer to potential pathogens. The apical surace of IECs is
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Figure 4: Histology of intestine. Shown is a hematoxylin- and eosin-stained section of
paraffin-embedded rat small intestine (lOx), with lumenal aspect labeled. From superf-
cial to deep, the small intestine is divided into four layers: the mucosa, the submucosa
(difcult to visualize in this section), the musculars, and the adventitia (not visible in this
section). The mucosa is fuher divided into epithelial and lamina propria layers that are
separated by a basement membrane (represented schematically by a black curve). Also
indicated is a Peyer s patch.
coated with a mucus layer that, besides acting as a physical barrier to microorganisms
contains secreted IgA immunoglobulins (discussed below) and lytic enzymes like defen-
sins (181). Any microorganism successfully penetrating the mucus layer is then con-
fronted with the epithelial surface itself, a continuous sheet of epithelial cells firmly ad-
hered to one another by ' tight junctions. When intact , these tight junctions prevent the
paracellular transit of lumenal material and force gut antigens to be endocytosed and bro-
ken down in a transcellular fashion (Figure 5). To cross the epithelium , pathogenic agents
must either 1) break down the integrty of these tight junctions or 2) bind to and penetrate
the IEC itself. Epithelial permeability is increased by cytokines like TNF-a, IFN-y, and
IL-4 (182- 184), and chronically increased epithelial permeability (due to leaky tight
junctions) is a hallmark of inflammatory bowel disease (185), celiac disease (88), and
food allergy (181).
Gut-associated lymphoid tissue
Mucosal vili greatly increase the surface area for absorption in the small intes-
tine. Such an advantage comes at significant risk, however, as many microorganisms seek
to exploit the intestinal mucosa as a means of invading a host. An additional complication
is the presence in the intestine of many non-pathogenic yet foreign antigens derived from
dietary sources or commensal bacteria. Not surprisingly, a specialized intestinal immune
system has evolved to provide a first line of defense against infectious agents yet main-
tain tolerance to antigens from typically non-pathogenic sources. Although poorly under-
stood, by no means is the intestinal immune system insignificant; it is estimated that up-

Figure 5: Traffcking of lumenal antigens across the intestinal epithelium. Maintenance
of epithelial integrty is critical to normal absorptive and immune fuction of intestinal
epithelial cells (IECs). When intact, tight junctions (shown schematically as white bulges
in epithelial cell membrane) prevent the paracellular transit of lumenal material (right)
and force gut antigens to be endocytosed and broken down in a transcellular fashion
(left). Chronically increased epithelial permeability (due to leak tight junctions) is a
hallmark of inflammatory bowel disease, celiac disease , and intestinal hypersensitivity.
wards of 10 lymphocytes inhabit the gut, more than any other organ (185). Based on
location, intestinal lymphocytes are classified as Peyer s patch lymphocytes , lamina pro-
pria lymphocytes , and intraepitheliallymphocytes.
Peyer s patches: Inductive sites for mucosal immunity and tolerance
Peyer s patches (PP), discretely organized lymphoid follicles scattered throughout
the length of the small intestine, are a major inductive site in the GALT for both active
mucosal immune responses and mucosal tolerance (185; 186). Cellular components of
PPs include M cells, macrophages, dendrtic cells, and PPLs, which are comprised mostly
of naive Band CD4+ T cells (187;188). M cells are specialized epithelial cells that blan-
ket the lumenal surface of PPs and sample gut material, especially particulate antigens
(185; 189). M cells transport such material basolaterally where it is taken up by PP
macrophages that then migrate into the lymphocyte-rich zones of the Peyer s patch and
present antigen to local T cells (190).
In the Peyer s patch, activated CD4+ T cells differentiate into TGF-~ secreting
helper cells (Th3 cells) that promote IgA class switching by PP B cells (191- 193). Acti-
vated PPLs also upregulate expression of a4~7, an integrn that directs homing of cells to
the lamina propria (194;195). Lymphocytes activated in this maner leave the Peyer
patch, pass through draining (mesenteric) lymph nodes and the thoracic duct, enter the
circulation, and eventually seed the lamina propria along the length of the GALT
(185;196). The role of Peyer s patches, IgA, and Th3 cells in mucosal tolerance is ad-
dressed later in this chapter.
Effector lymphocytes and dendritic cells of the lamina propria
The lamina propria (LP), which lies just below the basement membrane along the
entire GALT, is believed to act primarily as an effector site for normal intestinal immune
responses to gut pathogens (185;186). Intestinal LPLs include both Band T cells, the
majority of which are differentiated effector cells that have an activated phenotye and
express the a4~7 integrn associated with mucosal surfaces (185;197). Dendrtic cells
also exist in the lamina propria and appear to participate in both mucosal immunity and
tolerance (198).
Lamina propria B cells and IgA production
Of the B cells present in the LP many exist as IgA-secreting plasma cells
(185;188). IgA is the predominant antibody tye secreted at mucosal surfaces (185;188).
In secretions , IgA exists as an immunoglobulin dimer coupled by a protein called J chain
and surrounded by a glycoprotein called secretory component. By binding to specific re-
ceptors on the basolateral surface of intestinal epithelial cells, secretory component al-
lows IgA to be transported across the intestinal epithelium in a retrograde fashion and
secreted into the intestinal lumen. Within the lumen, IgA effectively occupies the docking
sites of many microorganisms, thus preventing them from binding to and penetrating the
epithleium.
Lamina propria regulatory cells
Recent reports suggest that lamina propria T cells that secrete primarily IL-
may function as regulators of intestinal immune responses and mucosal tolerance (199).
Mice genetically deficient in IL- lO lack these so-called T regulatory (Tr) I cells and ex-
hibit marked inflammatory bowel disease (199;200) that likely represents an overactive
immune response to gut antigens from tyically non-pathogenic sources (199;201).
Likewise, Trl clones have been shown to be immunosuppressive in vitro (202).
Lamina propria dendritic cells
The lamina propria harbors numerous DCs poised to receive antigens that traverse
the epithelium (181;203;204), but the fuction of these DCs remains debated. Intravenous
administration of LPS to mice mobilizes dendrtic cells from the intestine to mesenteric
lymph nodes (205), where they can activate peripheral T cells (206). Activated mucosal
lymphocytes acquire an effector phenotye, home to the lamina propria, and initiate ac-
tive intestinal immune responses (186). In apparent contrast to these studies, however
lamina propria DCs are associated with regulatory immune responses in the intestine
(207), and expansion of dendrtic cells with Flt3 ligand actually enhances the induction of
oral tolerance (198).
Intraepitheliallymphocytes
The presence of lymphocytes in the intestinal epithelium has been recognized for
over a centu (208), but the origins and fuctions of this unique GALT population are
stil under intense investigation (15;209). Intraepitheliallymphocytes are mostly granular
lymphocytes, have a distinct phenotye as compared to peripheral lymphocytes , include
thymus-dependent and thymus-independent T cell populations , and exhibit both tradi-
tional and novel lymphocyte functions.
Morphology of intraepitheliallymphocytes
The majority of IELs are granular lymphocytes (210-212), suggesting that IELs
are effector cells (209). Granules in IELs contain perf orin and granes but not hista-
mine (209;212). Accordingly, IELs exhibit various cytotoxic activities (discussed below)
(209).
Phenotype of intraepitheliallymphocytes
Preponderance of YO T cells in the IEL compartent. In humans , rats, and mice
lymphocytes of the intraepithelial compartent differ phenotyically from those of the
periphery. Most IELs are T cells, and cells expressing yoTCR are much more frequent in
IELs than in peripheral lymphocyte populations (15; 18;209). In rats, the percentage of
IELs expressing yoTCR has been reported to be 5-20% (213-216), and greater relative
numbers of yO T cells in the IEL are associated with young rats and rats housed under
germ-free conditions (217;218).
Non-conventional CD8 and CD4 ex ression b IELs. The majority of IELs are
CD8+ and, unlike peripheral CD8+ T cells, express a homodimeric form of CDS (CD8aa)
(21). In rats , the majority ofyoTCR+ IELs express CD8aa (21). CD4+ T cells are present
in the IEL at lower frequencies than in the periphery, and a percentage of CD4+ cells co-
express CD8aa (21). Greater relative numbers ofCD4+ T cells in the IEL are associated
with older rats and conventional housing (217).
Other cell surface markers ex ressed b IELs. Intraepithelial and peripheral lym-
phocytes differ with respect to a number of other cell surface antigens. Most IELs are
CDT (213), and CDS and CD28 tend to be expressed only on CD4+ or CD8a~+ IEL sub-
populations (217;219). Supporting the hypothesis that IELs represent an effector lympho-
cyte population, many IELs display markers tyically associated with activated and
memory T cells (209). In addition, the vast majority of IELs express a novel integrn
(ae~7) that is associated with epithelial lymphocytes (220;221). Expression of ae~7 may
account for the observation that adoptively transferred IELs tend to home back to the in-
testinal epithelium (222;223), and mice genetically deficient in ae (CD103) have a re-
duction in the number ofIELs but not peripheral lymphocytes (224).
Non- T cells in the IEL compartent. Besides T cells , the IEL compartent is also
comprised ofNK. The cell surface molecules NK-P1 and asialo GM1 are expressed by
a subpopulation of IELs (54;225;226), and IELs kil NK-sensitive targets (227-229). B
cells are not detected in the IEL compartment, and the presence of B cells in isolated
populations ofIELs is indicative of contamination by LPLs or PPLs (16).
Ontogeny of intraepitheliallymphocytes
mus- endent versus th us-inde endent intrae ithelial Ivrphoc es. Al-
though many IELs clearly arise in a thymus-dependent fashion, many lines of evidence
suggest that some IEL subpopulations arise in a thymus-independent fashion (230;231).
Neonatally thymectomy prevents the development of peripheral T cells but does not pre-
vent the generation oflELs (232). IELs also develop in athymic mice and rats (233;234).
In irradiated thymectomized mice given hematopoietic stem cells, peripheral T cell
populations of donor origin are absent, whereas CDSaa + IEL populations of donor origin
are detectable (235;236). Collections of lymphocytes found at epithelial cryts (so-called
crytopatches) may represent a location of extrathymic IEL ontogeny (237). Although no
cell surace marker yet differentiates between thymus-dependent and thymus-independent
- IELs, CD4- CD8aa+ IELs are most consistently of thymus-independent ontogeny (209).
Growth factors for intraepithelial lymphocytes. Several growth factors influence
the ontogeny of IELs. Interleukn- , which plays a major role in peripheral lymphocyte
development, stimulates the growth and proliferation of IELs (238;239). Stem cell factor
(SCF), critical for the development of hematopoietic cells and melanocytes, also influ-
ences IEL ontogeny (209). SCF-deficient mice are selectively deficient in yoTCR+ IELs
and have expanded numbers ofCD8+ CD4+ IELs (240;241).
Selection processes in the intestinal epithelium. The thymus-independent ontog-
eny of some IEL subpopulations poses the possibility that these cells may harbor autore-
active lymphocytes that escape negative selection (186;209;230). Indeed, autoreactive
cells are found in the intraepithelial but not peripheral lymphocyte comparent of mice
expressing a transgenic TCR specific for autoantigens (15;209;242-244). Supporting the
argument that thymus-independent IELs are not subject to the same selection processes as
thymus-dependent IELs is the observation that ~2-microglobulin- (~2m-) deficient mice
which are unable to assemble a functional MHC class I for thymic selection of CD8+ T
cells , have normal numbers of yoTCR+ but not a~TCR+ IELs (245). Non-classical anti-
gens recognized by yo T cells include mycobacterial glycoproteins , non-peptide phos-
phates, and the stress-related proteins MIC-A and MIC-B (8;246;247).
Function of intra epithelial lymphocytes
Cytotoxic activity of intraepitheliallymuhocytes . Intraepitheliallymphocytes dis-
play several cytotoxic activities in vitro. Antigen-independent mechanisms of cytotoxic-
ity include natural kiler activity (227-229) and redirected cytotoxicity (248). Antigen-
specific CTL activity by IELs against alloantigen (249) and virus-infected targets (250-
252) has also been demonstrated.
Cytokine secretion by intraeuitheliallymuhocvtes . Reflecting their activated state
mouse intraepithelial T lymphocytes spontaneously secrete cytokines including IFN-
(Thl-tye) and IL-5 (Th2-tye) (253;254). Stimulation of their TCR shifts this profie to
a predominantly Th1-tye profie (255). The significance of these cytokine activities re-
main unown, but it has been suggested that IELs modulate local immune responses
through the differential secretion ofThl or Th2 cytokines (15).
Activation athwa s of intrae ithelial lymphoc es. Due to their location, intra-
epithelial lymphocytes lay directly juxtaposed to enteric antigens , which may account for
their activated phenotye (223). Surprisingly, however, IELs exhibit impaired IL-2 pro-
duction and proliferation to traditional TCR stimuli such as anti-CD3 mAb , Concanavalin
, or phorbol ester plus calcium ionophore (223;256-259). Anti-CD2 and sheep eryhro-
cytes stimulate IL-2 production by human IELs (260), but rat IELs are mostly CDT
(213). In addition, although IELs are present in mice expressing an autoantigen-specific
transgenic TCR, there is no histologic evidence of intestinal pathology in these mice sug-
gesting that IELs are tolerized to self-antigen (15; 186;209;244).
Interaction of intraepitheliallymphocvtes and epithelial cells . Intraepitheliallym-
phocytes are surounded by intestinal epithelial cells, and it is generally accepted that
these two populations interact (19;185;209;261;262). As already mentioned, IELs are ca-
pable of IFN-y secretion, and this cytokine increases epithelial permeability and up-
regulates IEC expression of class I and class II MHC molecules (182;183;263). Commu-
nication is bi-directional , as intestinal epithelial cells express IL- 7 and SCF , two growth
factors that influence IEL ontogeny (262). Recent experiments have shown that yoTCR
IELs recognize stress-related proteins expressed by IECs and may support epithelial in-
tegrty through the expression of keratinocyte growth factor (KGF) following epithelial
damage (247;264;265). Indeed, mice genetically lacking yo T cells exhibit increased
epithelial permeability (265).
Intraepitheliallvmphocvtes and mucosal immunity. Although most IEL functions
reviewed to this point describe in vitro activities, several in vivo observations strongly
support the hypothesis that IELs participate in active intestinal immune responses. Intra-
epithelial lymphocytes, although present, are drastically reduced in number in germ free
animals (266) and increased in parasitized mice (267). Adoptive transfer of IELs from
Toxoplasma infected mice protects recipients from disease (268-270). Additionally, vi-
rus-specific T cells have been shown to migrate into the IEL comparment following ac-
tive viral infection (271-274).
Conclusions regarding intraepitheliallymphocytes
Intraepithelial lymphocytes represent a unique and intrguing lymphocyte com-
partent for several reasons. Unlike peripheral lymphocytes, their physical location in
the intestinal epithelium constitutively places them in direct or near-direct contact with
foreign antigen. In addition, the preponderance of yoTCR + and CD8aa + cells that may
respond to alternative antigen presentation and TCR stimuli differentiate them from pe-
ripherallymphocytes. Finally, their fuction remains poorly characterized in par due to
the fact that IELs have been notoriously diffcult to isolate for in vitro analyses (275).
Chronic physiologic inflammation in the intestine
As already suggested, the intestinal mucosa is unique histologically because of the
presence of large numbers of lymphocytes that appear activated phenotyically and mor-
phologically in absence of overt pathology (185;276). Such an observation has led to the
concept that a state of chronic yet "physiologic" inflammation exists in the intestine
(185). Physiologic inflammation is not seen in germ free animals but rapidly ensues fol-
lowing microbial colonization of the intestine (277). In addition, active infection and in-
flammatory bowel diseases are associated with exacerbations of intestinal inflammation
( 185).
Mucosal tolerance
The vast number of lymphocytes and the huge antigenic load in the gut demands
that intestinal lymphocyte populations have a heightened level of tolerance to foreign an-
tigens from sources that are not tyically pathogenic (e.g. diet and commensal flora)
(181; 185). Termed mucosal tolerance, this variation of peripheral tolerance has been the
subject of much investigation and appears to involve at least two inductive and three ef-
fector mechanisms (Figure 6). Disruption of mucosal tolerance is most likely responsible
for a number of intestinal disorders including inflammatory bowel diseases (201) and ce-
liac disease (87;88).
Inductive mechanisms of mucosal tolerance
Inductive mechanisms of mucosal tolerance include antigen uptake and process-
ing by M cells of the Peyer s patch and intestinal epithelial cells. Whether lumenal anti-
gens in question are of particulate or soluble form may dictate the induction mechanism
used. Particulate antigens tend to be processed by Peyer s patch M cells , and soluble an-
tigens tend to be processed by intestinal epithelial cells (278;279).
Effector mechanisms of mucosal tolerance
Regulatory and/or suppressive mechanisms are believed to maintain mucosal tol-
erance. Two effector mechanisms are responsible for mucosal tolerance of particulate an-
tigens sampled by Peyer s patches. First, secretory IgA that is synthesized by lamina pro-
pria plasma cells effectively adheres to and occupies the docking sites of many microor-
ganisms and toxins, thus preventing them from binding to and penetrating the epithelium
(187;188). Second, antigen processed by Peyer s patch lymphocytes generates local and
systemic CD4+ T cell populations that predominately secrete the immunoregulatory cyto-
kines TGF-~ (Th3 cells) or IL- lO (Trl cells) (199;280). These effector mechanisms ap-

Figure 6: Mechanisms of mucosal tolerance. Mucosal tolerance appears to involve at
least two inductive and three effector mechanisms. Inductive mechanisms include antigen
uptake and processing by M cells of the Peyer s patch (step 1) or intestinal epithelial cells
(step 2). Particulate antigens tend to be processed by Peyer s patch M cells , and soluble
antigens tend to be processed by intestinal epithelial cells. Two effector mechanisms are
responsible for mucosal tolerance to pariculate antigens sampled by Peyer s patches.
First, B cells activated in the Peyer s patch (maroon) isotye switch to IgA, migrate to
draining mesenteric lymph nodes (MLN), and differentiate into IgA secreting plasma
cells (step 3). Second, T cells activated in the Peyer s patch (geen) migrate to draining
MLN and differentiate into TGF-~-secreting Th3 cells or IL- 10-secreting Trl cells that
operate as regulatory cells either locally (in the mucosa) or systemically. A third effector
mechanism may be responsible for mucosal tolerance to soluble gut antigens processed
by intestinal epithelial cells. Transcellular antigen processing by intestinal epithelial cells
generates CD8+ T cells with immunosuppressive activity (tan), although their mechanism
of action is currently unkown (step 5).
pear to contrbute to oral tolerance, a specialized featue of mucosal tolerance (discussed
below) (278;279).
An additional effector mechanism of mucosal tolerance is initiated by transcellu-
lar traffcking of lumenal antigens by intestinal epithelial cells. These antigens are proc-
essed and presented on CD 1 , which promotes the generation of CD8 regula-
tory/suppressor cells in the intestinal mucosa (185;261;281). The relative contrbution 
this mechanism to oral tolerance is unkown
, but oral tolerance is inducible in JlMT mice
that have a genetically engineered disruption of the transmembrane region of the IgM
heavy chain and therefore lack B cells, M cells , and Peyer s patches (282).
Oral tolerance
Originally described by Wells in 1911 (283), oral tolerance is the phenomenon
whereby oral administration of an antigen induces a state of antigen-specific non-
responsiveness by systemic lymphocytes (278-280;284;285). Mechanisms of oral toler-
ance depend on antigen dose: high dose oral antigen induces clonal deletion or anergy of
antigen-specific lymphocytes , whereas low dose oral antigen generates regulatory Th
Th3 , or Tr11ymphocytes locally and systemically (280;285).
Oral administration of candidate autoantigens prevents autoimmunity in several
animal models. Oral myelin basic protein decreases exacerbations of induced EAE in
mice (280) and rats (286). Oral administration of tye II collagen inhibits the develop-
ment of collagen-induced artis in mice (287). Oral insulin, which protects NOD mice
from diabetes (288), fails to prevent (289) and may even exacerbate (290) spontaneous
diabetes in BBDP rats. Oral tolerance has been investigated as a potential therapeutic
modality for autoimmune disorders including tye 1 DM (278-280;284;285;291). Curent
attempts by researchers to prevent autoimmunity in human subjects by oral administra-
tion of candidate autoantigens have been largely unsuccessful, however, underscoring the
necessity for a greater understanding of the mechanisms of oral tolerance (278).
Intraepitheliallymphocytes and mucosal tolerance
The role of IELs in mucosal tolerance is unclear (185). In addition to their hypo-
responsiveness following TCR stimulation and their expression of immunomodulatory
cytokines (15;209), IELs also exhibit suppressive activity in vitro (214;292). Paradoxi-
cally, adoptive transfer oflELs has been shown to abrogate oral tolerance (293).
Chapter I, Section 6 - Objectives, Aims, Rationale, and Results
Overall objective of this dissertation
Type 1 diabetes mellitus is a devastating disease that often afflicts children and is
associated with significant morbidity and shortened lifespan. Historically, insulin injec-
tions have been the only therapeutic modality available for individuals with tye 1 DM
but islet cell transplantation is becoming an increasingly viable alternative. Significant
obstacles to transplantation stil remain, however, so other lines of investigation have
sought to decrease the incidence of tye 1 DM through preventative measures. Although
curent attempts at preventing tye 1 DM in humans have yet to be clinically effcacious
animal models of tye 1 DM have provided us a greater insight into disease pathogenesis
that one day may allow for successful disease prevention.
There is clearly a major role for the immune system in the pathogenesis of tye 1
DM in humans and animal models. Both genetics and environment contrbute to initiation
of disease, but much remains unkown regarding these earliest events that trgger the
autoimmune disease process. One major lymphoid organ, the intestine , constantly en-
counters environmental antigens , some of which influence expression of autoimmunity in
animal models. Intestinal intraepitheliallymphocytes are among the first cells of the im-
mune system that encounter potential environmental trggers of autoimmunity. The over-
all objective of this dissertation is to investigate whether defects in IEL number or func-
tion may contribute to the expression of autoimmunity in the BB rat model of type dia-
betes melltus. Four specific aims address this objective.
Specific aim #1 (Chapter II): Improve the methodology for isolation of rat
intraepitheliallymphocytes
Rationale and objectives for Aim #1
It is estimated that upwards of 100 x 10 intraepithelial lymphocytes inhabit the
rat small intestine. Despite these numbers, curent methodologies allow for the isolation
of only 5 - 15 x 10 IELs per rat, and IEL preparations are often contaminated with sig-
nificant numbers of intestinal epithelial cells. In addition, IEL yields generated by these
methodologies tend to be inconsistent between similar animals , and the isolation proce-
dure itself is quite time intensive. Moreover, some procedures utilize chemicals like eth-
ylenediaminetetraaceticacid (EDTA) or enzes like collagenase for the isolation of
IELs , and the affect of these pertbants on IEL phenotye or fuction is unown. I first
sought to develop an efficient new technique for the rapid isolation of large numbers of
highly purified rat IELs.
Summary of results for Aim #1
The technique is based in par on the susceptibility of intestinal epithelial cells to
hypoxic conditions that leave the basement membrane relatively undisturbed. The
sloughed epithelium carres with it the IELs , effectively dissecting away the lamina pro-
pria and Peyer s patches. Using this methodology, upwards of 50 milion IELs are recov-
erable. These cells are of very high purty (::97%) and contain 5 major subsets, including
populations of yo T and NK cells at levels much higher than previously described.
Specific aim #2 (Chapter II): Determine phenotype and function of intraepi-
thelial natural kiler cells
Rationale and objectives for Aim #2
Experiments conducted for Aim #1 identified a population of NK-PlA+ CDT
intraepithelial natural killer (IENK) cells. Peripheral natural kiler cells function in innate
immunity and may have additional regulatory functions. The presence of a potential im-
munoregulatory population at the intestinal epithelium, site of first contact between envi-
ronmental antigens and the immune system, prompted me to study further the phenotye
and function of these IENK cells.
Summary of results for Aim #2
Using the new and improved protocol for the isolation of rat intraepithelial lym-
phocytes, I now report the phenotyic and functional characteristics of these IENK cells.
The data suggest that the rat IEL compartent harbors a large population ofNK-P1A
CDT cells that function as NK cells but display an activated phenotye and an unusual
cytokine profie that clearly distinguish them from splenic NK cells. Unlike splenic NK
cells, IENK cells are CD25+ ART2+ CD45RC- and spontaneously secrete the cytokines
IFN-y and IL- , suggesting that these distinctive intraepithelial NK cells may participate
in the regulation of mucosal immunity.
Specific aim #3 (Chapter IV): Analyze intraepithelial natural kiler cell nurn-
ber and function in BB rats
Rationale and objectives for Aim #3
Diabetes-prone BB rats lack peripheral ART2+ regulatory cells due to homozy-
gosity at the lyp gene locus. Diabetes can be induced in diabetes-resistant BB rats by de-
pletion of ART2+ regulatory cells and co-administration of an immune stimulant like poly
I:C. Although peripheral ART2+ regulatory cells appear to influence disease expression
in BB rats, less is known about IEL populations in these rats. I therefore investigated IEL
number and fuction in BB rats , giving particular attention to intraepithelial natual kiler
cells.
Summary of results for Aim #3
I now demonstrate that, prior to diabetes in both BBDP rats and in BBDR rats that
have been have been treated to become diabetic, reduced total number of IELs are present
as compared to untreated BBDR and WF rats. Interestingly, there is a selective deficiency
of IENK cell number and function in all BB rats as compared to control WF rats. After
one week of diabetes-inducing treatments, the number and fuction of IENK cells in
BBDR rats is further reduced. The deficiency of BBDP rat IENK cells can be corrected
by engraftent of bone marow from histocompatible WF donors.
Specific aim #4 (Chapter V): Provide preliminary evidence that defective
mucosal tolerance in BB rats potentially contributes to the expression of
autoimmune diabetes
Rationale and objectives for Aim #4
Genetics and environment both determine the expression of autoimmune diabetes
in rats and humans. One important class of environmental factors 
- diet and enteromicro-
bial agents - may participate in this process through the intestinal immune system, which
must possess unique mechanisms for dealing with the huge antigenic load of intestinal
contents. For example, dietary manipulation influences the expression of autoimmune
diabetes in BBDP rats , suggesting a role for mucosal tolerance and the intestinal immune
system in the immunopathogenesis of this disease in BBDP rats. In this chapter, I provide
preliminary evidence that inappropriate intestinal immune responses are translated into
systemic autoimmunity in the BB rat.
Summary of results for Aim #4
I establish that, unlike BBDR and WF rats, BBDP rats are deficient in yoTCR
IELs, a population of T cells that may playa role in normal mucosal tolerance mecha-
nisms. I also report preliminary data showing that systemic manifestations of autoreac-
tivity may initiate in the intestine; autoreactive cells appear in mesenteric lymph nodes
that drain the intestine prior to cervical lymph nodes , and such cells may initiate a tye 2
autoimmune phenomenon driven by IL-4. These findings support the argument that a
failure in mucosal tolerance in BBDP rats, perhaps secondary to deficiencies in one or
more IEL subpopulations, trggers activation of autoreactive T cells peripherally and
contrbutes to the immunopathogenesis of spontaneous diabetes in BBDP rats.
CHAPTER II
A NEW ISOLATION METHOD FOR RAT
INTRAEPITHELIAL LYMPHOCYTES
Summary of Chapter II
Intraepitheliallymphocytes play critical roles in gut immunity. In mice, yo T cells
are a large component of the IEL population. In the rat, yo IELs are reportedly much less
common, but technical issues suggest that previous analyses should be interpreted cau-
tiously. The study of IELs in rats has been impeded by isolation procedures that are
lengthy and complex , leading to small cell yields. For this reason , it is possible that rat
IELs analyzed in previous studies have not been representative of the entire IEL com-
partent. I report a new method for the isolation of rat IELs that is based on the selective
removal of intestinal epithelial cells under conditions that leave the basement membrane
undistubed. The method is rapid and requires neither enzyatic digestion, nor surgical
removal of Peyer s patches , nor vigorous mechanical manipulation of the intestine. The
yield of rat IELs using this method is 5- 10 fold greater than that reported for other meth-
ods. Morphological and phenotyic analyses demonstrated that the purified cell popula-
tion is comprised of IELs and is not contaminated with lamina propria or Peyer s patch
lymphocytes. Phenotyic analysis revealed 5 major subsets of IELs based on differential
cell surface expression of CD4, CD8 , and a~ T cell receptor. Among the a~ T cell re-
ceptor negative cells were populations of yo T and NK cells present at levels not previ-
ously detected. The isolation of IEL subpopulations using this methodology should fa-
ciltate studies of the function of these cells in gut immunity.
Introduction to Chapter II
Intestinal lymphoid cells are present in three physically and fuctionally distinct
tissue compartents: the lamina propria, Peyer s patches, and the intraepithelial space
(16). Analyses of cell populations in each of these compartents has been impeded by
isolation methods that yield small numbers of cells and do not reproducibly prevent
cross-contamination (16;216;294-297). This has been particularly tre for analyses of rat
IELs, only 5- 10 milion of which have tyically been isolated from one animal.
Different laboratories have reported variable cell yields and IEL phenotyes
(21;214;216;217;298-300). Nonetheless, based on available purification methods, a
working consensus has been reached on the phenotye of rat IELs (54;215-
217;294;301;302). The majority appear to be CD8+ (294;301). Many of the CD8+ IELs
express the CD8aa homodimer (21). The majority of rat IELs (::95%) also express the
AR T2 surface differentiation alloantigen at high density (213 ;234;298;302-304). Most
investigators have reported that ::90% of IELs in euthymic rats express the a~ T cell re-
ceptor (TCR) whereas 0:10% express the yoTCR (21;54;213;216;300;302).
The original protocols developed for IEL isolation require dissection to remove
Peyer s patches, and mincing of the tissue to physically disrupt the epithelium
(16;295;297;305). This method is limited by variable, sometimes extensive , contamina-
tion of the IEL preparation with lamina propria lymphocytes. To address this problem
the original protocols for IEL isolation (16;295) have required enzatic digestion, che-
lation with agents like EDTA, paning, and/or magnetic bead separation
(16;295;297;305). None of the modifications have proven entirely satisfactory.
An alternative method for IEL isolation everts, ligates , and distends the intestine
which is then incubated with dithioeryhrtol (DTE) and subjected to repeated rigorous
vortexing (210). Using discontinuous Percoll gradient centrfugation, yields of 5 x 10
IELs per rat that are 90% pure have been obtained (216). Contamination of this IEL
preparation with lymphocytes from lamina propria and Peyer s patches is minimal. The
low cell yield, however, makes it uncertain that phenotyic and fuctional characteristics
of IELs prepared in this way are representative of the entire, much larger, IEL compart-
ment (210;216).
To address these issues, I have developed an effcient new technique for the rapid
isolation of large numbers of highly purfied rat IELs. The technique is based in par on
the susceptibility of intestinal epithelial cells to hypoxic conditions that leave the base-
ment membrane relatively undistubed. The sloughed epithelium carres with it the IELs
effectively dissecting away the lamina propria and Peyer s patches. IELs prepared in this
way are high in yield and purty. They contain 5 major subsets, including populations of
yo T and NK cells present at levels much higher than previously described.
Materials and Methods of Chapter II
Animals
Ten to 16 week old WF (RT1 , ART2 ), BN (RT1 , ART2 ), DA (RT1 , ART2
and F344 (RT1 V, ART2 ) rats were obtained from Harlan Sprague-Dawley (Indianapolis
IN). DR-BBlWor (RT1 , ART2 ) and PVG.RTl (RT1 , ART2 ) rats were obtained from
BMR, Inc. (Worcester, MA). Except where noted, all analyses were performed using 10-
12 week old WF rats.
Rat tissue donors were kiled in an atmosphere of 100% CO . Animals in this
study were continuously monitored for infection and were serologically free of Sendai
virus , pneumonia virus of mice, sialodacryoadenitis virus, rat corona virus, Kilham rat
virus, HI (Toolan s virus), GD7, Reo- Mycoplasma pulmonis lymphocytic chorio-
meningitis virus, mouse adenovirus , Hantaan virus, and encephalitozoon cuniculi. Ani-
mals of either sex were studied. All animals were maintained in accordance with recom-
mendations in the Guide for the Care and Use of Laboratory Animals (Institute of Labo-
ratory Animal Resources, National Research Council, National Academy of Sciences
1996) and the guidelines of the Institutional Animal Care and Use Committee of the Uni-
versity of Massachusetts Medical Center.
Antibodies
The hybridoma cell line secreting the 6A5 anti-ART2b (rat IgG1) is maintained in
our laboratory. Monoclonal antibodies (mAbs) directed against a~TCR (clone R73),
CD8a (clone OX-8), CD8~ (clone 341), CD4 (clone OX-35), B220 (CD45R, clone
iii HIS24), CD25 (IL-2 receptor a-chain, clone OX-39), CD2 (LFA, clone OX-34), CD3
(clone G4. 18), CD5 (clone OX- 19), CD28 (clone 11-319), CD45RC (OX-22), NK-PIA
(10/78), anti-yo T cell receptor (clones V45 and V65), and the appropriate isotye con-
trois for each mAb were obtained from BD PharMingen (San Diego , CA).
Flow cytometry
Single, two, and three-color flow cytometrc analyses were performed as previ-
ously described (121 ;306). Briefly, 1 x 10 viable lymph node cells or IELs were reacted
with a mixture of fluorescein isothiocyanate- (FITC-), biotin-, and/or phycoeryhrn- (PE-
) conjugatedmAbs for 20 min. at 4 C. All IEL analyses were performed after nylon wool
or Percoll-density gradient purfication to remove the large number of contaminating
dead epithelial cells. Cells were then washed, reacted with Cy-ChromeQl -conjugated
streptavidin (BD PharMingen) to visualize biotinylated mAbs, washed again, and fixed
with 1 % paraformaldehyde. FITC- , biotin- and PE-conjugated isotye control immuno-
globulins were used for all analyses. Cells were analyzed using a FACScan(j instrment
(Becton Dickinson, Sunyvale, CA). Lymphoid cells were identified by their forward and
side light-scatter profiles and the detection of ART2, a~TCR, or yoTCR staining. The
composite phenotyes of lymphoid cell subsets for up to four antigenic markers were
determined by combining the results of multiple 2 and 3-color analyses of replicate sam-
pies of lymphocytes, each incubated with a different combination of antibodies.
To characterize the subpopulation containing NK- + cells using thee color
flow cytometr, I exploited the unique staining patterns of CDSa, CD4 , and a~TCR on
IELs. Because -=-=1% of IELs express the CD8a- CD4- a~TCR+ phenotye, fuher
analysis of CDSa- CD4- a~TCR- IELs was possible by labeling with CD8a and CD4
selecting the CD8a- CD4- IEL subset, and performing three color analysis using a third
fluorochrome.
To characterize the CD8+ CD4- a~TCR- subpopulation, I again exploited the
unique staining patterns of CD8a, CD4 , and ~TCR on IELs. Because CD8a + CD4
a~TCR- IELs comprise -=-=1 % of IELs, it was possible to stain for CD8a and a~TCR
select the CDSa + a~TCR- cells, and examine this population using a third fluorochrome
g. anti-yoTCR using the V65 mAb. IELs expressing the CD8a CD4-a~TCR- pheno-
tye were shown to be y8TCR+ (see Figue 13). Subpopulations of cells with this pheno-
tye were therefore identifiable by dual labeling for V65 and a second fluorochrome.
Strategies for analyzing the remaining three a~TCR populations were as follows.
Because CD8a- CD4+ a~TCR- cells comprise -=1% of total IELs, CD8a- CD4+ a~TCR
IELs could be analyzed by staining for CD8a and CD4, selecting for CD8a- CD4+ cells
and examining this population using a third fluorochrome. Because CD8a + CD4 +
a~TCR- cells comprise -=1% of total IELs, CD8a+ CD4+ a~TCR+ IELs could be ana-
lyzed by staining for CD8a and CD4, selecting for CD8a+ CD4+ cells, and examining
this population using a third fluorochrome. Finally, because CD8a- CD4- a~TCR+ cells
comprise -=1 % of total IELs , CD8a + CD4- a~TCR+ IELs could be analyzed by staining
for CD4 and a~TCR, selecting for CD4- a~TCR+ cells , and examining this population
using a third fluorochrome.
.)l Intraepitheliallymphocyte preparation
As shown schematically in Figue 7 , IELs were prepared by dissecting free of the
pancreas the proximal 3-4 cm of intestine including the duodenum, and the bowel was
transected at the level of the pyloric sphincter. The remainder of the small intestine was
dissected free of omentum by gentle blunt dissection, transected 1 cm proximal to the
ileo-cecal junction, and removed en bloc. Care was taken to avoid perforation of the in-
testine during dissection. Intestinal contents were removed by gently flushing the lumen
with 50 ml of cold (4 C) RPMI- 1640 over a 3 minute period using a 1 mm gavage tube
inserted into the proximal lumen. Flushing to remove fecal material was performed gen-
tly, at low pressure , and without squeezing the bowel , so as not to perforate the bowel
wall or distub the epithelial mucus coating that contains large numbers of lymphoid
cells. The intestine was then immersed in cold RPMI 1640 and incubated on ice for 60-
120 minutes. IELs were recovered in a two step procedure.
Step 1: After cold incubation, the intestinal lumen was flushed at low pressure
(over several minutes) with 10 ml of medium consisting of HE PES-buffered HBSS con-
taining 1 mM DTE and 10% Fetalclone(8 I (a defined neonatal bovine serum, HyClone
Logan, UT) at 37 C. The lumenal eluate was saved.
Step 2: The weakly adherent epithelial cells and mucus coating remaining in the intestine
were then squeezed out by manual compression as follows. The proximal end 
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Figure 7: Schematic of IEL isolation protocol. The entire small intestine is removed and
gently flushed with cold RPMI- 1640 to remove lumenal contents and then incubated in
ice-cold RPMI- 1640 for 60- 120 minutes to delaminate epithelial cells and IELs from the
basement membrane. Detached cells were recovered by flushing the intestine two times
with a total of 50 ml of modified HEPES-buffered HBSS media at 37 C. IELs were then
purfied by nylon wool purfication or Percoll density gradient centrfugation, and viable
cells exhibiting lymphoid morphology were quantified by the method of Tryan blue us-
ing a hemocytometer. Listed are yields and purity for IELs isolated from adult WF rats.
the intestine was grasped between thumb and index finger and suspended vertically over
a polystyene container. The thumb and index finger of the other hand were then slid
along the entire length of the gut, compressing it from duodenum to distal ileum to ex-
trde mucus and cellular contents. Care was taken to avoid tearing the tissue.
The specimen was subjected to a total of 5 cycles of flushing (Step 1) and
squeezing (Step 2) to extrde all intra-lumenal contents. The contents of all five 10 ml
flushes and extrsions were combined in one 50 m1 polystyene test tube. The tube was
then gently swirled to suspend all cells. Clumps of material present in the dispersed
sediment were allowed to settle for 10 min. The supernatant containing single dispersed
epithelial cells and IELs was then removed by pipetting into a second tube and centr-
fuged at 350 x G for 5 minutes. The resulting pellet, containing IELs , eryhrocytes , and
epithelial cells , was then recovered and subjected to either nylon wool or density gradient
centrfugation for fuher purification.
The viability of IELs prepared in this way was assessed immediately after their
recovery by the method of Tryan blue exclusion. I observed that :;95% of the lymphoid
cells were viable. In contrast, :;90% of the epithelial cells in the freshly isolated popula-
tion failed to exclude the dye.
Lymph node cell preparation
Cervical and mesenteric lymph nodes were removed and single cell suspensions
were prepared by gentle extrsion through stainless steel sieves into cold medium (306).
Intestine was removed prior to the recovery of mesenteric lymph nodes.
Nylon wool purification of IELs
Nylon wool purification of IEL suspensions was performed as described previ-
ously (16). Briefly, pelleted cells were suspended in 10 ml cold RPMI containing 5%
Fetalclone(I I , and passed through a loosely packed nylon wool column at the rate of 
drop every 1-2 seconds. The column was washed with cold medium containing 5% Fetal-
clone (I I. The number of viable cells with lymphoid morphology was quantified using a
hemocytometer and the method of Tryan blue exclusion.
Discontinuous percoll density gradient purification of IELs
A two step discontinuous Percoll density gradient centrfugation procedure was
used in some experiments (216). Briefly, pelleted cells were re-suspended in 35 ml RPMI
containing 5% Fetalclone(I I at room temperature; 15 ml of Percoll was then added to
generate a 30% Percoll solution. The cell suspension was centrfuged at 350 x G for 15
minutes at room temperature. Non-viable epithelial cells were excluded from the 30%
Percoll solution, whereas eryhrocytes , lymphocytes, and viable epithelial cells localized
to the pellet. The cell pellet was suspended in 15 ml of a 45% Percoll solution. A second
75% Percoll solution was layered under the 45% solution , and the discontinuous Percoll
gradient was then centrfuged at 350 x G for 30 minutes. Viable epithelial cells were re-
covered from the supernatant at the 45% interface. Eryhrocytes and debris migrated into
the layer of75% Percoll. Viable IELs were collected from the interface between the 45%
and 75% Percolliayers. The number of viable cells that excluded Tryan blue was quan-
tified using a hemocytometer and was :;95% in all cases.
Histology
Samples of 16 week old WF rat intestine for histological analysis were taken at
three different stages of the IEL isolation procedure. The first was obtained immediately
after the animal was killed in an atmosphere of 100% C02. The second was recovered
after incubation at 4 , but before perfsion with medium at 37 C. The third was recov-
ered after 5 perfsions and extrsions. Specimens were immediately fixed in 10% buff-
ered formalin or Bouin ' s fixative. Paraffn-embedded tissue sections of all samples were
stained with hematoxylin and eosin and examined by light microscopy. Samples of the
extrded intra-lumenal contents were embedded in paraffn, stained with hematoxylin
and eosin, and examined by light microscopy. Cytospin-prepared slides of Percoll-
purfied IEL were prepared and stained with Giemsa for analysis of purity.
Results of Chapter /I
Intestinal morphology before and after IEL isolation: Peyer s patches and
lamina propria remain intact
Samples of WF intestine were taken at different stages of the isolation procedure
and examined by light microscopy. Figue 8 , Panel A shows the anatomy of normal 16
week old WF rat jejunum. Panels B , C , and D show progressive changes in gut morphol-
ogy durng processing for the recovery of IELs. They document delamination (Panel B)
and removal (Panels C and D) of the intestinal epithelium from the basement membrane.
Panels C and D also document the presence of intact lamina propria and Peyer s patches
in the residual processed intestine. Panel E shows the morphology of cells present in the
. ! 
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Figure 8: Histological analysis of gut and isolated cell populations at various stages of
IEL preparation. A: Normal 16 week old WF rat jejunum showing epithelium closely
apposed to lamina propria (x 10). B: Appearance of rat jejunum after incubation for 120
min at 4 C. The epithelial layer is delaminating from the basement membrane along
cleavage planes (arows) with no disruption of the lamina propria (x 10). C and D: Ap-
pearance of the lumenal surace of the jejunum after completion of the five cycles of in-
testinal perfsion and extrsion. Panel C shows that most epithelial cells are absent from
the vili, although some remain (x 20). The arow identifies a point of demarcation be-
tween residual epithelium and denuded, but intact, lamina propria from which the epithe-
lium has sloughed. Panel D shows additional areas of lamina propria (arrows) and an in-
tact Peyer s patch (asterisk); both are denuded of gut epithelium (x 20). E: Hematoxylin
and eosin stained paraffn-embedded sample of the cells present in the crude lumenal per-
fusate of the intestine. Small round cells consistent with lymphocytes are abundant, as are
larger epithelial cells (x 20). F: Giemsa-stained cytospin sample of Percoll density gradi-
ent-purfied IELs. Larger cells containing granules are indicated by arrows. (x 60).
unpurified lumenal washing after five cycles of extrsion. Numerous mononuclear cells
are present together with epithelial cells.
Yield and purity of IEL preparations
IEL yield and purty were measured after nylon wool or Percoll purfication of the
lumenal washings. Nylon wool purification resulted in higher yields of IELs but slightly
lower purity than did Percoll purification.
Nylon wool purification
Yields following nylon wool purification averaged 33.6 x 10 viable IELs per rat
(range 27.2 to 48.0 x 10 , N=7 , Table 3). Flow cytometrc analysis of the purified cells
based on forward- and side-scatter demonstrated that lymphocytes comprised 80% of
total cells (Table 3 and Figure 9).
Discontinuous percoll gradient purification
Compared with nylon wool purfication, discontinuous Percoll density gradient
centrfugation resulted in lower IEL recovery but greater purty. Average yield was 21.8
X 10 viable IELs per rat (range 17.8 to 26.6 x 10 , N=4, Table 3). Flow cytometrc analy-
sis revealed that ::97% of cells were lymphocytes (Figue 9). Analysis of the light-
scattering properties of both the nylon wool and Percoll-purified lymphoid cells revealed
that they were slightly larger than peripheral lymph node cells (Figue 9). Morphological
analyses of Percoll-purified cells revealed large numbers of mononuclear cells similar in
TABLE 3
YIELD OF PURIFIED WF RAT INTRAEPITHELIAL LYMPHOCYTES
Percentage of Cells in Lymphoid Cells Recovered
Purifcation Technique
(x 10Lymphoid Gate
Nylon Wool 79.9:! 8.9 (N=7) 33.6:! 8. 1 (N=7)
Percoll Gradient 97.4 21.8:! 3.6 (N=4)
Legend to Table 3: The total number of viable mononuclear cells present in the purfied
preparations was determined using a hemocytometer. Contaminating large epithelial cells
were excluded. The percentage of lymphocytes present in the purified cell populations
was measured by flow cytometr on the basis of forward- and side-scatter. The number
of individual samples tested is shown in parenthesis except in the case of the percentage
of lymphocytes present in Percoll-purfied cells. In this instance, the percentage was
measured on a single pool of IELs from 4 animals. Data are expressed as the mean:! s.
c. H
------ -.---' ---. "
Nylon Wool
Purified IELs
. . . . "" .." ". " . 
IB '
FSC
-tl-
 -- - - ----,._-_._ . "
Density Gradient
Purified IELs
c. H
FSC-H -
,, - .--. --
Lymph Node
Cells
c. H
F.s
.-I:.
Figue 9: Flow cytometrc profies based on light scatter of
WF rat IELs and peripheral lymph node cells
Figure 9: Flow cytometric profiles based on light scatter of WF rat IELs and peripheral
lymph node cells. Forward scatter (horizontal axis) is plotted against side scatter (vertical
axis). Shown are representative profies of nylon wool-purfied WF rat IELs (top panel),
Percoll gradient purified IELs (middle panel), and peripheral lymph node cells (bottom
panel). The gate was established on the peripheral lymph node cell population. Compara-
ble results were obtained in 4-7 individual animals (Table 3).
appearance to unfractionated lymph node cells (Figure 8 , Panel F). Some of these mono-
nuclear cells are large and appear to contain granules.
Phenotype of purified IELs
The phenotye of purified intestinal lymphocyte populations was determined by
flow cytometr. In preliminar studies, it was determined that the phenotyes of the in-
testinal lymphoid cells purified by nylon wool and by Percoll density gradient centrfu-
gation were qualitatively similar (data not shown). The phenotyic analyses presented
below were performed on nylon wool-purified cells.
Isolated cells are predominantly ART2+ CD8a + 8220-
The phenotye of cells isolated using my methodology displayed the consensus
phenotye of IELs (54;216;217;294;301 ;302). Consistent with previous reports
(213;298;302;304), the percentage of ART2+ cells was very high (92 :t 3%, Figure 10).
More than half (62 :t 5%) of the IELs expressed CD8a, and -60% of the CD8a+ cells
were CD8a . Less than 5% of the IEL population was B220+ (i.e. CD45R+ B cells).
Consistent with previous reports (213;298;302), the ART2+ cells in the IEL
population (Figue 10) expressed ART2 at a surface density -10-fold greater than lymph
node cells (Figue 10). Taken together, these phenotyic and morphological results con-
firm that my methodology selectively isolates IELs while excluding contaminating lam-
ina propria and Peyer s patch lymphocytes, a large number of which express B220.
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Figure 10: Flow cytometric analysis of ART2b expression on WF rat IELs and peri ph-
eral lymph node cells. Fluorescence intensity (horizontal axis) is plotted against cell
number (vertical axis). Shown are representative profies of ART2b expression on lym-
phocyte-gated nylon wool purfied WF rat IELs (left panel) and WF rat cervical lymph
node cells (right panel). The insets show fluorescence profies of the same cell popula-
tions reacted with FITC-conjugated isotye control immunoglobulin. Comparable results
were obtained in 3-6 individual animals.
Differential expression of CD4, CDS, and apTCR classifies rat IELs into five
major subpopulations
Differential expression of CD8a, CD4, and a~TCR expression segregated ::99%
of the total population of purified IELs into one of five major non-overlapping subsets
(Table 4 Figue 11). As expected on the basis of previous reports
(21;54;215;217;294;301), CD8a CD4-a~TCR+ cells comprised a major subpopulation
(32%) oflELs (Figue 11). CD8a- CD4+ a~TCR+ and CD8a+ CD4+ a~TCR+ cells com-
prised -9% and -6% of IELs, respectively. Surrisingly, CD8a
- CD4- a~TCR- and
CD8a+ CD4- a~TCR- cells comprised -30% and -25% of the purfied IEL population
respectively (Figue 11). The three remaining permutations of these three surface anti-
gens (CD8a CD4+ a~TCR-, CD8a CD4+ a~TCR-, and CD8a CD4- a~TCR ) together
were observed on less than 1 % of the total population (Figue 11 , Table 4).
Natural kiler cells and y3TCR+ T cells are abundant in the two a~TCR- rat
IEL populations
Unexpectedly, 23.7:t 4.2% (N=6) of all IELs were observed to express the NK-Pl anti-
gen characteristic ofNK cells and NK T cells (Figure 12 , top panel). To determine if any
of these were NK T cells , I characterized fuher the each of the five IEL subpopulations.
I observed that 64. 1 :t 9. 1% (N=6) of CD8a
- CD4- IELs (-99% of which are a~TCR-
see above) were NKR- , accounting for most (87. 1 :t 6.5%) of the NK-P1 IEL popu-
lation (Figue 12, middle panel). This phenotye identifies them as NK cells. In
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Figure 11: Three color flow cytometric analysis of the expression of CD4, CD8, and
aflCR by WF rat IELs. The expression ofCD4 (vertical axis) and CD8 (horizontal axis)
was determined on lymphocyte-gated, nylon wool purfied a~TCR+ (left panel) and
a~TCR- IELs (right panel). Shown is a single representative analysis of the five major
IEL sub-populations defined by these surace markers. Comparable results were obtained
in six individual analyses (Table 4).
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Figure 12: Flow cytometric analysis ofNK-Pl and ART2b expression on
WF rat IELs
Figure 12: Flow cytometric analysis ofNKR-Pl and ART2b expression on WF rat IELs.
Fluorescence intensity (horizontal axis) is plotted against cell number (vertical axis).
Shown are representative profies of NK-P1 expression on lymphocyte-gated nylon
wool purified WF rat IELs (top panel), NK-P1 expression on CD8- CD4-cells (middle
panel) and ART2b expression on NK-P1 + IELs (bottom panel). The insets show fluo-
rescence profiles of the same cell populations reacted with FITC-conjugated isotye con-
trol immunoglobulin. Comparable results were obtained in 6 individual animals.
addition, I observed that the majority of NK-P1 + NK IELs express high levels of cell
surace ART2 (Figure 12 , bottom panel). In dual label analyses , I observed that 8% of
the IELs co-expressed CD3 and NK- , a phenotye that is consistent with that ofNK
T cells. Additional dual-label analyses using anti-CD8a and anti-CD3 antibodies re-
vealed that -:1.5% of the IEL population is CDT CD8a , making it unlikely that the NK
IEL population is significantly contaminated with CD8+ peripheral NK cells.
A second surprising observation was that 24.4 :! 3.3% (N=6) of all IELs were la-
beled by the V65 anti-yoTCR mAb (Figure 13 , left panel). Because a~TCR and yoTCR
are not co-expressed on T cells, and because the data above indicate that the great major-
ity of CD8- CD4- a~TCR- cells are NK cells, I next tested the hypothesis that the
yoTCR+ cells would be found in the CD8+ CD4- a~TCR- subpopulation. I observed that
94.9:! 1.5% of the CD8a+ a~TCR- population was y8TCR+ (Figure 13 , right panel), ac-
counting in tu for 95% of all yoTCR+ IELs.
To confirm that this high percentage ofyoTCR+ IELs was not specific to the WF
rat, I also measured the number ofCD8 a~TCR- IELs isolated in the same way from rats
of five additional strains. The number of CD8+ a~TCR- IELs in these strains was 19.0 :!
3% (range 10.0% to 27. , N= 9 samples). This percentage is comparable to that ob-
served in WF rats of the same age (Table 4).
I also measured for the percentage of yOTCR+ IELs using the V45 mAb that is
known to react with a subset of yoTCR + cells (307). I observed that V 45 labeled 2.0 :!
0.4% (N=6) of total IELs and 7. 1 :! 1.1% (N=6) ofV65+ IELs (data not shown).
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Figure 13: Flow cytometric analysis of yOICR expression on WF rat IELs. Fluorescence
intensity (horizontal axis) is plotted against cell number (vertical axis). Cells were reacted
with the V65 mAb to identify yoTCR+ cells. Shown are representative profies ofyoTCR
expression on lymphocyte-gated nylon wool purfied total WF rat IELs (left panel) and
on CD8+ a~TCR- cells (right panel). The insets show fluorescence profiles of the same
cell populations reacted with Cy-Chrome -conjugated isotye control immunoglobulin.
Comparable results were obtained in 6 individual animals.
Phenotypic characteristics of the five major IEL subsets
Each the five IEL populations defined on the basis of differential expression of
CD8a, CD4, and a~TCR was further analyzed for expression of seven additional phe-
notyic markers (Table 5). To do so, I again exploited the unique staining patterns of
CD8a, CD4 , and a~TCR on IELs (see Methods).
The expression of CD2 , CD3 , CDS , CD25 , CD28 , CD45RC intennediate, and ART2b
on each of the five major subpopulations of WF IELs is shown in Table 5. Consistent
with previous reports (213;298;302), ART2 was expressed uniformly and at high density
on 4 of the 5 IEL subsets. In contrast, its expression on the CD4+ CD8- IEL subset was
heterogeneous and at low density, a pattern also observed on CD4+ peripheral T cells
(308).
Consistent with previous reports (213), I observed that, unlike peripheral T cells
few IELs expressed CD2. Those cells that were CD2+ were found in the CD4+ CD8- sub-
population. Only one subpopulation failed to express CD3; this was the CD4- CDS- sub-
set, which also failed to express a~TCR or yoTCR and, as documented above, was com-
prised predominantly of NK cells.
Most IELs , including yoTCR+ IELs, appeared to be in an activated state as evi-
denced by their uniform expression of CD25. Surrisingly, despite the expression of
CD25 , many IELs , including those in the yoTCR+ subset, did not express CD28. CD28 is
a co-stimulatory molecule expressed constitutively on most peripheral T cells and at high
levels on activated T cells.
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Legend to Table 5: Subset percentages for each major IEL subset, total IELs , and periph-
erallymph node cells (LNCs). Each the five nylon wool-purfied WF rat IEL populations
defined in Table 4 on the basis of differential expression of CDSa
, CD4, and a~TCR was
fuher analyzed for expression of the seven additional phenotyic markers listed in the
leftost column. Phenotyes shown in parentheses are inferred, not directly determined
(See Methods). For comparison, the expression of these seven additional phenotyic
markers was also analyzed using samples of total IELs and CD4+ peripheral T cells. Each
IEL and lymph node data point represents the mean percentage :f s.d. measured in 6 and 3
individual samples, respectively. The percentages of CD4+ peripheral lymph node cells
expressing each of these seven phenotyes were essentially identical to the percentages
expressed by CD8a+ peripheral lymph node cells (data not shown).
Most subsets of IELs contained low percentages of CD45RCintermediate cells. Only
the CD4- a~TCR+ subset contained levels of CD45RC intermediate cells (34%) that ap-
proached those observed in peripheral CD4+ T cell populations (56.4%, Table 5). The
percentages of CD4+ peripheral lymph node cells expressing each of these seven pheno-
tyes was essentially identical to the percentages expressed by CD8+ peripheral lymph
node cells (data not shown).
The percentage of CD5+ cells vared among the different IEL subsets. CDS was
expressed by a very low percentage ofyOTCR+ and CD8- CD4- IELs , approximately half
of CD4- a~TCR+ IELs, and the great majority of CD8a + CD4+ and CD8a- CD4+ IELs.
Discussion of Chapter /I
The analysis of rat IEL populations recovered using my new isolation procedure
has generated three principal findings. First, the method leads to the recovery of 5- 10 fold
more IELs than are recovered using older methods (213;216;292;294;299). The method is
reproducible and yields lymphoid cell preparations that are of high purty and exhibit the
consensus morphologic and phenotyic characteristics of tre IELs. Second, analysis of
rat IELs prepared using the new method revealed the presence of yo T cells at levels not
previously appreciated. In general
, -
25% of the cells in each preparation were yoTCR
cells. Third, three-color microfluorometrc analysis classified ::99% of the rat IELs into
one of 5 major subpopulations based on their expression of TCR, CD4 and CD8. Sur-
prisingly, one of these subpopulations was comprised predominantly ofNK cells.
Isolation technology
The new method that I describe is rapid and reproducibly yields large numbers of
viable IELs. The technique is based on the propensity of intestinal epithelial cells to
slough off the gut basement membrane after exposure to cold and hypoxic culture condi-
tions that leave the basement membrane relatively undisturbed. The sloughed epithelium
carres with it the IEL population, effectively dissecting away the lamina propria and
Peyer s patches.
The procedure yields a population of cells that fulfill three criteria that define a
successful IEL purfication process. First, the lamina propria and Peyer s patches remain
intact throughout the isolation procedure. Second, the morphology and light-scattering
properties of the recovered cells are those of intestinal epithelial lymphocytes. Finally,
the phenotye of the purified cells is consistent with that of an IEL population (216;304).
The methodology is noteworthy for two additional reasons. The first is its techni-
cal simplicity. It requires no special reagents or equipment, nor does it require extensive
or vigorous mechanical disturbance of the intestine. It takes only 2-3 hours, yet repro-
ducibly generates large numbers of pure IELs.
Second, and more importantly, the methodology appears to generate cell popula-
tions that are more representative of the entire IEL compartent than are populations
generated by older methods. I believe this to be the case because my method overcomes
two obstacles that have previously impeded recovery of pure IELs. First, it dissects away
epithelial cells from the intestine without disrupting the basement membrane. This pre-
vents contamination of IEL preparations with lamina propria and Peyer s patch lympho-
cytes. Second, it eliminates many purification steps that have previously been required.
These include incubation in chelating agents, mincing, vigorous shaking, eversion of the
intestine, and panning (16). Each of those procedures can cause substantial non-specific
cell losses , leading to low cell yields. Previously published isolation protocols yield 5-
milion IELs per rat (213;216;292). The IEL population in the rat has , however, been es-
timated to be 10-20 fold larger (309;310). The method I have developed routinely yields
30-50 millon IELs per rat.
yoTCR+ rat IELs
Consistent with previous reports (213), many of the IELs isolated with my proce-
dure were CD8+ ART2+ a~TCR+ (21;216;217;304). Few were CD4+ CD8+ or CD8-
CD4 . A major new finding, however, was the identification of a population of yOTCR
IELs that comprise -25% of total IELs recovered. Previously it has been reported that
V65-stained yOTCR+ IELs comprise either 0:10% (54;216;300) or 10-20% (214;215) of
the rat IEL population. The percentage of yoTCR+ cells has been reported to be 40-50%
of the total IEL population in the mouse (18), and the present data suggest that the rat IEL
population may be more like that of the mouse than previously thought.
It could be argued that the high percentage ofyoTCR+ IELs I observed reflects a
selective loss of a~TCR+ IELs due to hypoxic isolation conditions, but I think such an
explanation is unlikely. First, the absolute number of a~TCR+ cells that I recovered was
higher than that produced by other methods. In addition, analysis of lymphoid cells im-
mediately after the flushing step in my procedure revealed 90% viability.
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I recognize, however, that a number of factors other than isolation methodology
could influence yoTCR+ IEL percentages. For example, there could be compartent-
alization of yoTCR + cells in the gut, and the percentage of these cells could vary along its
length. My procedure isolated IELs from the entire small bowel, and it is possible that
previous reports based on the older methodology simply used different regions of the
bowel. In a preliminar study, however, I found high percentages of yoTCR+ IELs in
proximal, middle, and distal small intestine (Derrck Todd, unpublished observations).
It could also be argued that the proportion of yoTCR + cells in the WF rat IEL
compartment may differ from the proportion in rats of other strains or ages. My analysis
of 5 phenotyically normal strains at -10 weeks of age suggests that, although there is
some strain-to-strain variability, the percentage in WF rats is not uniquely high. Whether
the percentage is also high in older or younger animals analyzed by my method is not yet
established, however.
Rat IEL subpopulations
My three-color microfluorometrc analysis identified five major subpopulations of
IELs based on the expression of CD4, CD8 , and TCR. These five major subpopulations
were fuher categorized using additional phenotyic criteria.
One of these five subpopulations , comprising CD8- CD4+ a~TCR+ cells , has pre-
viously been interpreted to be indicative of contamination with lamina propria and/or
Peyer s patch lymphocytes (16). I believe, however, that this interpretation is not correct.
lymphocytes are a sensitive measure of contamination of IEL populations with lamina
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propria and Peyer s patch lymphocytes (216), and I observed very low numbers ofB cells
in my IEL preparations (16;213).
Essentially all of the cells in each of the five major IEL subpopulations expressed
the activation marker CD25 , suggesting that the intestinal environment activates IELs
irrespective of their intestinal or thymic origin. The presence of CD25+ IELs fuher sug-
gests that IL-2 may be produced in the intestinal tissue and may in part control the func-
tional activity of IELs. This inference is supported by the detection of abundant IL-
mRA in preparations of purfied IELs (216).
The variable expression of CD5 I observed in the IEL subpopulations has been
previously noted, and it has been suggested that the variability is age-related (213 ;217).
My data suggest that, in addition to age, expression of CD5 may be subset-dependent.
Depending on subset, the proportion of CD5+ cells varied from very low to very high
(Table 5).
Intraepitheliel NK cells
The present studies have also identified and characterized a population of a~-
and yoTCR- IELs that express the NK-P1 marker; such cells are NK cells (44). This
population of cells was almost completely restrcted to the CD4- CD8- IEL population
and are CDT. They are unlike peripheral NK cells in the rat, which are CD2+ (311) and
CD8+ (53). Cells positive for NKR-P1 staining comprised 25-30% oflELs. The majority
of the NK- + NK cells were also ART2+ and CD25
. In a preliminary report, it has
been suggested that peripheral NK cells express low levels of ART2 (149), and recent
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work in our laboratory has confirmed this report (Chapter III). In contrast
, I observed that
ART2 is expressed on NK IELs at a very high density that was comparable to that ob-
served on TCR+ IELs (213;298;302).
Conclusion to Chapter II
In conclusion, I report a new isolation method for rat IELs that is noteworthy for
its reproducible high yields. IELs isolated using this method include five major sub-
populations, among them significant numbers ofyoTCR+ and NK cells. The rapidity, ef-
ficiency, and product purty that characterize the method should facilitate fuctional and
developmental studies of IEL subpopulations in the rat. Detailed analysis of IEL sub-
populations using this new method may facilitate analyses of the mechanisms of oral tol-
erance.
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CHAPTER II
AN ATYPICAL POPULATION OF NATURAL KILLER CELLS THAT
SPONTANEOUSLY SECRETE IFN-y AND IL-4 IS PRESENT IN THE
INTRAEPITHELIAL LYMPHOID COMPARTMENT OF THE RAT
Summary of Chapter "I
The intestinal lymphoid compartent of the rat is large and diverse, but the phe-
notye and fuctions of its constituent cell populations are not fully characterized. Using
new methodology for the isolation and purfication of rat intestinal intraepithelial lym-
phocytes , I previously identified a population of a~- and yo- TCR- NK-P1A + NK cells.
These cells were almost completely restrcted to the CD4- CD8- IEL population, and un-
like peripheral NK cells in the rat, they were CDT. I now report that rat intraepithelial
NK and peripheral NK cells are similar in morphology, in their ability to lyse NK-
sensitive targets, and in their ability to suppress a one-way mixed lymphocyte cultue. 
contrast, however, intraepithelial and splenic NK cells differ markedly in two respects.
First, IENK cells express high levels of ART2 (a marker of regulatory T cells in the rat)
and CD25 , whereas peripheral NK cells do not. Second, unlike splenic NK cells , a sub-
stantial fraction of IENK cells appear to spontaneously secrete IL-4 and/or IFN-y. I con-
clude that the rat IEL compartment harbors a large population ofNK-P1A CDr cells
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that function as NK cells but display an activated phenotye and unusual cytokine profile
that clearly distinguish them from splenic NK cells. Their phenotyic and fuctional
characteristics suggest that these distinctive intraepithelial NK cells may participate in the
regulation of mucosal immunity.
Introduction to Chapter III
The intestine is the largest lymphoid organ in the body, challenged constantly by
an enormous quantity and diversity of antigens. The intestinal lymphoid compartent is
not only large but also very diverse, and the phenotye and fuctions of its constituent
cell populations are not fully characterized (185). In addition, mucosal lymphoid tissues
appear to be regulated by unique mechanisms that govern highly specialized processes
like oral tolerance and controlled (or physiologic) chronic inflammation. Defects in the
fuction of intestinal immune system regulation have been associated with celiac disease
(88) and inflammatory bowel diseases (199;201;312). In addition, there are specialized
lymphoid populations, in particular intraepithelial T lymphocytes (209), which respond to
alternative pathways of activation. Coupled with the specialized antigen-presenting capa-
bilties of intestinal epithelial cells (261), these lymphoid populations are thought to par-
ticipate in immune responses that are under the control of distinct but as yet poorly char-
acterized regulatory factors (185).
Using new methodology for the isolation and purfication of rat intestinal IELs , I
previously identified a population of a~- and yo-TCR- NK-P1A+ intraepithelial NK
cells (26). These cells were almost completely restrcted to the CD4- CDS- IEL popula-
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tion, and unlike peripheral NK cells in the rat, they were CD2-. I now report the pheno-
tyic and fuctional characteristics of these IENK cells. The data suggest that the rat IEL
compartment harbors a large population of NK-P1A+ CDT cells that function as NK
cells but display an activated phenotye and an unusual cytokine profie that clearly dis-
tinguish them from splenic NK cells. Their phenotyic and functional characteristics sug-
gest that these distinctive intraepithelial NK cells may paricipate in the regulation of mu-
cosal immunity.
Materials and Methods of Chapter "I
Animals
, DA, and BN rats of both sexes were obtained from Harlan Sprague Dawley
(Indianapolis, IN). Additional WF rats of both sexes were obtained from Charles River
Laboratories (Wilmington, MA). All animals were certified to be serologically free of
Sendai virus, pneumonia virus of mice, sialodacryoadenitis virus , rat corona virus, Kil-
ham rat virus , HI (Toolan s virus), mouse poliovirus (GD7), Reo- Mycoplasma pulmo-
nis lymphocytic choriomeningitis virus mouse adenovirus , Hantaan virus
, and En-
cephalitozoon cuniculi. All animals were housed in a viral-antibody free facility until
used and maintained in accordance with recommendations in the Guide for the Care and
Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Re-
search Council , National Academy of Sciences , 1996) and the guidelines of the Institu-
tional Animal Care and Use Committee of the University of Massachusetts Medical
School.
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Antibodies
For flow micro fluorometr, fluorochrome- or biotin-conjugated mAbs directed
against NK-P1A (clone 10/78), CD2 (clone OX-34), CD3 (clone G4. 18), CD5 (clone
OX- 19), CD8a (OX-8), CD25 (IL-2 receptor a-chain, clone OX-39), CD28 (clone
11319), CD45RC (clone OX-22), CD54 (ICAM- , clone 1A29), and a~-TCR (clone R73)
were obtained from BD PharMingen (San Diego, CA). The hybridoma secreting the 6A5
rat anti-rat ART2b (IgG ) monoclonal antibody (mAb) is maintained in our laboratory
(26).
For measurement of IL-4-secreting cells by ELISpot, paired mAbs (purfied OX-
81 and biotinylated Bll-3) directed against IL-4 were obtained from BD PharMingen.
For measurement oflFN-y by ELISpot, the captue mAb (clone' DB- l) was obtained from
BioSource International (Camarillo , CA) and the detection rabbit anti-rat IFN-y polyc1o-
nal antibody was obtained from Torrey-Pines Biolabs (La Jolla, CA) and biotinylated as
described (313). Isotye control mouse IgG1 , mouse IgG2a, and mouse IgG3 , secondary
antibody (anti-rat IgG1), alkaline phosphatase-conjugated streptavidin, and CyChrome
conjugated streptavidin were purchased from BD PharMingen. Horseradish peroxidase-
(HR-) conjugated avidin D was purchased from Vector Laboratories, Inc. (Burlingame
CA). Recombinant rat IL- , IFN-y, and IL-4 were purchased from R&D Systems (Min-
neapolis, MN).
107
Cell preparation
Intraepithelial lymphocytes were prepared from rat small intestine using previ-
ously described methods with minor modifications (26). Briefly, the entire small intestine
was gently flushed with cold RPMI- 1640 (Gibco, Grand Island, NY) to remove lumenal
contents and then incubated in ice-cold RPMI- 1640 for 60- 120 minutes to delaminate
epithelial cells and IELs from the basement membrane. Detached cells were recovered by
flushing the intestine two times with a total of 50 ml of HEPES-buffered HBSS media
containing 1 mM dithioeryhrtol (Sigma) and 10% Fetalclone I (a defined neonatal bo-
vine serum, HyClone, Logan, UT) at 37 C. IELs were then purfied by Percoll density
gradient centrfugation, and viable cells exhibiting lymphoid morphology were quantified
by the method ofTryan blue using a hemocytometer.
Thymi , spleens , and mesenteric lymph nodes were removed from rats killed in an
atmosphere of 100% CO . Single cell suspensions were prepared by gentle extrsion
through stainless steel sieves into medium consisting of cold RPMI- 1640 supplemented
with 5% Fetalclone I as described (26;121). Spleen cell preparations were washed in
medium and eryhrocytes were lysed in a hypotonic buffer (0. 15 M , 1.0 mM
KHC0 , 0. 1 mM NazEDTA pH 7.4). For cytotoxicity assays, eryhrocyte-depleted sple-
nocytes were suspended in medium, adsorbed against polystyene plates for one hour at
, and non-adherent spleen cells were recovered by gentle rinsing of the plates with
ice-cold medium.
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Flow cytometry
Single, two , and three-color flow microfluorometrc analyses were performed as
described (26). Briefly, 1 x 10 viable splenocytes or IELs were suspended in ice-cold
F ACS medium (isotonic PBS supplemented with 1 % Feta1clonel& I) and reacted with a
mixture of 6A5 anti-ART2b mAb and/or biotin-conjugated antibodies for 30 min. at 4
Cells were then washed with F ACS medium, reacted with FITC- and PE-conjugated an-
tibodies , and/or Cy-chrome -conjugated streptavidin for 30 min. at , washed with
F ACS medium, and fixed with 1 % paraformaldehyde in PBS. FITC- , biotin- and PE-
conjugated isotye control immunoglobulins were used for all analyses. Cells were ana-
lyzed using a FACScanl& instrent (Becton Dickinson, Sunyvale, CA). Lymphoid cells
were identified by their forward and side light-scatter profiles.
IEL and splenocyte subpopulations were purified by flow microfluorometry.
Freshly isolated IELs and splenocytes were reacted either with FITC-conjugated anti-
bodies directed against NK-P1A or with FITC- and PE-conjugated antibodies directed
against NK-P1A and CD3 , respectively, and sorted by FACScan . As documented in
Figue 14 for one representative sample, the purity of all sorted IEL populations was
::95%. The purity of sorted splenic T and NK cell populations was also documented by
flow micro fluorometr to be ::97%. The percentage of contaminating NK-P1A+ CD3
(N T) cells was consistently very low (0:0. 1 %) in the sorted cell populations in all ex-
periments.
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Figure 14: Purity of sorted intraepitheUal NK cells. IELs were isolated from 4-S week
old WF rats, reacted with anti-NK-P1A and anti-CD3 mAbs (Panel A), and sorted by
flow micro fluorometr using the indicated gates into NK-P1A + CDT (Pan l B) and
NK-P1A- CD3+ (Panel C) populations as described in Methods. The percentage ofpuri-
fied NK-P1A+ CDT IENK cells and NK-P1A- CD3+ T cells, as indicated, was very
high. Shown is the result of a single representative experiment. Comparable purity was
achieved in all sorts of both IELs and splenocytes performed as part of subsequent ex-
periments.
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Morphology
Purified preparations of IEL and splenocyte subpopulations were suspended in
isotonic PBS and spun onto glass slides using a Shandon Cytospin 2 (Shandon, Inc.
Pittsburgh, P A). Cells were reacted with Wright-Giemsa stain and evaluated by light mi-
croscopy by a qualified pathologist (Bruce Woda, M.
Cytotoxicity assay
Cytotoxic activity of lymphoid populations was measured using a previously de-
scribed Cr-release microcytotoxicity assay with minor modifications (314). NK-
sensitive Y AC- 1 virus-induced mouse T cell lymphoma (315) and NK-resistant
C58NT(D) (316) target cells were obtained from the American Type Cultue Collection
(ATCC , Manassas , VA) and maintained in our laboratory in AIM-V media (Gibco) sup-
plemented with 2.2 x 10- M 2-mercaptoethanol. Target cells in growth phase were la-
beled with Cr as sodium chromate (150 f.Ci/milion cells , New England Nuclear, Bos-
ton, MA), and 1.0 x 10 Cr-labeled cells were added to each well of a 96 well microtiter
plate. Unfractionated IELs, purfied subpopulations of IELs, and adherent-cell-depleted
splenocytes were added at effector to target (E:T) cell ratios ranging from 75: 1 to 3: 1 , and
the plates were incubated for four hours at 37 C in a humidified atmosphere of 95% air-
5% CO . All assays were performed in trplicate and averaged.
Total releasable radioactivity ("Cpmmaximat) was determined by incubating an ali-
quot of Cr-labeled target cells with 1% Triton X- 100. After incubation, cells were pel-
leted by centrfugation, and 100 f.l aliquots of supernatant were transferred to a separate
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microtiter plate containing 100 f.l Optiphase Supermix ~-scintilation fluid (Wallac, Inc.
Gaithersburg, MD) and counted ("cpmtest ) using a 1450 Microbeta Trilux instrment
(Wallac). In all assays reported here, release of Cr in the absence of effector cells
cpmspontaeous ) was 0:12% and 0:22% of total Cr release for Y AC- 1 and C58NT(D)
cells, respectively. Specific cytotoxicity was calculated as a percentage using the raw
counts per minute (cpm) and the formula:
m -ctest spontaeous 100peCI IC YSIS /0 = 
cpmmaima - cpmspntaeous
Suppressor cell assays
Mixed lymphocyte culture
Inhibition of peripheral T lymphocyte proliferation by syngeneic WF IELs was
measured in a one-way mixed lymphocyte culture (MLC). Responder cells were WF rat
MLN cells. Stimulator cells were either syngeneic WF (R T 1 U) thymocytes or allogeneic
DA (RT1 a) or BN (RT1 n) thymocytes. Stimulator thymocytes were given 2 Gy of gamma
radiation (-0. 1 Gy/min) using a 13CS source (Gammace1l40 , Atomic Energy of Canada
Ottawa, ON, Canada). Assays were performed in 96 well plates incubated at 37 C in a
final volume of 200 f.l of supplemented AIM-V media in a humidified atmosphere of
95% air-5% C02. In preliminary experiments it was determined that optimal MLN cell
proliferation in the absence of IELs was obtained after 5 days of incubation using 4.0 x
responder cells and 8.0 x 10 allogeneic stimulator cells. Unfractionated IELs and
purfied subpopulations of IELs syngeneic to the responder cells were added to cultues
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at IEL:responder cell ratios ranging between 1:400 and 2.5:1. 3 thymidine (1 Ci/well
New England Nuclear) was added to each well for the final 18-24 hours of cultue , and
total incorporation of 3 thymidine into DNA was determined as described (317). Radio-
activity was measured using a 1450 Microbeta Trilux instrment (Wallac). All assays
were performed in trplicate and averaged. The extent of suppression was calculated as a
percentage using the raw cpm and the formula:
% Suppression = r 1 - 
cpmtest allo - cpm test syn 00%
l cpmma allo - cpmma syn
where cpmtest allo are counts from the incubation of IEL, responder, and allogeneic stimu-
lator cells, cpmtest syn are counts from incubation of IEL, responder, and syngeneic stimu-
lator cells, cpmmax allo are counts from the incubation of responder and allogeneic stimu-
lator cells only, and cpmmax syn are counts from the incubation of responder and syngeneic
stimulator cells.
Transwell(8 assay
To determine if a soluble factor mediated IEL-induced suppression, mixed lym-
phocyte cultues were performed using 24-well Costar TranswellQ! plates (3 M pore di-
ameter, Fisher Scientific , Pittsburgh, P A). Responder WF MLN cells were incubated in
PBS (5.0 x 10 cells/ml) containing 1 m carboxyfluorescein succinimidyl ester (CFSE)
for 15 minutes at 37 C as described (318). After labeling, responder cells were incubated
with stimulator thymocytes from syngeneic WF or allogeneic DA or BN rats prepared as
described above, with 1.0 x 10 WF responder cells and 3.2 x 10 stimulator cells placed
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in the lower chamber of each test well. IELs from 5-7 week old WF rats (2.0 x 10 cells)
were added to either the lower chamber or the upper insert chamber of test wells. Cell
mixtures were cultured in supplemented AIM-V media at a final volume of 800 J-l per
well. Plates were incubated at 37 C for 5 days in a humidified atmosphere of 95% air-
. After harvest, the intensity of the intracellular CFSE signal in viable lymphocytes
was measured by flow micro fluorometr and used as an index of cell proliferation as de-
scribed (319). The absolute number of mitotic events that had occured per 10 responder
cells in the analysis was calculated using the method of Wells et al. (320).
ELiSpot analyses
Interferon-y and IL-4 production was first measured using a previously described
ELISpot assay with minor modifications (321 ;322). Briefly, 96-well Nunc Maxisorp
plates (Fisher Scientific) were incubated overnight at 4 C with coating antibodies (1 J-g
per well) diluted in sterile PBS. Plates were washed once with PBS (4 OC) and blocked for
2 hours with PBS containing 4% bovine seru albumin (BSA, w/v). Plates were then
washed once with PBS at 4 , and cells to be assayed were suspended in supplemented
AI-V medium and 100 J-l of the cell suspension was added to each well. The optimal
number of IELs assayed per well was determined in preliminary experiments and varied
from 1 to 9 X . The optimal number of splenocytes assayed per well was also deter-
mined in preliminary experiments and varied from 1 to 52 X 10 . For all ELISpot analy-
ses, plates were incubated at 37 C in a humidified atmosphere of 95% air-5% CO for
20-24 hours in the absence of additional stimulation except as noted. Stimuli included
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recombinant rat IL-2 (10 or 6000 U/ml) or the combination ofphorbol myrstate acetate
(PMA, 5 ng/ml) and ionomycin (0.4 Jlg/ml). After incubation, cultue media was de-
canted, and distiled H containing 0.05% Tween 20 was added to the wells for 5-
minutes to lyse the cells. Plates were then washed 5 times with PBS- 05% Tween 20
using an Ultrawash Plus plate-washer (Dynatech Laboratories, Burlington, MA). Bi-
otinylated detection antibodies (0.5 Jlg/well diluted with PBS containing 1 % BSA) di-
rected against IL-4 and IFN-y or an irrelevant antigen (trnitrophenol, TN) were then
added to test wells. Plates were agitated on a plate shaker at room temperatue for 60 to
120 minutes and then washed 5 times with PBS- 05% Tween 20.
Next, 100 Jll of a 1: 1000 dilution of alkaline phosphatase-conjugated streptavidin
in PBS containing 1% BSA was added to each well. Plates were again agitated at room
temperature for 60- 120 min, washed 10 times with PBS- 05% Tween 20, and then
washed once with PBS alone. A solution of 0.6% agarose (w/v, tye VII low gellng tem-
peratue, Sigma) containing 0. 1 M 2-amino-2-methyl- propanol (Sigma), 16.2 mM
MgCh, 0.008% Triton X-405 (v/v, Sigma), and 2.3 mM 5-bromo-4-chloro- indolyl
phosphate (Sigma) was preheated to 42 C and layered onto the plates, which were then
incubated overnight at 37 C in a humidified atmosphere of95% air-5% CO . The number
of discrete spots visible in each well was counted using a light microscope at 2x power.
Each cytokine assay was performed using 4 wells, three of which were assayed using the
cytokine-specific developing antibody and one of which was assayed using the irrelevant
biotinylated control antibody. For analysis, the number of spots observed in the control
well for each quadrplicate assay was subtracted from the number of spots counted in
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each of the three test wells. The maximum number of spots observed in any control well
was three. The adjusted number of spots present in each of the test wells was then aver-
aged. To account for the varous numbers of cells added per well, data have been nor-
malized to numbers of spots per 10 cells.
Quantification of cytokine production by cell-ELISA
The amount of IFN-y and IL-4 secreted by IELs was quantified using a modi fica-
tion of the cell-ELISA assay (323), which is designed to avoid arifact influenced by the
consumption of the cytokines that are secreted by cultued cells. For these assays , un-
stimulated unsorted, sorted and remixed IELs (1-5 x 10 per well) were processed exactly
as detailed in the first paragraph of the ELISpot method described above (through the end
of the cultue, addition of biotinylated antibodies, and washes). For quantification, addi-
tional wells were prepared in the same way at the same time, but graded amounts of
IFN-y or IL-4 instead of cells were added to these wells. Theefold dilutions of cytokine
were added to wells in amounts that ranged from 1.2-900 pg for IFN-y and 0. 33.3 pg
for IL-
After the incubation, addition of detection antibodies directed against IL-4 and
IF- or TN, and washes, 100 Jll of a 1:2500 dilution of HRP-conjugated avidin D in
PBS containing 1 % BSA was added to each well. Plates were agitated at room tempera-
tue for 60- 120 min, washed 10 times with PBS- 05% Tween 20, and then washed once
with PBS alone. Next, 100 Jll of a solution containing 0.05M Na2HP0 , 0.025 M
NaCitrate, 1 mg/ml o-phenylenediamine (OPD , Sigma), and Jlllmi 30% v/v H was
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added to each test well, and plates were incubated at room temperatue for 5- 10 minutes.
The reaction was stopped by adding 25 Jll of 3N HCl to each well , and absorbance at 790
nm was measured using a microplate reader (Model 3550, BioRad Laboratories , Hercu-
les, CA). Each IEL population (unsorted, sorted, remixed) was assayed in 6 wells of
which 3 were developed using the cytokine specific antibody and 3 with the anti- 
antibody. Each standard was assayed in 3 wells that were developed using the cytokine
specific antibody.
For wells to which the cytokine alone had been added, a standard cure was gen-
erated by linear regression using the softare supplied with the plate reader (Microplate
Manager PC, version 4. , Biorad Laboratories). Cures for both IFN-y and IL-4 were lin-
ear in the region of interest (r::0.98 for each assay). The amount of cytokine present in
each well that had been incubated with IELs was determined by the softare. Because
the cytokines produced in the course of the ELISpot were captured and not degraded, the
data are presented as pg of cytokine produced/1 0 cells/24 h. No cytokine was detected in
wells that were developed with the TN-specific detection antibody or in wells to which
neither cells nor cytokines had been added.
Statistics
Parametrc data are presented as arithmetic means :f 1 s.d. except in figures de-
picting the results of a single experiment performed in trplicate or quadruplicate. In those
instances , the result is shown as the mean :f standard error of the mean. Pairs of means
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were compared using two-tailed t-tests with separate varance estimates and the Bonfer-
roni adjustment for multiple comparisons as required (324;325).
Results of Chapter III
:';f:
J1.
The relative percentage of NKR-P1A+ cells in the intraepithelial compart-
;;'
ment of rats decreases with age
In a preliminary experiment, IELs were isolated from WF rats of different ages
and the percentage of NK-P1A + cells present was measured by flow cytometr. As
shown in Figure 15 , the percentage ofNK-P1A+ cells present in the IEL compartent
declined with age, decreasing from 50% in weanling rats to 17% in retired breeder rats
).16 weeks old. At certain time points, the percentages of NK-P1A+ CD3+ or NK-
PlA+ a~-TCR+ (NK T) cells present in the IEL compartment were also measured and
were consistently .:2% (Figure 15). The absolute number of IENK cells was determined
at two time points. I observed that the yield of IELs from 4-6 week old rats was 5. 1 :! 1.
X 10 per rat (N=7), of which an average of 5 x 10 were IENK cells. The yield of
IELs from much larger rats ).16 week old was 27.2 :! 6.4 x 10 per rat (N= 11), of which
an average of 5 x 10 were IENK cells. Except as noted, rats 4-8 weeks old were used in
subsequent experiments.
')'
::
i
~
~
~
J:-
t
' 
'
~
~
~
"
 
,
;" 
" ;:
f."
rr
i;j
''
r#~
~
~
~~
~
~
A
A
\
:;'
'''
.
.
 
30
(7)
8-
 N
KR
-
P1
A
-
V
 
N
K
R
-
P1
A
+
 C
D3
.
 
.
6.
. 
NK
R-
P
1A
 a
pr
CR
(4)
(3)
(2)
(3)
 (3
) (
3) 
(2)
 (3
) (2)
0-
 
-
0 
- 
-
-
 
8-
.
.
 
.
 
.
 
.
 
.
 
.
 
.
 
.
6,
. .
 . 
. .
 . 
.
 
.
9 
to
 1
 0
 11
 to
 1
2
A
g
e
 
(W
ee
ks
)
Fi
gu
re
 1
5:
 P
er
ce
nt
ag
es
 o
fN
K
- P
1A
+
 IE
Ls
 a
s 
a 
fu
nc
tio
n 
of
 a
ge
4 
to
 6
7 
to
 8
13
 to
 1
6
::
16
120
Figure 15: Percentage ofNKR-PlA+ IELs as afunction of age. IELs were isolated from
WF rats of either sex at various ages and reacted with either anti-NK-P1A alone, or the
combination of anti-NK-P1A mAb plus either anti-CD3 or anti-a~-TCR mAb as de-
scribed in Methods. The percentages of NK-P1 A , NK-P1A+ CD3 , and NK-P1A
a~- TCR + cells were measured by flow microfluorometr. Each data point represents the
mean:J 1 s. ; the number of independent measurements for each data point is indicated
in parentheses.
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Intraepithelial and splenic NKR-P1A + CD3- NK cells express different cell
surface antigens
It is known that intraepithelial and splenic NK cells differ with respect to the ex-
pression of at least two cell surface antigens. The majority of splenic NK cells express
CD2 and CD8a, whereas -:10% oflENK cells express these surface antigens (26;54). To
investigate whether intraepithelial and splenic NK-P1A+ CDT NK cells differ pheno-
tyically in other respects, I measured the expression of a panel of cell surface antigens
on both populations. Using 7 week old WF rats, I confirmed that the percentage of cells
expressing CD2 and CD8a was significantly lower in the IENK than in the splenic NK
cell population (Table 6). In addition I observed several other differences of substantial
magnitude. The percentage of cells expressing CD5 , CD45RC, and CD54 was also sig-
nificantly lower in the IENK than in the splenic NK cell population. Conversely, the per-
centage of cells expressing CD25 and ART2b was significantly higher in the IENK than
in the splenic NK cell population. Only CD28 was expressed on similar percentages of
IENK and splenic NK cells. Representative histograms documenting the expression of
CD2, CD8a, ART2b, CD25 , and CD45RC on IENK and splenic NK cells are shown in
Figure 16.
Purified populations of intraepithelial and splenic NK cells are morphologi-
cally similar
Because IENK cells differ from splenic NK cells phenotyically, these populations were
next purified by flow cytometr as described in Methods and examined for the
.
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Figure 16: Phenotypic analysis ofintraepitheUal and splenic NK cells. Shown in the left-
most upper and lower panels are representative flow cytometrc profiles of NK-P1A
(horizontal axis) and CD3 (vertical axis) staining of intraepithelial lymphocytes (IELs
upper panel) and splenocytes (lower panel) prepared from 7 week old WF rats. Cells in
the indicated gated regions (N-P1A+ CDT) were selected and analyzed for expression
of each indicated antigen. In each of the histograms, intensity of labeling (horizontal axis)
is plotted against cell number (vertical axis). Solid lines indicate fluorescence associated
with specific staining, and the dashed lines indicate fluorescence associated with isotye
control antibody staining. The experiment was repeated on cell samples from at least 3
individual animals, all of which yielded comparable results. The overall data set for each
population is presented in Table 6.
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presence of the azurophilic cytoplasmic granules that are characteristic of peripheral NK
cells (314). Light microscopic analysis revealed that nearly all cells in the purfied IENK
population had the appearance of large granular lymphocytes with azrophilic granules
(Figure 17 A). These granules were even more prominent than those present in purfied
splenic NK cells (Figue 17B). Azophilic granules were absent in the majority of intra-
epithelial (Figure 17C) and splenic (Figure 17D) T cells.
Both intraepithelial and splenic NK cells lyse NK-sensitive targets
I next measured specific lysis of NK-sensitive Y AC- 1 cells (315) and NK-
! '
resistant C58NT(D) cells (316) in the presence of unfractionated IELs and monocyte-
depleted spleen cells. Both IELs and monocyte-depleted spleen cells kiled Y AC- 1 but
not C58NT(D) targets (Figue l8A). Flow microfluorometrc analysis of the IEL and
spleen cell populations in these two experiments revealed that 44-58% and 8-9% of each
population, respectively, consisted of NK-PlA + cells. Re-analyzing the data in Figue
18A using effector-to-target cell ratios based on these percentages, I found that the spe-
cific killng of Y AC- l cells by NK-P1A+ IENK and splenic NK cells was similar at
similar calculated NK-to-target cell ratios (Figure 18B).
To exclude the possibility that cytotoxic T cells may have contrbuted to Y AC-
kiling by unfractionated IELs , the experiment was repeated using purified populations of
NK-P1A+ and NK-P1A- IELs. In this experiment, 35% of IELs were NK-P1A . I
observed that NK-P1A+ IELs effciently kiled Y AC- 1 targets, whereas NK-P1A-
IELs did not (Figure 18C). In control experiments, I observed that unstained, unsorted
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Figure 17: Morphology of purifed IENK cells and T cells in IEL preparations. Intraepi-
theliallymphocytes (Panels A, C) and splenocytes (Panels B , D) were isolated from 4-
week old WF rats and sorted into NK-P1A+ CDT (Panels A, B) and NK-P1A- CD3
(Panels C , D) fractions , which were then reacted with Wright-Giemsa stain. Purfied NK
cells exhibit the morphology of large granular lymphocytes , with abundant azophilic
granules (arrows) present in the cytoplasm (Panels A, B). Few purfied T cells exhibit
azurophilic granules (Panels C, D). Splenic but not intraepithelial T cells also appear in
general to be smaller than splenic NK cells. (x 100).
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Figure 18: Cytotoxic activity of IENK cells. Panel A: IELs and monocyte-depleted sple-
nocytes (SPCs) were prepared from WF rats 5-6 weeks of age and immediately tested for
their abilty to kil Y AC- l and C58NT(D) cells as described in Methods. Each data point
represents the average of two individual experiments, each performed in trplicate. Panel
B: For both experiments in Panel A, the percentage of NK-P1A + cells in each effector
cell population was determined by flow micro fluorometr. In those two individual ex-
periments, the percentages ofNK-P1A+ IELs were 59% and 44% , and the percentages
of NK-P1A + spleen cells were 8% and 9%. These percentages were then used to cal-
culate NK:target cell ratios using the raw data from Panel A. Open and filled symbols
represent the data from the individual experiments, and each data point represents the
mean of a trplicate determination. Panel C: IELs were isolated from 6-week-old WF rats.
An aliquot of these cells was not manipulated further. Another aliquot was reacted with
anti-NK-P1A antibody and not manipulated fuher. A final aliquot was reacted with
anti-NK-P1A antibody and then fractionated by flow micro fluorometr. A final popu-
lation of effector cells was generated by remixing sorted NK -PI A + and NK -PI A- cell
populations at the 35:65 ratio of the pre-sort IEL preparation. Each cell population was
tested for its ability to kil Y AC- 1 cells. Each data point represents the mean of a single
experiment performed in triplicate. The experiment was repeated a second time with
similar results.
,'P
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IELs and stained, unsorted IELs exhibited similar Y AC- 1 kiling activity. Finally, sorted
NK-P1A+ and NK-P1A- IEL fractions that were remixed at the pre-sort ratio of35:65
also exhibited Y AC- 1 kiling at IEL:Target ratios comparable to those observed using
unsorted IELs (Figue 18C).
Intraepithelial NK cells suppress mixed lymphocyte cultures
Because splenic NK cells are known to suppress mixed lymphocyte cultures
(64;68), I analyzed NK cells of intra epithelial origin for similar capability. In preliminary
experiments , unfractionated IELs isolated from 7- 15 week old WF rats were tested for
their ability to suppress a one-way allogeneic MLC. I observed that responder cell prolif-
eration to alloantigen was substantially reduced in the presence of IELs at IEL:responder
ratios of approximately 1:10 or greater (Figue 19A). At such ratios, proliferation was
reduced to levels observed in control experiments using syngeneic stimulator cells. In
additional control experiments , responder cells did not proliferate in the presence of IELs
alone, nor did IELs proliferate in the presence of allogeneic stimulator cells alone (data
not shown).
Having demonstrated that IELs can suppress a one-way MLC, I next sought to determine
which subpopulation of IELs was responsible for the effect. IELs from WF rats were
fractionated into NK-P1A+ CDT IENK and NK-P1A- CD3+ intraepitheial- (IE-) T
cell subpopulations, and their ability to suppress alloreactive T cell proliferation was
compared. As shown in Figure 19B , the suppressive activity of sorted IELs appeared to
be restrcted exclusively to the IENK subpopulation. There was no suppressive activity
100
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Figure 19: Suppressor cell activity of IELs. Panel A: IELs were isolated from WF rats 7-
15 weeks of age and immediately tested for their ability to suppress a one-way MLC as
described in Methods. Responder cells were WF mesenteric lymph node cells. Stimulator
cells were thymocytes from either syngeneic WF rats or allogeneic DA (filled symbols)
or BN rats (open symbols). Shown are the results of two individual experiments. The ab-
solute cpm (mean :t SEM of a trplicate determination) associated with positive control
allogeneic MLCs performed in the absence ofIELs was 4.2 :t 0.3 x 10 for tral 1 and 8.
:t 0.3 X 10 for tral 2. The cpm for negative control syngeneic MLCs was 0.2:t 0.0 x 10
in both trals. Panel B: IELs were isolated from 5-7 week old WF rats, reacted with anti-
NK-P1A and anti-CD3 antibodies, and fractionated into NK-P1A CDT IENK and
NK-P1A-CD3+ IE-T cell populations by flow microfluorometr. The purity of each
fractionated subpopulation was :;95%. For the assay of remixed cells , the ratio of IENK
to IE- T cells was 3 :2 , approximately the same as that in the pre-sort IEL preparation. The
data shown in Panel B represent the result of a single experiment performed using BN
allogeneic stimulator cells; comparable results were obtained in a second independent
tral using DA allogeneic stimulator cells. The absolute counts per minute for allogeneic
and syngeneic MLCs performed in the absence oflELs was 9.2 :t 0.5 x 10 and 0. 1 :t 0.
X 10 , respectively. Each data point in both panels represents the mean percent suppres-
sion of a trplicate assay:! SEM, calculated as described in Methods. There were no dif-
. :!
ferences in outcome as a function of the strain of the stimulator cell donor (DA or BN).
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associated with sorted IE- T cells. The suppressive activity of sorted IENK and IE- T cells
that were subsequently remixed was comparable to that of both sorted IENK cells alone
(Figure 19B) and unsorted IELs (Figue 19A).
Having demonstrated that NK-P1A CDr (IENK) cells are responsible for IEL-
mediated suppression of a one-way MLC, I next sought to determine whether a soluble
mediator or cell-to-cell contact was more likely to be responsible for this effect. In this
experiment, the MLC was performed using Transwelli! methodology, and the prolifera-
tion of CFSE-labeled responder cells in contact with unfractionated IELs was compared
with the proliferation of responder cells separated from IELs cells by a permeable mem-
brane. As shown in Figue 20, retention of fluorescence, indicative of suppression, oc-
curred when responder cells, allogeneic stimulator cells and IELs were incubated on the
same side of the Transwelli! membrane. Loss of fluorescence , indicative of responder cell
proliferation and an increase in the absolute number of mitotic events, occurred when re-
sponder cells and allogeneic stimulator cells were separated from IELs by the membrane.
IENK cells spontaneously produce IFN-y and IL-4
To investigate the possible immunoregulatory role of IENK cells , I measured their secre-
tion of IFN-y and IL-4 using ELISpot methodology. In a preliminar experiment, IELs
were isolated from 5- 11 week old WF rats and incubated overnight in the presence of
PMAIionomycin or IL-2 (10 U/ml). I observed that the frequencies of IFN-y secreting
IELs under these conditions of stimulation were 25 and 45 spots/1 cells, respectively. In
three separate assays, however, the frequency of cells secreting IFN-y in the absence of
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Figure 20: Suppressive activity of IELs in a one-way MLC. A one-way MLC was per-
formed using a Transwelli! apparatus. IELs were isolated from 5-7 week old WF rats. WF
responder cells were labeled with CFSE, and WF syngeneic and DA allogeneic stimula-
tor cells were prepared as described in Methods. Cells were harvested after 5 days of
culture and the intensity of CFSE labeling in the recovered cell population was deter-
mined by flow micro fluorometr using a lymphocyte gate. The overall percentage of re-
sponder cells with reduced CFSE fluorescence , indicative of proliferation, is indicated for
each experimental condition. In addition, the absolute number of mitotic events that had
occured per 10 responder cells in the analysis was estimated by the method of Wells
al. (320); these calculated numbers are shown in rectangles in each panel. In the absence
of IELs , as expected, proliferation of allogeneic but not syngeneic responder cells was
observed (Panels A, B). When IELs were incubated with responder and stimulator cells
on the same side of the Transwelli! membrane , the proliferation of allogeneic responder
cells was reduced to a level comparable to that observed for syngeneic responder cells
(Panels C , D). In contrast, when IELs were separated from responder and stimulator cells
by the Transwelli! membrane , the proliferation of allogeneic responder cells (Panels E , F)
was similar to that observed in the absence ofIELs (Panels A, B). The two insets present
magnified views of the low intensity CFSE gate demonstrating periodic peaks of label-
ing, consistent with waves of proliferation as described (319). Shown are the results of
one of two experiments using different IEL preparations that yielded similar results.
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any in vitro stimulating agent was comparable: 33 , and 23 spots/10 cells. The results
for IL-4 in this same experiment were similar. PMAionomycin and IL-2 stimulated cells
generated 22 and 55 spots/l04 cells , respectively, and cells cultured in the absence of 
vitro stimulation yielded 35 , 39 , and 46 IL-4 spots/10 cells.
I next tested the hypothesis that IENK cells spontaneously secrete IFN-y and IL-
and were the source of these cytokines in my preliminary experiment. Because the secre-
tion of IL-4 has not previously been associated with peripheral NK cells, populations of
spleen cells were assayed in parallel with cells of intestinal origin. As shown in Figure
, I confirmed by ELISpot that the frequency of un-stimulated IELs that produced either
IFN-y or IL-4 was substantial. In contrast, few un-stimulated splenocytes produced IFN-
and none appeared to produce IL-4. Addition of up to 6000 U/ml IL-2 to these cultures
resulted in only a modest increase in the frequency of cells that secreted IFN-y and no
increase in the number of cells that secreted IL-
Analysis of sorted populations of IENK and IE- T cells localized the production of both
IFN-y and IL-4 by IELs to the IENK subpopulation (Figure 21). Additional assays con-
firmed that un-stimulated splenic NK and T cells did not spontaneously secrete IL-4 and
only a few secreted IFN-y. Addition of 10 U/ml IL-2 to the splenic NK cell cultures had
little effect on the number of cells that produced either cytokine. When 6000 U/ml was
added to the splenic NK cell cultures, the frequency of cells that produced IFN-y rose to
levels comparable to those observed for un-stimulated IENK cells, but the number of
cells that produced IL-4 remained low. The frequency of sorted intraepithelial and splenic
T cells that secreted IFN-y was small, and no cells that secreted IL-4 were detectable.
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Figue 21: IENK cells spontaneously produce IF- and IL-
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Figure 21: IENK cells spontaneously produce IFN-y and IL-4. Intraepitheliallympho-
cytes and splenocytes were isolated from 4-8 week old WF rats as described in Methods.
Pools of IELs from 8- 10 donors and splenocytes from 2 donors were processed to gener-
ate five populations for assay. One aliquot of cells of each tye (unstained unsorted cells)
was not further manipulated. The remaining cells were reacted with anti-NK-P1A and
anti-CD3 antibodies; one aliquot of these (stained unsorted cells) was not further ma-
nipulated, and the remaining cells were fractionated by flow micro fluorometr into NK
cell (purifed NK cells) and T cell (purifed T cells) populations. A final population of
cells (remixed NK and T cells) was prepared from aliquots of fractionated NK and T cells
that were re-mixed at the same ratio as that determined by flow micro fluorometr to have
been present in the pre-sort cell preparation. IEL samples (white bars) were incubated
overnight in the absence of any in vitro stimulation. Splenocyte samples were incubated
in the presence of 0 (crosshatched bars), 10 (black bars), or 6000 (diagonal bars) U/ml of
IL-2. Each preparation of sorted, unsorted, and re-mixed cells was then assayed in trpli-
cate for the presence of IFN-y (Panel A) or IL-4 (Panel B) by ELISpot as described in
Methods, and data are reported as spots per 10 cells added to the assay. The analysis of
IELs (open bars) was repeated four times, including two assays that were also used to
generate the additional data shown in Figure 22. The analysis of all other cell populations
was repeated twice. Each bar represents the average of the two or four independent trals.
,"!
In the case of data points with values greater than 10 spotS/1Q4 cells, markers (.) indi-
cate the actual values obtained in the trials.
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Comparable and consistent results were obtained in control assays of stained, unsorted
cells and a remixed population of sorted NK and T cells (Figue 21).
To exclude further any possibility that contaminating IE- T cells may have been
responsible for the cytokine production attbuted to the IENK population, an additional
ELISpot assay was conducted. In this assay, graded numbers of purfied IE- T cells were
added to a constant number of purified IENK cells, and the number of IFN-y and IL-
producing cells measured as above. As shown in Figue 22, there was no detectable
change in the number of cytokine producing cells as a fuction of the number of IE- T
cells that were added to the IENK cells. In each experimental condition, the number of
cytokine-positive cells , when expressed as positive cells per 10 IENK cells in the assay,
remained constant.
Quantification of IFN-y and IL-4 production by IENK cells
Having quantified the number of IENK cells that produced IFN-y and IL-4 spon-
taneously, I next sought to determine the amount of cytokine produced. To circumvent
the problem of reutilization of cytokines inherent in such determinations , I developed the
modified "cell-ELISA" (323) described in Methods. As shown in Figue 23 , I again con-
firmed that un-stimulated IELs and IENK cells, but not IE- T cells , produce readily de-
tectable quantities of both IFN-y and IL-4. IENK cells produced IFN-y at a rate of -150
pg/10 cells/24 hand IL-4 at a rate of -1 pg/IQ4 cells/24 h. Results for unsorted and re-
mixed IELs gave consistent results based on the fraction of IENK cells present in these
.:y
populations.
200
150
100
200
150
100
IENK Cells (x10 )
IE- T Cells (x10 )
Figue 22: IE-T cells do not affect the production ofIFN-y and 1L-4 by IENK cells
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Figure 22: The presence of IE-T cells does not affect the spontaneous production of IFN-
rand IL-4 by IENK cells. Purfied populations of IENK and IE- T cells were prepared
from 8- 10 WF rats (4-S weeks old) by flow microfluorometr as described in Methods.
Graded numbers of purfied IE- T cells were added to a constant number of purified IENK
cells as indicated, and each cell mixtue was assayed in trplicate by ELISpot to quantify
the number of cells secreting IFN-y (Panel A) or IL-4 (Panel B). Data are reported as
spots per 10 IENK cells added to the assay. The experiment was performed twice; mark-
ers (.) indicate the values obtained in each tral, and the bars indicate the average value.
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Figue 23: Quantity ofIFN-y and IL-4 produced by un-stimulated IENK cells
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Figure 23: Quantity of IFN-y and IL-4 produced by un-stimulated IENK cells. Purfied
IENK and IE- T cells were prepared from 8- 10 WF rats (4-8 weeks old) as described in
Methods. Unsorted, sorted, and remixed populations were incubated overnight in the ab-
sence of any in vitro stimulation. The amount of IFN-y (Panel A) and IL-4 (Panel B) se-
creted by each preparation was then quantified by "cell-ELISA" as described in Methods.
Data is reported as pg of cytokine produced/10 cells/24 h. The experiment was per-
formed twice; markers (.) indicate the values obtained in each tral, and the bars indicate
the average value.
-:,."
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Discussion of Chapter III
Summary of findings
Situated at the intestinal epithelium, IELs are in direct contact with lumenal anti-
gens and are among the first cells to encounter intestinal pathogens (15;209). Although
numerous reports have identified in vitro and in vivo fuctions for IELs , the role of these
cells in the intestinal immune system remains unclear in part because IELs have been
notoriously diffcult to isolate. In developing an isolation protocol that yields large num-
bers of highly pure IELs, I have recently overcome this impediment and described a
population ofNK-P1A+ CDT IELs.
Lymphocytes that express the NK-P1 surace antigen but not a T cell receptor
are NK cells (44;45;52;55;326). This definition distinguishes NK cells from NKT cells
which co-express NK-P1 and a functional TCR (46;50;51). Accordingly, I have termed
NK-P1A+ CDT IELs "intraepithelial natual killer" cells. My preliminary observation
that IENK cells comprise a significant percentage of rat IELs, paricularly in young ani-
mals , warranted their fuher study. Using the new IEL isolation methodology, I was able
to investigate phenotyic and functional characteristics of IENK cells. Although these
experiments were conducted in WF rats, significant numbers of IENK cells are present in
at least one other rat strain (54).
145
Similarities between intraepithelial and splenic NK cells
Morphology
Azrophilc , cytoplasmic granules were present in the majority of purfied NK-
P1A+ CDT IELs and splenocytes. Such granules have long been observed in peripheral
NK cells (327) and harbor cytotoxic molecules like perf orin (56). Granules in IENK cells
were noticeably more prominent than those in splenic NK cells, but the significance of
this observation is unown. Contaminating IENK cells may have accounted for the oc-
casional granular cell present in the purified NK -PI A - CD3 + IE- T cell fraction, but yo T
cells , which constitute a significant percentage of CD3+ IELs in rats (26), also exhibit a
granular morphology (328).
Cytotoxicity
The ability of freshly isolated lymphocytes to kil Y AC- 1 cells is a hallmark of
NK cytotoxicity (314;315), and rat IELs kil these NK-sensitive targets (228). My ex-
periments confirmed that, when normalized for NK-P1A + cells, freshly isolated IELs
and splenocytes kill Y AC- l cells at comparable effciencies. I extended these findings by
localizing Y AC- 1 specific lysis to purfied NK-P1A+ IELs, which actually demon-
strated enhanced NK activity as compared to unsorted or remixed populations. This sug-
gests that NK-P1A- IELs interfere with IENK cytotoxicity, but it remains to be deter-
mined whether NK-P1A- IELs actively suppress IENK cytotoxicity or whether purified
NK-P1A+ IELs, removed from NK-P1A- cells , simply encounter Y AC- 1 targets more
frequently. A similar observation has been made in mice splenocytes (327). It should be
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noted that, under the experimental conditions described here, labeling IENK cells with
anti-NK-P1A mAb does not enhance kiling activity. Moreover, the exclusion of NKT
cells from analyses of purfied NK-P1A+ IELs was unecessary because, in the absence
of high-dose IL-2 stimulation in vitro NKT cells exhibit poor Y AC- 1 kiling (46). Inter-
estingly, maximal Y AC- l specific lysis by rat IELs occurs in weanling animals (229), an
observation consistent with my ontogeny data. In summary, the experiments presented
here show that Y AC- l specific lysis by rat IELs is attbutable to IENK cells.
Suppression of oneway mixed lymphocyte culture
A growing number of reports have demonstrated that NK cells possess suppres-
sive activity in vitro and in vivo (64-71), and NK-mediated suppression of a oneway
MLC is thought to occur via killng of allogeneic antigen presenting cells (64;68). In my
one way MLC , IENK cells act as potent suppressors of T cell proliferation. Equal num-
bers of IE- T cells do not suppress the MLC, arguing against competition for nutrents in
the media as a mechanism of suppression. Furhermore, both IENK and IE-T cells ex-
press similar levels of CD25 (26), so the explanation that IENK cells act as an "IL-
sink" is equally unlikely. The blockade of IEL suppression by a TranswellCI membrane
suggests that cell-to-cell contact is necessary for suppressive activity, although a highly
localized release of inhibitory cytokines by IENK cells cannot be ruled out. The exact
mechanism whereby cell-to-cell contact would result in IENK-mediated suppression ofT
cell proliferation remains unanswered, but it may involve killng of allogeneic APCs or
direct suppression of allo-reactive T cells. My results do not necessarily contradict those
"- .y
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of previous studies, which have shown that rat IELs exert suppressive activity through
soluble mediators (214;292;322;329). IEL preparations from such studies may have been
contaminated by significant numbers of intestinal epithelial cells that may interfere with
in vitro IEL assays (296;330).
Differences between intraepithelial and splenic NK cells
Phenotypic differences
Phenotyic differences between intraepithelial and circulating T cells have con-
trbuted to the theory that IELs represent a distinct T cell compartent with unique ori-
gins and functions (209). My flow microfluorometrc analyses of CD2 , CD8a, CD5
CD25 , CD45RC, CD54, and ART2 suggest that the same is tre for IENK cells as com-
pared to splenic NK cells. With respect to expression of ART2 , CD45RC , and CD25
IENK cells more closely resemble IE- T cells (26) than splenic NK cells, implying that
the intraepithelial environment may influence the expression pattern of these surace an-
tigens. Nearly all IENK cells display the ART2+ CD45RC- phenotye associated with
peripheral CD4+ regulatory T cells in the rat (133;331). Intraepithelial but not splenic NK
cells also express CD25 , the IL-2Ra molecule expressed by activated T and NK cells
(332). Interestingly, a population of CD25+ cells has recently been associated with regu-
latory activity mediated by cell-to-cell contact (333-335). In fact, -85% and -30% of
overall IELs in rats and humans, respectively, express CD25 (26;336).
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Spontaneous secretion of IFN-y and IL-
Upon activation, peripheral NK cells secrete IFN-y (56), and activated NKT cells
can produce both IFN-y and IL-4 (46). At the time of this article, however, no manuscript
known to the authors has reported IL-4 production by NK- + CDT NK cells. There-
fore, I was surprised to find that 1-2% of freshly isolated IENK cells tested positive in
both IFN-y and IL-4 ELISpots. Convincing evidence for the presence of dual-secretors
was not attainable by this assay. The frequencies observed for spontaneous IFN-y and IL-
4 secretion are similar to those for mouse IE- T cells, which spontaneously secrete IFN-
(and IL-5) (209;253;337). Clearly, however, mouse and rat IELs are different, as very
few rat NK-P1A- CD3+ IE-T cells spontaneously produce IFN-y or IL-4. Spontaneous
cytokine production provides additional evidence that rat IENK cells are activated. Inter-
estingly, freshly isolated IENK cells appear maximally activated because, despite their
expression ofCD25 , addition ofIL-2 to the ELISpot assay fails to up-regulate production
of either cytokine. The observation that splenic NK cells
, stimulated in vitro with 6000
U/ml IL- , produce IFN-y at frequencies similar to those of unstimulated IENK cells
challenges the hypothesis that these are trly distinct cell populations. Perhaps the phe-
notyic and functional differences between intraepithelial and splenic NK cells are sim-
ply a consequence ofIENK cells being activated in vivo. Such reasoning would not have
predicted, however, the marked difference in IL-4 secretion between unstimulated IENK
cells and stimulated splenic NK cells. Thus, despite similarities in morphology, cytotox-
icity, and MLC suppression, the different phenotyic and functional characteristics of
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intraepithelial and splenic NK cells provide strong evidence that these are indeed two
distinct cell populations.
IENK cells and active immune responses in the intestine
Because of their location at the intestinal epithelium, IELs are believed to func-
tion as a "first line of defense" against intestinal pathogens (8; 19), and numerous in vitro
studies have suggested a role for IELs as effector cells in intestinal immune responses.
IELs display several cytotoxic activities in addition to NK cytotoxicity, including anti-
gen-specific cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and activity in
redirected cytotoxicity assays (209). Upon stimulation, IELs express inflammatory Th1-
associated cytokines like IFN-y (15;209). Ligands for intraepithelial yo T cells include
mycobacterial and synthetic non-peptide phosphoantigens , mycobacterial and autologous
heat shock proteins, and the epithelial stress antigens MICA and MICB (8; 19;247;338).
Several in vivo studies support the arguent that IELs playa role in intestinal
immune responses to pathogens. Viral infection induces expansion of IFN-y secreting
IELs (272;273). Adoptive transfer of IELs from Toxoplasma- infected mice protects re-
cipients from disease presumably via mechanisms involving IFN-y (268-270). In rats, the
CD4+ IEL population expands with age in conventionally housed but not in germ free
animals (217). Taken as a whole, both in vitro and in vivo experiments support the ar-
guement that IELs playa protective role against pathogens in intestinal immune re-
sponses.
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Peripheral NK cells are a critical component of the innate immune system, and
mice inoculated with a murine cytomegalovirus exhibit enhanced viral replication if de-
pleted of NK cells prior to infection (339-341). In this manuscript, I have demonstrated
that IENK cells share phenotyic and functional similarities with peripheral NK cells
suggesting that IENK cells playa role in mucosal defense. To this end, natural cytotoxic-
ity may delete infected or transformed epithelial cells, and IFN-y has been shown to in-
crease epithelial cell permeability and up-regulate expression of MHC class II (209). The
expression of CD25 and spontaneous secretion of IFN by IENK cells suggest that these
cells are constitutively activated in vivo perhaps scouring the epithelium for
stressed/damaged epithelial cells.
IENK cells and "Physiologic Inflammation" in the intestine
Despite their vast numbers and continuous exposure to intestinal antigens, T lym-
phocytes of the intestinal epithelium and lamina propria appear to be restrcted to a state
of "physiologic inflammation" by as of yet undefined regulatory mechanisms (185). A
systemic manifestation of this mucosal tolerance is the phenomenon of oral tolerance
whereby orally administered antigens induce antigen-specific nonresponsiveness in sys-
) .
temic lymphocytes (285). Disruption of mucosal tolerance has been postulated to con-
trbute to inflammatory and allergic disorders that are not necessarily limited to the intes-
tine (185). Autoreactive T cells also exist in the IEL, presumably because a portion of
IELs are non-thymic ally derived and therefore evade traditional selection processes
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(230;231;243;342;343). Consistent with mucosal tolerance
, autoreactive IELs do not
normally cause disease (244;344;345).
Several factors appear to contrbute to mucosal tolerance. Intestinal epithelial
cells present antigen via non-classical CD 1 d molecules and induce CD8+ suppressor cells
that may help protect patients from inflammatory bowel diseases (185;201;261). Fur-
thermore, regulatory cytokines like IL- , IL- , and TGF-~ protect animals from in-
flammatory bowel disease and are critical to the induction and maintenance of oral toler-
ance diseases (199;280;285 ;291 ;346). In addition, altered mechanisms of TCR signaling
make IELs relatively nonresponsive to mitogen stimuli when compared to peripheral
lymphocytes (257-259;347;348).
Consistent with mucosal regulatory activity, IENK cells suppress T cell prolifera-
tion and secrete the immunoregulatory cytokines IFN-y and IL-4. Whether IENK cells
communicate with other mucosal lymphocytes remains to be determined
, however. It is
conceivable that IENK cells inhibit aberrant mucosal immune responses by directly sup-
pressing T cell proliferation or by killng inappropriately activated APCs. With respect to
the secretion of IFN-y and IL- , IENK cells resemble peripheral NKT cells which have
recently been shown to possess regulatory activity 
in vivo (46;47;349;350). The mecha-
nism whereby NKT cells regulate immune responses may involve IL-4 drven deviation
from cell-mediated immunity (Thl) to humoral mediated immunity (Th2) (46). Co-
secretion ofIL-4 and IFN-y is also a fuction of ThO-tye T cells , a T cell population that
is postulated to be the precursor to Th I-
tye and Th2-tye T cells. Because IENK cells
lack surface expression of a T cell receptor complex and because I am unable to show
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IFN-y and IL-4 dual secreting cells, I cannot claim that IENK cells are NK T cells or ThO
cells. It remains an attactive hypothesis that IENK cells regulate immune responses at
the intestinal epithelium through the differential expression of IFN-y or IL-4. It should be
noted that IENK-mediated secretion of IL-4 is independent a TCR signal, further sup-
porting the argument that the IEL compartent is unique.
Conclusion to Chapter II
In conclusion. I have demonstrated that the rat IEL compartent harbors a large
population of NK-P1A CDr cells that fuction as NK cells but display an activated
vhenotye and highly unusual cvtokine profile that clearly distinguish them from splenic
NK cells. Their phenotyic and fuctional characteristics suggest that these distinctive
intraepithelial NK cells may Varticipate in the regulation of mucosal immunitv.
-:,
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CHAPTER IV
DEFICIENCIES IN GUT NATURAL KILLER CELL NUMBER AND
FUNCTION PRECEDE DIABETES ONSET IN BB RATS
Summary of Chapter IV
BBDP rats spontaneously develop autoimmune diabetes mellitus and are severely
deficient in peripheral T cells. BBDR rats do not spontaneously develop autoimmune
diabetes , have normal numbers of peripheral T cells, and can be induced to become dia-
betic by injection ofa cytotoxic anti-ART2a mAb and low doses of poly I:C. Using a new
quantitative method of isolating large numbers of highly purfied intraepithelial lympho-
cytes, I have documented previously the presence of a major IEL subpopulation that exhib-
its phenotyic and fuctional properties of activated natual killer cells. Intraepithelial NK
cells also secrete spontaeously the immunoregulatory cytokines IFN-y and IL-4. I now
demonstrate that, prior to diabetes, both BBDP and ART2a-depleted BBDR rats have a
reduced total number of IELs and exhibit a selective deficiency of IENK cell number and
fuction as compared to control BBDR rats. The deficiency ofBBDP rat IELs can be cor-
rected by engraftment of bone marow from histocompatible WF donors. My results sug-
gest 1) that the peripheral lymphopenia in BBDP rats extends to the IEL compartent
particularly to IENK cells, 2) that in BBDR rats the diabetes-inducing treatment depletes
f:1
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IELs, paricularly IENK cells, and 3) that the defect in BBDP rat IELs is intrnsic to
hematopoietic cells, not intestinal stromal cells.
Introduction to Chapter IV
The cause of autoimmune diabetes in BB rats, NOD mice , and humans is stil un-
known, but both genetic and environmental factors appear to participate. One important
class of environmental factors--iet and enteromicrobial agents-participates in this
pathogenic process through the ediation of the gut immune system. Gut immune tissue
is regulated by unique mechanisms that control the physiological inflammation induced
by huge antigen loads. It harbors unique lymphoid populations that respond to alternative
activation pathways and subserves oral tolerance (185). I hypothesize that defects in gut
immunity predispose to systemic autoimmunity and diabetes, and I have tested that hy-
pothesis in the BB rat.
BBDP rats , which are severely T celllymphopenic, spontaneously develop auto-
immune diabetes mellitus (4). BBDR rats, which were derived from BBDP forebears, are
non-lymphopenic and never become spontaneously diabetic when housed in a V AF envi-
ronment (4). BBDR rats do, however, become diabetic in response to infection with
KRV, depletion of ART2a+ regulatory T cells, and/or immune system activation with
poly I:C (4). Both BBDP and BBDR rats appear to share a common diabetes susceptibil-
ity locus iddm4 but only the former is homozygous for the lyp locus responsible for
lymphopenia (351 ;352).
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In recent studies, I have documented the existence of a new population of intra-
epithelial gut natual killer cells in the rat that spontaneously secrete IL-4 and IFN-
Here I report that cells with these characteristics appear to be dramatically deficient in
BBDP rats and in BBDR rats that are treated to induce autoimmune diabetes.
Materials and Methods of Chapter IV
Animals
BBDR and BBDP rats were obtained from BMR, Inc (Worcester, MA). WF rats
were obtained from Harlan Sprague Dawley (Indianapolis, IN). Animals of either sex
were used in all experiments. All animals were certified to be serologically free of Sendai
virus, pneumonia virus of mice, sialodacryoadenitis virus , rat corona virus , Kilham rat
virus , HI (Toolan s virus), mouse poliovirus (GD7), Reo- Mycoplasma pulmonis lym-
phocytic choriomeningitis virus , mouse adenovirus , Hantaan virus , and Encephalitozoon
cuniculi. All animals were housed in a V AF facility until used and maintained in accor-
dance with recommendations in the Guide for the Care and Use of Laboratory Animals
(Institute of Laboratory Animal Resources, National Research Council, National Acad-
emy of Sciences, 1996) and the guidelines of the Institutional Animal Care and Use
Committee of the University of Massachusetts Medical School.
Antibodies
Fluorochrome-conjugated mAbs directed against CD3 (clone G4. 18), NK-P1A
(clone 10/78), and RT7.2 (clone HIS41) were obtained from BD PharMingen (San Diego
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CA). Tissue culture supernatant containing the NDS58 rat anti-rat RT7.l (IgG2b) was
obtained from Serotec, Ltd. (Oxford, UK). Hybridoma cells secreting the DS4.23 rat anti-
rat ART2a (IgG2b) are maintained in our laboratory. For measurement of IL-4-secreting
cells by ELISpot, paired mAbs (purfied OX-81 and biotinylated Bll-3) directed against
IL-4 were obtained from BD PharMingen. For measurement of IFN-y by ELISpot, the
captue mAb (clone DB- I) was obtained from BioSource International (Camarillo, CA)
and the detection rabbit anti-rat IFN-y polyclonal antibody was obtained from Torrey-
Pines Biolabs (La Jolla, CA) and biotinylated as described (313). Isotye control mouse
IgGl and mouse IgG3 , secondary antibody (anti-rat IgG2b), and alkaline phosphatase-
conjugated streptavidin were purchased from BD PharMingen.
Diabetes induction protocol
To induce diabetes, BBDR rats 25-28 days of age were treated with intraperito-
neal injections of DS4.23 mAb (50 Jlg 5 times weekly) and poly I:C (5 Jlg/100 g body
weight 3 times weekly) as described (125). Rats were treated for one week, approxi-
mately half the time required for diabetes onset (125).
Cell preparation and bone marrow transplantation
Intraepithelial lymphocytes were prepared from rat small intestine by Percoll(!
density gradient centrfugation using minor modifications of a method developed in our
laboratory (26). Viable cell numbers were quantified by the method of Tryan blue using
a hemocytometer. Cells for bone marrow transplantation were prepared from 6 week old
donor rats as described (353). Bone marrow recipients 6 weeks of age were treated with
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750 rads of gamma radiation (-0. 1 Gy/min) using a 13 Cs source (Gammacell 40, Atomic
Energy of Canada, Ottawa, ON, Canada) and immediately injected intravenously with
150-200 x 10 bone marrow cells.
Flow cytometry
Single and two-color flow cytometrc analyses were performed as described (26).
Briefly, 1 x 10 viable lymphocytes were suspended in ice-cold F ACS medium (isotonic
PBS supplemented with 1 % FetalcloneOY I) and reacted as indicated with purified NDS58
anti-RT7.1 mAb for 30 min. at 4 C. Cells were then washed with FACS medium and re-
acted with FITC- and PE-conjugated antibodies for 30 min. at C. Cells reacted with
NDS58 mAb in the primary incubation were reacted with FITC-conjugated anti-rat
IgG2b mAb in the secondary incubation to visualize RT7. 1 staining. All samples were
then washed with F ACS medium and fixed with 1 % paraformaldehyde in PBS. FITC-
and PE-conjugated isotye control immunoglobulins were used for all analyses. Cells
were analyzed using a FACScanOY instrment (Becton Dickinson, Sunnyvale, CA).
Analyses were gated on lymphoid cells, which were identified by forward and side light-
scatter profies.
Cytokine analyses
Interferon-y and IL-4 production was measured by ELISpot assay as described
(354). The optimal number of IELs assayed per well varied from 2.5 to 20 x 10
. The
number of discrete spots visible in each well was counted using a light microscope at 2x
power. Each cytokine assay was performed using 4-6 wells, with all wells but one as-
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sayed using the cytokine-specific developing antibody and the remaining well assayed
using the irrelevant biotinylated control antibody. For analysis, the number of spots ob-
served in the control well for each multiplicate assay was subtracted from the number of
spots counted in each of the test wells. The maximum number of spots observed in any
control well was three. The adjusted number of spots present in each of the test wells was
then averaged. To account for the various numbers of cells added per well, data are nor-
malized to number of spots per 10 cells.
Statistics
Parametrc data are presented as arithmetic means :i 1 s.d. except in figues de-
picting the results of a single experiment performed in trplicate or quadrplicate. In those
instances , the result is shown as the mean :i standard error of the mean. Pairs of means
were compared using two-tailed t-tests with separate variance estimates and the Bonfer-
roni adjustment for multiple comparsons as required (324).
Results of Chapter IV
Decreased intraepitheliallymphocytes in pre-diabetic BBDP and BBDR rats
The number of IELs recovered from normal, untreated BBDR rats was compara-
ble to that recovered from normal WF rats and tended to increase somewhat with age
(Table 7). In contrast, the number of IELs recoverable from the BBDP rat was substa-
tially less , with the magnitude of the difference increasing with age. Treatment of BBDR
rats with poly I:C and an anti-ART2a mAb for one week, according to a protocol known
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TABLE 7
IEL NUMBER IN WF AND BB RATS
IEL Yield (x 10 cells)
Strain Treatment 6 weeks old 9 weeks old
None 8:t 1.5 (6)a 12.8:t 1.1 (5)C
BBDR None 7 :t 2.3 (8) 14. 1 :t 2.4 (8)d
BBDR anti-ART2a mAb plus 3.3 :t 0.4 (4)
poly I:C
BBDP None 2.2 :t 0. 8 (4) 1.6 :t 0. 7 (8)e
Legend to Table 7: IELs from WF and BB rats were isolated and counted as described in
Methods. BBDR rats were either untreated or treated for one week with anti-ART2a mAb
plus poly I:C to induce diabetes as described in Methods. Each data point represents the
) !
mean:f 1 s. ; the number of rats tested is indicated in parentheses. The BBDP rats at
these time points were not yet diabetic. a: Statistically similar to untreated BBDR of the
same age and p.:O.OOl vs. treated BBDR and BBDP of the same age and vs. 9 week old
WF. b: Statistically similar to BBDP of the same age. c: Statistically similar to untreated
BBDR and p':O. OOl BBDP of the same age. d: p.:O.OOI vs. BBDP of the same age and vs.
6 week old untreated BBDR. e: Statistically similar to 4-6 week old BBDP.
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to induce diabetes in these animals, was associated with a reduction in the number of
IELs to levels similar to those observed in the spontaneously diabetic BBDP rat.
Intraepithelial natural kiler cell number and function are reduced in pre-
diabetic BBDP and BBDR rats
Intraepithelial NK-PlA+ CDT NK cells may play an important immunoregula-
tory function in the gut (Chapter III). I therefore tested the hypothesis that the reduction
in IEL number associated with the prediabetic state in BB rats is associated with defects
in IE NK cell number or fuction. Consistent with previous observations (354), the per-
centage of IELs expressing the NK-P1A+ CDT NK phenotye was 50% (Table 8).
Also consistent with previous observations (354), I observed that a substantial number of
unfractionated WF IELs spontaneously secreted both IFN-y and IL-4 (Table 8). These
cytokine-producing IELs are known to be IENK cells (354). In contrast, both the percent-
age ofIENK cells and the number ofIFN-y and IL-4 producing cells in both BBDP and
untreated BBDR rats was dramatically reduced, and treatment of BBDR rats to induce
diabetes was associated with an even greater deficit in both parameters.
The IENK cell deficiency in BBDP rats results from a hematopoietic defect
I next sought to determine if the deficiencies in IENK cell number and fuction in
BB rats were the result of a defect in hematopoietic progenitors or the developmental mi-
croenvironment of the host. To do so , I performed a reciprocal bone marrow transplanta-
tion analysis using BBDP and normal WF rats. Using the RT7 allotyic marker to distin-
guish cell origin, I observed that WF bone marrow appeared to generate an IEL com-
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TABLE 
INTRAEPITHELIAL NK CELLS IN WF AND BB RATS
IENK Cells IFN- IL-
Strain Treatment (%t (spots/104 cells) (spots/l04 cells)
WF (4) None 50.6:t 5. 44:t 12 47:t lO
BBDR (8) None 17.4:t 2.1 7:t 2 10 :t 4
BBDR(4) anti-ART2a mAb 1.2 :t 0. 1 :t 0 O:t 0
plus poly I:C
BBDP (4) None 11.8:t 1.7 3:t 1 1 :t 0
Legend to Table 8: IELs from WF and BB rats 4-6 weeks old were isolated as described
in Methods. BBDR rats were either untreated or treated for one week with anti-ART2a
mAb plus poly I:C to induce diabetes as described in Methods. The percentage of NK-
P1A+ CD3- (IENK) cells was determined by flow microfluorometr. The number of
unfractionated, unstimulated IELs secreting IFN-y or IL-4 was determined by ELISpot
after overnight cultue as described in Methods. Each data point represents the mean :f 
; the number of independent determinations is indicated in parentheses. a: Each of the
4 values differs from all others at the p 005 level. b: p OOl vs. all other groups; no
other paired comparisons are statistically significant. c: p OOl vs. all other groups. d:
025 vs. treated DR and BBDP.
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parent in BBDP rats that was normal with respect to both the number of IELs recover-
able and the percentage of IENK cells (Table 9). Both parameters were comparable to
those observed in both unmanipulated WF rats and radiated WF rats of the same age
transplanted with syngeneic WF bone marow (Table 9). In contrast, transplantation . of
BBDP bone marrow into radiated WF recipients failed to generate a normal IEL com-
partment of BB rat origin (Table 9). Although the number of IELs recovered was high
most of these cells were of WF origin, and the percentage of IENK cells was intermediate
between that of unmanipulated WF and BBDP rats (Table 9).
Discussion of Chapter IV
Summary of findings
The potential regulatory properties of IENK cells led me to investigate these cells
in pre-diabetic BB rats , which are known to have defects in peripheral ART2+ regulatory
cells (118). I first analyzed overall IEL numbers and found that IEL recovery was re-
duced in pre-diabetic BB rats. Upon further inspection, I observed reduced relative num-
bers of IENK cells in untreated BBDR rats as compared to normal WF rats. This defi-
ciency was more pronounced in BBDR rats following one week of diabetes-inducing
treatment and also in pre-diabetic BBDP rats. Spontaneous IFN-y and IL-4 secretion by
unfractionated IELs was likewise decreased in untreated BBDR rats and further de-
creased in treated BBDR and in BBDP rats. Using reciprocal bone marrow chimeras
, I
was able to show that the IENK cell deficiency in BBDP rats results from a hematopoie-
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Legend to Table 9: WF (RT7. ) and BBDP (RT7. 1 +) rats 6 weeks of age were random-
ized and either not treated fuher or irradiated and transplanted with either WF or BBDP
bone marrow as indicated. When 12 weeks of age
, all rats were kiled, and IELs and bone
marrow lymphocytes were isolated and analyzed by flow microfluorometr. Each data
point represents the mean :f 1 s.d. for four individual animals. a: No paired comparisons
between the transplanted hosts and non-transplanted controls are statistically significant.
b: p 05 VS. BBDP WF chimeras. No other paired comparisons between these two
groups are statistically significant.
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tic defect. Details of these findings are discussed in this section
, and broader implications
of these results are also addressed.
OveralilEL deficiency in pre-diabetic BB rats
Untreated BBDR rats resembled normal WF rats with regards to overall IEL
numbers recovered using my new IEL isolation methodology. This relationship was con-
sistent regardless of rat age. Treatment ofBBDR rats with anti-ART2 mAb plus poly I:C
for 1 week, approximately half the time required to induce diabetes (125), dramatically
reduced the number of IELs recovered from these rats. The number of IELs recovered
from BBDP rats was also reduced and comparable to that of treated BBDR rats. BBDP
rat lymphocytes are more prone to apoptosis (121), so it could be argued that mechanical
manipulation of IELs during the isolation protocol resulted in lower IEL recovery in
BBDP rats. Histologic analysis , however, has also suggested previously that IEL numbers
are decreased in BBDP rats (302). My quantification of IEL yields therefore establishes
that pre-diabetic BB rats are deficient in overall IEL numbers
, and it is plausible to hy-
pothesize that such a deficiency impacts normal mechanisms of mucosal tolerance.
IENK cell deficiency in BBDR rats
Treatment of BBDR rats with anti-ART2 mAb plus poly I:C depletes peripheral
ART2+ regulatory T cells and induces diabetes (125). I therefore analyzed IELs from un-
treated and treated BBDR rats for the presence and function of IENK cells
, which may
represent a regulatory lymphocyte population in the intestinal mucosa. Despite normal
overall numbers of IELs, reduced relative numbers of IENK cells were observed in un-
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treated BBDR rats. I have already established that IENK cells in WF rats are entirely re-
sponsible for spontaneous IFN-y and IL-4 secretion, so unfractionated BBDR rat IELs
were measured for this activity as a reflection of IENK cell fuction. Consistent with the
argument that IENK cells are responsible for spontaneous IFN-y and IL-4 secretion, this
activity was reduced in unfractionated IELs from untreated BBDR rat.
Treatment of BBDR rats with anti-ART2 mAb plus poly I:C for 1 week fuher
reduced the relative number of IENK cells and spontaeous cytokine secretion by
unfractionated IELs to nearly undetectable levels. The relative number of intraepithelial T
cells was preserved in treated BBDR rats, suggesting that the diabetes-inducing treatment
preferentially depleted IENK cells. This relatively selective depletion of IENK cells by
my diabetes-inducing treatment was a surrising result given that nearly all IELs express
high levels of ART2 by flow cytometr analysis (26). Diabetes-inducing treatment does
not show such selectivity peripherally, as ::95% of peripheral ART2+ cells are depleted in
treated BBDR rats (164). Although the anti-ART2 mAb definitely reaches the IEL com-
partent following intraperitoneal injection (unpublished observation), it remains unclear
whether complement proteins are able to access and lyse IELs in situ.
Several mechanisms may explain the relatively selective IENK cell depletion in
treated BBDR rats. If antibody-labeled IELs are not depleted in situ then perhaps only
ART2+ precursor cells en route to the IEL compartent are depleted by the diabetes-
inducing treatment. A more rapid turnover by IENK cells as compared to intraepithelial T
cells would therefore explain the relatively selective depletion of IENK cells in treated
BBDR rats. Indeed, peripheral NK cells are exquisitely sensitive to radiation treatment
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(355), supporting the hypothesis that tuover of peripheral NK cells is more rapid than
that of peripheral T cells. It could also be argued that, if IEL depletion does occur in situ
IENKcells may be more sensitive to complement-mediated lysis, thus accounting for
their relatively selective depletion in treated BBDR rats. Heightened sensitivity to com-
plement is often observed with cells that have down-regulated expression of decay accel-
erans factor (DAF, CD59), another GPI- linked protein (356), but there is curently no
evidence for a decreased expression of DAF by IENK cells. Possible implications of se-
lectively depleting a potential regulatory population from the IEL compartment of BBDR
rats are discussed below.
IENK cell deficiency in BBDP rats
Given the peripheral lymphopenia of BBDP rats (124), it is not overly surrising
to find a similar lymphopenia in the IEL compartment of BBDP rats, especially since the
majority oflELs in normal rats are CD8a+ and ART2+ (26). Interestingly, however, there
was a relatively selective decrease in the percentage IENK cells in BBDP rats that was
even more pronounced than in untreated BBDR rats. This observation contrasts that of
splenic NK cells, which are relatively increased in BBDP rats and decreased in BBDR
rats (53). Accordingly, spontaneous IFN-y and IL-4 secretion by unfractionated BBDP rat
IELs was likewise dramatically reduced to undetectable levels.
One possible explanation for the relatively selective deficiency in IENK cells ob-
served for BBDP rats is that there is a defect in one or more stroma-derived IEL growth
factors. Such is the case in several other animal models that exhibit selective IEL defi-
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ciencies. In Sl/Sld mice, which are natually deficient in SCF, there is a selective and
nearly complete lack of yoTCR + IELs (241). In addition, experimental mice genetically
deficient in IL-7 also exhibit a relatively selective deficiency in yo TCR+ IELs (238).
It is unlikely, however, that a stroma-derived defect accounts for the selective
IENK deficiency in BBDP rats because normal WF bone marrow completely restores the
IEL compartment in BBDP rats. Thus, the overall IEL deficiency and the relatively se-
lective IENK deficiency in BBDP rats were attbutable to a hematopoietic-derived de-
fect. Similar results have been demonstrated for peripheral lymphocyte populations of
BBDP rats reconstituted with bone marrow from BBDR rats (353). The exact natue of
the hematopoietic-derived defect that leads to peripheral lymphopenia in BBDP rats is
unkown, but it may involve the enhanced apoptosis of deficient lymphocyte subpopula-
tions (121).
Several animal models besides the BBDP rat exhibit relatively selective deficien-
cies in IEL subpopulations secondar to one or more hematopoietic-derived defects. In
WlWv mice, which are naturally deficient in c-kit (the receptor for stem cell factor), and
in genetically engineered IL- 7R knockout mice there are predictable deficiencies in yo
TCR+ IELs similar to that of Sl/Sld and IL- /- mice, respectively (238;241). Mice that
are genetically deficient in the Linker of Activated T cells (LAT) lack CD4+ and CD8~+
IEL subpopulations (357). In addition, genetically engineered mice lacking the IL-2 re-
ceptor ~ (IL-2R~) chain exhibit a selective deficiency ofCD8aa+ a~TCR+ and yoTCR
IELs; interestingly, these mice also lack NK cells peripherally (358).
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Implications of IENK cell deficiency in BB rats
Regardless of the exact mechanism of selective IENK cell deficiencies in treated
BBDR rats or in BBDP rats , it should be emphasized that the decreased relative number
of IENK cells precedes diabetes in both cases. Furhermore, there is also a loss of IENK-
associated spontaneous IFN-y and IL-4 secretion by unfractionated IELs in pre-diabetic
BB rats. Peripheral NK T cells, which have repeatedly been implicated as regulatory cells
in mice, also express IFN-y and IL-4 independent of exogenous cytokine stimulation
(46;47;349). A loss of the potentially regulatory IENK cells in the intestinal epithelium of
pre-diabetic BB rats may contrbute to the disruption of mucosal tolerance and predispose
these animals to activation of autoreactive T cells peripherally.
Conclusion to Chapter IV
With respect to diabetes, I have documented that spontaneously diabetic BBDP
rats are severely deficient in IENK cells. Similarly, BBDR rats are also deficient in IENK
cells as compared to the normal WF strain rat. Interestingly, however
, when BBDR rats
are induced to become diabetic using a standard protocol consisting of anti-ART2 mAb
plus poly I:C (4), levels ofIENK cells and associated spontaneous IFN-y and IL-4 activ-
ity become nearly undetectable. The NK-like phenotye and function, together with an
unusual cytokine profile-constitutive expression of IL-4 and IFN-y in the local micro-
environment of the gut-suggests that IENK cells are specialized cells that may be sub-
serving gut-specific functions. The present data suggest that one such fuction may relate
to the expression of autoimmune diabetes in genetically susceptible individuals.
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CHAPTER V
PRELIMINARY DATA: A DISRUPTION OF MUCOSAL TOLER-
ANCE IN BBDP RATS TRIGGERS AUTOREACTIVE T CELLS AND
LEADS TO AUTOIMMUNITY
Summary of Chapter V
BBDP rats spontaneously develop autoimmune diabetes mellitus and are severely
deficient in peripheral ART2+ T cells. Dietary manipulation influences expression of dia-
betes in BBDP rats , suggesting a role for the intestinal immune system in disease etio-
pathogenesis. BBDR rats do not spontaneously develop autoimmune diabetes
, have nor-
mal numbers of peripheral ART2+ T cells , and can be induced to become diabetic by in-
jection of a cytotoxic anti-ART2a mAb plus low doses of poly I:C. Using a new, quantita-
tive method of isolating large numbers of highly purfied intraepithelial lymphocytes, I
have documented previously the presence of a unique IEL subpopulation in non-
autoimmune susceptible WF rats that consists of intraepithelial natual killer cells and is
selectively deficient in pre-diabetic BB rats. In this chapter, I establish that, unlike BBDR
and WF rats, BBDP rats are also deficient in yoTCR+ IELs , a population of T cells that
may playa role in normal mucosal tolerance mechanisms. I also report preliminary data
showing that systemic autoreactivity may be initiated in the intestine; peripheral autore-
active lymphocyte populations appear to emanate first from mesenteric lymph nodes that
drain the intestine, and such cells may initiate a tye 2 autoimmune phenomenon drven
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by IL-4. These findings support the arguent that a failure in mucosal tolerance in BBDP
rats , perhaps secondar to deficiencies in one or more IEL subpopulations, trggers acti-
vation of autoreactive T cells peripherally and contrbutes to the immunopathogenesis of
spontaneous diabetes in BB rats. They also call into question the general applicability of
the Thl-model of autoimmune diabetes that has been the benchmark of disease patho-
genesis in the NOD mouse.
Introduction to Chapter V
The majority of BBDP rats spontaneously develop autoimmune diabetes by 120
days of age (4). BBDP rats have a severe peripheral lymphopenia with a reduction of
CD4+ T cells (124) and an almost complete lack ofCD8+ (359;360) and ART2a+ T cells
(118). The basis for the severe peripheral T cell deficiency, which results from reduced
thymic emigration (120) and an enhanced rate of intrahepatic T cell apoptosis (121), has
been traced to the hematopoietic stem cell (361). Transfusion of lymphocytes from nor-
mal histocompatible rats prevents the development of diabetes provided that ART2a
cells become engrafted (122;123). Coisogenic BBDR rats , which have normal numbers
of peripheral T cells, never spontaneously develop autoimmune diabetes when main-
tained in a V AF environment, but can be induced to become diabetic by injection of a
cytotoxic anti-ART2a mAb and low doses of poly I:C, an immune system activator (125).
The phenotye and functions of intestinal lymphocytes are not fully characterized
but these cells appear to govern mucosal processes like oral tolerance and controlled (or
physiologic) chronic inflammation (185). Defects in regulation of the intestinal immune
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system are associated with celiac disease (88), inflammatory bowel disease
(199;201;312), and possibly autoimmune diabetes (362). Gluten-rich diets and perhaps
oral insulin - which protects NOD mice from diabetes (288) - may accelerate autoim-
mune diabetes in BBDP rats (170; 177;290). In contrast, hydrolyzed casein-containing
diets reduce the incidence of spontaneous diabetes in BBDP rats (170; 177). Lack of tol-
erance to dietary gluten has been implicated in the immuno-pathogenesis of celiac disease
(87;88), and several studies have documented a correlation between tye 1 DM and celiac
disease in humans (86;363-365).
I have recently described a new method for the isolation and purfication of rat
intestinal IELs that routinely yields 30-50 milion IELs per adult rat (26). Analysis of
IELs isolated by this new method has demonstrated the presence of five IEL subpopula-
tions based on the differential expression of a~TCR, CD8a and CD4 , with a major sub-
population consisting of intraepithelial NK cells (26). IENK cells are unique in that they
display an activated phenotye and spontaeously secrete the immunomodulatory cytoki-
nes IF- and IL-4. I have shown previously that BB rats, particularly pre-diabetic BBDR
and BBDP rats, are deficient in the relative number and function of IENK cells.
A second subpopulation of IELs expresses the yo TCR and was shown by me to
comprise a second major IEL comparent in normal WF rats. I now establish that, prior
to diabetes, BBDP rats but not BBDR rats exhibit a selective deficiency of yoTCR+ IEL
cells as compared to WF rats. I extend these findings to peripheral lymphocyte compart-
ments and demonstrate that mesenteric lymph nodes draining the intestine of pre-diabetic
BB rats preferentially harbor autoreactive lymphocytes as compared to cervical lymph
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node lymphocytes. By analyzing the cytokine profie 
of mesenteric lymph nodes
, serum
IgE levels , and tissue sections of intestine and pancreas
, I also present preliminary data
suggesting that the autoimmune phenomenon in BB rats results from a disruption of nor-
mal mucosal tolerance mechanisms and is a 
tye 2-drven autoimmune process
, similar to
allergic hypersensitivity.
Materials and Methods 
of Chapter V
Animals
BBDR and BBDP rats were obtained from BMR
, Inc (Worcester, MA). WF rats
were obtained from Harlan Sprague Dawley (Indianapolis
, IN). Athymic W AG-rnu/rnu
rats were obtained from the colony at the University of Massachusetts (Worcester
, MA)
and used at 12 weeks of age. Animals of either sex were used in all 
experiments. All
animals were certified to be serologically free of Sendai virus
, pneumonia virus of mice
sialodacryoadenitis virus
, rat corona virus
, Kilham rat virus, HI (Toolan s virus), mouse
poliovirus (GD7), Reo- Mycoplasma pulmonis lymphocytic choriomeningitis virus
mouse adenovirus
, Hantaan virus
, and Encephalitozoon cuniculi. All animals were
housed in a V AF facility until used and maintained in accordance with recommendations
in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal
Resources, National Research Council
, National Academy of Sciences
, 1996) and the
guidelines of the Institutional Animal Care and Use Committee of the University of Mas-
sachusetts Medical School.
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Antibodies
Fluorochrome-conjugated mAbs directed against CD3 (clone G4. 18) and yoTCR
(clone V65) were obtained from BD PharMingen (San Diego, CA). For measurement of
IL-4-secreting cells by ELISpot, paired mAbs (purified OX-81 and biotinylated Bll-
directed against IL-4 were obtained from BD PharMingen. For measurement ofIFN-y by
ELISpot, the capture mAb (clone DB- I) was obtained from BioSource International
(Camarillo, CA) and the detection rabbit anti-rat IFN-y polyclonal antibody was obtained
from Torrey-Pines Biolabs (La Jolla, CA) and biotinylated as described (313). Isotye
control mouse IgG 1 and mouse IgG3 and alkaline phosphatase-conjugated streptavidin
were purchased from BD PharMingen.
Cell preparation
Intraepithelial lymphocytes were prepared from rat small intestine by Percoll(8
density gradient centrfugation using minor modifications of a method developed in our
laboratory (26). Viable cell numbers were quantified by the method of Tryan blue using
a hemocytometer. Single cell suspensions of splenocytes and lymph node lymphocytes
and were prepared by gentle extrsion through stainless steel sieves into medium con-
sisting of cold RPMI- 1640 supplemented with 5% Fetalclone(8 I as described (121). For
preparation of lymph node lymphocytes , cervical and mesenteric cells were processed
separately.
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Manipulation of BBDR and BBDP rats
Treatment of BBDR Rats with a diabetes-induction protocol
BBDR rats 25-28 days of age were treated with intraperitoneal injections of anti-
ART2a mAb (50 Jlg 5 times weekly) and poly I:C (5 Jlg/100 g body weight 3 times
weekly) as described (125). Rats were treated for 7- 12 days , less than the time required
for diabetes onset (4).
Prevention of diabetes in BBDP rats by BBDR splenocytes
BBDP rats 25-28 days of age were injected intraperitoneally with splenocytes
from age-matched, untreated BBDR donors. Splenocytes were not depleted of eryhro-
cytes , and each recipient animal received the equivalent of one entire donor spleen.
Adoptive transfer of lymph node lymphocytes and diagnosis of diabetes
For adoptive transfer experiments, 20 x mesenteric or cervical lymph node
lymphocytes from pre-diabetic BBDR rats that had received 7 days of the anti-ART2a
plus poly I:C diabetes-induction protocol (-5 weeks old) were isolated and infused intra-
venously into athymic W AG-rnu/rnu recipients at 12 weeks of age. BBDP rats and adop-
tive transfer recipients were monitored for diabetes by testing for glycosura three times
weekly (Tes- Tape, Eli Lily, Indianapolis, IN). The diagnosis of diabetes in glycosuric
animals was confirmed by a plasma glucose concentration of::200 mg/dl.
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Flow cytometry
Single and two-color flow cytometrc analyses were performed as described (26).
Briefly, 1 x 10 viable intraepithelial and splenic lymphocytes were suspended in ice-cold
F ACS medium (isotonic PBS supplemented with 1 % Fetalcloneif I) and reacted with
FITC- and PE-conjugated antibodies for 30 min. at 4 C. All samples were then washed
with F ACS medium and fixed with 1 % paraformaldehyde in PBS. FITC- and PE-
conjugated isotye control immunoglobulins were used for all analyses. Cells were ana-
lyzed using a FACScanif instrment (Becton Dickinson, Sunyvale, CA). Analyses were
gated on lymphoid cells, which were identified by forward and side light-scatter profies.
Cytokine analyses
Interferon-y and IL-4 production was measured by ELISpot assay of MLN and
cervical lymph node (CLN) lymphocytes from BB and WF rats as described (354) except
that cells were incubated for the overnight culture in the presence of PMA and ionomy-
cin. Included in this study were untreated WF rats
, untreated BBDR rats , untreated BBDP
rats, BBDR rats that had been treated for 12 days with the diabetes-induction protocol
and BBDP rats that had received an infusion of splenic lymphocytes from untreated
BBDR rats to prevent diabetes. All rats were 5-6 weeks old, and none were diabetic. The
optimal number of IELs assayed was determined in preliminary experiments to be 1 x 10
cells per well.
The number of discrete spots visible in each well was counted using a light micro-
scope at 2x power. Each cytokine assay was performed using 4-6 wells , with all wells but
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one assayed using the cytokine-specific developing antibody and the remaining well as-
sayed using the irrelevant biotinylated control antibody. For analysis , the number of spots
observed in the control well for each multiplicate assay was subtracted from the number
of spots counted in each of the test wells. The maximum number of spots observed in any
control well was three. The adjusted number of spots present in each of the test wells was
then averaged. To account for the various numbers of cells added per well, data are nor-
malized to number of spots per 10 cells.
Histology
Samples of intestine and pancreas were obtained from 16 week old untreated
BBDR and diabetic BBDP rats. Specimens were immediately fixed in 10% buffered for-
malin. Paraffn-embedded tissue sections of all samples were stained with hematoxylin
and eosin and examined by light microscopy.
Preliminary Results of Chapter V
Deficiency in y8TCR+ IELs in pre-diabetic BBDP rats
Using flow cytometr, I measured directly the relative numbers of yo T cells in
IELs and splenocytes isolated from 4-6 week old BB rats , none of which were diabetic.
The percentage of CD3+ IELs expressing the yoTCR in untreated and treated BBDR rats
was similar to that ofWF rats and greater than that ofBBDP rats (Figure 24). In addition
the percentage of overall IELs exhibiting a CD3+ yoTCR+ phenotye in untreated and
treated BBDR rats (32.5 :t 2.7% and 50.5 :t 4. 1 % , respectively) was greater than that ob-
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Figure 24: Flow cytometric analysis of y8ICR expression on intraepitheUal T cells in
WF and BB rat IELs. IELs were isolated from 4-6 week old rats, reacted with mAb spe-
cific for CD3 and yoTCR (V65 clone), and analyzed by flow cytometr. Fluorescence
intensity (horizontal axis) is plotted against cell number (vertical axis). Shown are per-
centages and representative profiles of yoTCR expression on gated CD3+ lymphocytes as
described in Methods (solid line). Fluorescence associated with isotye staining is also
indicated (dashed line). Included in this study were WF rats untreated BBDR rats , BBDR
rats that had received one week of diabetes-inducing anti-ART2a plus poly I:C (treated
BBDR), and BBDP rats. Comparable results were obtained in at least 4 individual ani-
mals.
ISO
served in BBDP rats (5.3 :t 2.0%). The percentage of CD3+ splenocytes expressing the
yOTCR was actually increased in BBDP rats (12.
1 :t 2.9%) versus WF and untreated
BBDR rats (6.9 :t 0.9% and 7.7 :t 1.6%, respectively). In a separate analysis ofIELs and
splenocytes isolated from 7-9 week old BB rats
, BBDP rats exhibited comparable differ-
ences in IEL but not splenic yo T cells (data not shown).
Mesenteric lymph node cells in BBDR rats harbor autoreactive cells prior to
diabetes expression
I next sought to ascertain whether any potential defects in intestinal mucosal tol-
erance might have implications on peripheral autoreactive lymphocyte 
populations. Ac-
cordingly, MLN cells, which drain the intestine (205), and CLN cells were isolated from
BBDR rats that had received 7 days of the diabetes induction protocol and then tested
independently for their ability to adoptively transfer autoimmune diabetes to athymic re-
cipients. Gut-draining MLN from treated BBDR rats transferred diabetes to athymic rats
earlier than did CLN (Figure 25).
Mesenteric lymph node cells in pre-diabetic BB rats exhibit a type 2 cyto-
kine profile
To better understand the mechanism that permits the early appearance of autore-
active cells in the MLN of BB rats
, IFN-y and IL-4 production was analyzed by ELISpot
as described in Methods. Low levels of each 
cytokine were detected in the MLN and
CLN populations of control WF and untreated BBDR rats (Table 
10). Treatment for 12
days with anti-ART2 mAb plus poly I:C to induce diabetes induced a 
surrisingly high
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Figure 25: Diabetes expression in athymic rats that received mesenteric or cervical
lymph node lymphocytes from pre-diabetic BBDR rats. Athymic WAG rnu/rnu rats were
intravenously administered 20 x mesenteric (broken line) or cervical (solid line)
lymph node lymphocytes from BBDR rats that had been treated for 1 week with the anti-
ART2a plus poly I:C diabetes-induction protocol. Recipient animals were monitored for
diabetes as described in Methods (n = 5 for each group). Shown is a Kaplan-Meyer graph
of the cumulative percentage of diabetes-free recipients (y-axis) plotted versus time (x-
axis).
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TABLE 10
CYTOKINE PRODUCTION BY CLN AND MLN FROM WF AND BB RATS
IL- IFN-
(spots/10 cells :t SEM) (spots/10 cells:t SEM)
Strain Treatment CLN MLN CLN MLN
None O:t 0 2:t 1 O:t 0 O:t 0
BBDR None O:t 0 4:t I I :t 1 2:t 0
BBDR anti-ART2a 1 :t I 38 :t 5 1l:t3 2:t I
plus poly I:C
BBDP None 2:t 1 19:t 3 4:t 1 O:t 0
BBDP Splenocyte 2:t 0 7:t 2 2:t 0 O:t 0
Transfusion
Legend to Table 10: MLN and CLN lymphocytes from WF and BB rats 4-6 weeks old
were isolated as described in Methods. BBDR rats were either untreated or treated for
one week with anti-ART2a mAb plus poly I:C to induce diabetes as described in Meth-
ods. BBDP rats were either untreated or transfused intraperitoneally at 4 weeks of age
with lymphocytes from one BBDR spleen to prevent diabetes as described in Methods.
The number of PM A plus ionomycin stimulated lymphocytes secreting IF-y or IL-4 was
determined by ELISpot after overnight culture as described in Methods. Each data point
represents the mean :f 1 SEM for one individual animal.
r"CCC I
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production of IL-4 in MLN but not CLN of pre-diabetic BBDR rats, whereas just a mod-
est rise in IFN-y production was detected only in the CLN of treated BBDR rats (Table
10). A similar situation occurred in BBDP rats; IL-4 but not IFN-y was markedly in-
creased in the MLN but not CLN of pre-diabetic BBDP rats, whereas infusion of splenic
lymphocytes from BBDR rats to prevent diabetes abrogated IL-4 production by BBDP rat
MLNs (Table 10). Using Light Cycler(8 technology to quantify IL-4 mRA, transcript
levels from CLN and MLN samples closely correlated to ELISpot results (data not
shown). Levels of serum IgE were also measured (by ELISA) and found to be elevated in
pre-diabetic BB rats as compared to non-diabetic controls (data not shown).
Eosinophils in the intestine and islets of diabetic BBDP rats
Interleukn-4 and IgE are tyically associated with tye 2 (Th2) immune re-
sponses like allergic hypersensitivity (181). I next analyzed samples of intestine and pan-
creas from 16 week old untreated BBDR rats and from age-matched BBDP rats that had
diabetes for -1 month. Gross analysis revealed that the intestine of BBDP but not BBDR
rats hypercontracted upon evisceration (not shown). Histologic analysis demonstrated
that the intestine of BBDR rats appeared normal, whereas the muscularis layer of BBDP
rat intestine was thickened and hyperplastic (Figue 26). In addition, eosinophils were
present between the circular and longitudinal muscularis layers in BBDP but not BBDR
rats (Figue 26). Additional histologic analysis of pancreas tissue revealed normal islet
architectue in BBDR rats, whereas eosinophils were present in the insulitic lesion of dia-
betic BBDP rats (Figure 26).
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Figure 26: Histological analysis of small intestine and pancreas from BBDR and BBDP
rats. Jejunum and pancreas were isolated from 16 week old BBDR rats and from age-
matched BBDP rats that had diabetes for -1 month. Samples were paraffn-embedded
stained with hematoxylin and eosin, and analyzed via light microscopy. Samples of jeju-
num and pancreas from BBDR rats (Panels A and B
, respectively) show no evidence of
pathology. Samples of jejunum from BBDP rats (Panel C) exhibit a thickened and hyper-
plastic muscularis with eosinophils present between circular and longitudinal muscle lay-
ers (arows). Samples of pancreas from BBDP rats (Panel D) demonstrate insulitis with
eosinophils present in the infiltrate (arrows). Shown is a representative field for each
sample. Magnification is indicated in parentheses.
) :
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Discussion of Chapter V
Environmental factors, including dietar antigens
, influence the expression of
spontaneous autoimmune diabetes in BBDP rats (4; 170; 177). In addition, oral insulin
which protects NOD mice from diabetes (278), does not prevent and may actually exac-
erbate diabetes in BBDP rats (289;290). What is it about the intestinal microenvironment
in BBDP rats that contrbutes to such findings? The intestine is one site where lympho-
cytes encounter a major load of environmental antigens (181). Accordingly, tolerance
mechanisms unique to the intestinal mucosal are necessary, including physiologic chronic
inflammation and oral tolerance (185). Such processes are postulated to be governed by
specialized intestinal regulatory cell populations, but the natue and fuction of these
cells is stil poorly characterized. Failure of mucosal tolerance has been implicated in the
pathogenesis of inflammatory bowel disease (199;201;312), celiac disease (88) and per-
haps autoimmune diabetes (362).
It has been shown previously that pre-diabetic BB rats exhibit severe deficiencies
in peripheral and intestinal lymphocytes (4;366). Deficient cell populations include po-
tential regulatory cells, a lack of which may predispose these animals to autoimmune dia-
betes (4;25;164;366). Preliminary data presented in this chapter suggest that
, in addition
to IEL deficiencies, several systemic defects are also observed in pre-diabetic BB rats
that may be indicative of a failure of mucosal tolerance.
188
Summary of preliminary data
Prior to diabetes, intraepithelial yo T cells are deficient in BBDP but not BBDR
rats. It is likely that the yo T cell deficiency ofBBDP rats is due to a hematopoietic defect
because engraftent ofWF bone marrow into irradiated BBDP rats reconstitutes yOTCR
IELs (unpublished observation). Several antigen-independent fuctions have been as-
cribed to intraepithelial yo T cells, most likely reflecting the restrction in yoTCR reper-
toire (19). These fuctions include: maintenance of epithelial integrty (264;265), cyto-
toxicity of stressed intestinal epithelial cells (8; 19), and regulation of mucosal immune
responses (15;367). Interestingly, increased intestinal permeability and inflammation oc-
curs in humans with tye 1 diabetes melltus (362;368;369) and in BBDP but not BBDR
rats prior to diabetes and independent of dietary antigen (370). It is conceivable that such
a finding is a direct consequence of the yOTCR+ IEL deficiency in BBDP rats.
These data may also provide a link between lymphocytes of the intestine and pe-
riphery. Lymphocytes of the MLN, which drain the intestine, are capable of adoptively
transferrng diabetes to athymic rats earlier in disease pathogenesis (prior to diabetes in
donor rats) as compared to CLN lymphocytes
, suggesting that activated autoreactive pe-
ripherallymphocytes appear in the MLNs prior to systemic circulation. A similar finding
has been reported in NOD mice (371;372).
I also provide surprising yet preliminary evidence that autoimmune diabetes in
BB rats may be the result of an IL-4 driven tye 2 immune response. Mesenteric but not
cervical lymph nodes from pre-diabetic rats produced high levels of IL-4 that were asso-
ciated with elevated serum IgE. By histology, the intestine of BBDP rats resembled the
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allergic hypersensitivity tyically seen in food allergy. These data directly challenge the
dogma established in NOD mice that autoimmune diabetes is a Th1-mediated disease
(32-34). Of note, there exists at least one report that Th2-polarzed T cells induce insulitis
and diabetes when administered to NOD.scid mice (373).
Although my data argue that Th2-tye MLN lymphocytes contrbute to the ex-
pression of autoimmune diabetes in BB rats, how do I reconcile these preliminary data
with the observation that Th 1 cytokines are elevated in acutely inflamed islets of BB rats?
Several explanations may account for these apparently contradictory data. First, there
may be an issue of location; Th2-tye autoreactive T cells may preferentially home to the
intestine or MLN, whereas Th1-tye autoreactive T cells may home to the pancreas. Al-
ternatively, there may be an issue of timing; with the earliest autoreactive cells acquiring
a Th2-cytokine profie in the gut, and later autoreactive cells acquiring a Th I-tye cyto-
kine profie in the pancreas. Finally, it is not uneasonable to hypothesize that the Th1
model of autoimmune diabetes established in the NOD mouse (33) is not directly appli-
cable to the BB rat. Supporting this argument is the observation that both recombinant
IFN-y (159;160) and anti-IFN-y mAb (158) prevent diabetes in BBDP rats.
The correlation between IL-4 protein, IL-4 mRA, serum IgE, and histology
strongly argues that the phenomenon observed in preliminary experiments is real, but
there is stil room to question whether or not the Th2 profie actually contrbutes to dia-
betes expression. Typically, Th2 immune responses occur in response to allergy or para-
sitic infection. It is possible that, concurent with this preliminary experiment, there was
an undetected environmental allergen or parasitic infection in our rat colony. Independent
''t..
"!!,
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of diabetes , immunodeficient animals (untreated BBDP and treated BBDR rats) may have
therefore been more susceptible to systemic immune responses against the unown
agent. Although the possibility of parasites is raised whenever eosinophils are observed
in the islet or intestine of BBDP rats (374;375), our animals are routinely screened for
parasites and consistently test negative (Barbara Whalen, personal communication). Fur-
ther experimentation in this subject is clearly necessar.
Systemic implications of mucosal lymphocyte deficiencies in BBDP rats
How might deficiencies in intraepithelial NK and yo T cell populations contrbute
to systemic immune defects observed in pre-diabetic BB rats? Failure of mucosal toler-
ance is associated with local and systemic autoimmune disease (88;199;201;362), and
both intraepithelial NK and yo T cells may act locally as regulatory cells. Increased intes-
tinal permeability is associated with deficiencies in intraepithelial yo T cells (264;265)
and allergic responses to dietary antigen (181 ;203 ;204). The loss of epithelial integrty in
food allergy is in part attbutable to "leak" tight junctions that allow for the paracellular
passage of lumenal antigens (181). Therefore, LP DCs, which tyically receive antigen
that has been processed and transported in a trans cellular fashion by IECs (181), may be
directly exposed to intestinal antigens. The migration of activated dendrtic cells to re-
gional mesenteric lymph nodes (205) sets the stage for systemic immune responses (206)
and may be responsible for defects observed in the MLN of pre-diabetic BB rats. Alter-
natively, autoreactive lymphocytes may circulate through the intestine and become acti-
vated in situ due to a lack of properly controlled physiologic inflammation (199).
191
Failure of mucosal tolerance and autoimmune diabetes
Besides being responsible for intestinal disorders like inflammatory bowel disease
(IBD) and celiac disease, failure of mucosal tolerance may also influence the expression
of autoimmune diabetes in humans and rodents (362). The role of cow s milk protein in
the pathogenesis of human tye 1 DM is stil debated (108-112). In addition, a link be-
tween celiac disease, an allergic reaction to dietar gluten, and autoimmune diabetes has
been increasingly recognized in humans (86;363-365). Data presented here suggest that a
similar dietary allergy may occur in BB rats. Whether or not dietary gluten induces dia-
betes in BB rats remains to be proven, but several studies have shown that dietary gluten
abrogates the diabetes-protective effect of a hydrolyzed casein diet (170; 177). In contrast
dietar supplementation with BSA or whole milk protein does not abrogate the diabetes-
protective effect of a hydrolyzed casein diet (172).
Conclusion to Chapter V
Although stil poorly understood, there is clearly a role for environmental factors
in the pathogenesis of autoimmune diabetes in humans and rodents. The intestine is po-
tentially a major source of such environmental pertbants. I have provided preliminary
data suggesting that, prior to diabetes, several immunologic defects can be detected in the
mesenteric but not cervical lymph nodes of BB rats
, thus implicating defects in intestinal
mucosal tolerance in the pathogenesis of systemic autoimmunity. These results need to be
investigated fuher. If applicable to human tye 1 diabetes melltus, then perhaps diabe-
togenic intestinal antigens can be identified and eliminated from at-risk individuals.
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CHAPTER VI
COMPREHENSIVE DISCUSSION
Chapter VI
, Section 1 - General Background 
to Discussion
Review of clinical rationale
Type 1 diabetes mellitus continues to cause significant morbidity and mortality in
children and young adults despite modern advances in patient care. No 
modifiable risk
factors for tye 1 DM have curently been identified
, so disease incidence has yet to de-
crease and may even be on the rise (376). These concerns
, together with the rising eco-
nomic cost of health care
, necessitate the development of alternative modalities designed
to decrease the incidence of tye 1 DM. Before we can hope to prevent this disease in
humans, however, a greater understanding of the immunopathogenesis of tye 1 DM is
necessar. For any disease
, ethical and moral issues surounding experimentation in hu-
mans hinder the study of disease pathogenesis in humans. Accordingly, animal models of
human disease prove to be an invaluable tool
, and our laboratory has made extensive use
of the BB rat, a rodent model of tye 1 diabetes mellitus.
Overview of Chapter VI
The objective of this chapter is to discuss my findings as they relate to autoim-
mune diabetes and mucosal tolerance. Section 2 of this chapter states my working hy-
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pothesis regarding the immunopathogenesis of autoimmune diabetes in BB rats. Section 3
explains my rationale for studying intestinal intraepithelial lymphocytes. Section 4 re-
views in a broader context the data presented in Chapters II-
, with paricular attention
given to Chapters III. Section 5 postulates a mechanism whereby defects in mucosal tol-
erance may contrbute to autoimmune diabetes in BB rats. Finally, Section 6 addresses
the applicability of this work to human tye I diabetes melltus and suggests future di-
rections for continuation of this work.
Chapter VI
, Section 2 - The Immunopathogenesis 
of Autoim-
mune Diabetes in SS Rats: A Working Hypothesis
Based on experiments conducted prior to this dissertation
, I have expanded the
Balance Hypothesis" (Chapter I, Section 4 - Figure 3) into a working hypothesis that at
least three factors contrbute to the immunopathogenesis of autoimmune diabetes in BB
rats (summarized in Table 11). First, autoreactive T cells are generated in the thymus.
Second, the relative number of peripheral ART2+ regulatory T cells is insufficient to pre-
vent autoimmunity by autoreactive ARTT T cells (the "Balance Hypothesis ). Third
there occurs an aberrant activation of autoreactive T cells that subsequently initiate
autoimmunity in the absence of sufficient regulation by ART2
+ T cells.
Generation of auto reactive T lymphocytes
The development of spontaneous autoimmune diabetes in BBDP rats that can be
adoptively transferred to non-diabetic rats via lymphocytes strongly argues for the pres-
TABLE 11
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THREE FACTORS CONTRIBUTE TO AUTOIMMUNE DIABETES IN BB RATS
Spontaneous BBDP Rat
1. Autoreactive cells
Inducible BBDR Rat
Generated in thymus (pro-
grammed by iddm4?)
2. Insuffcient ART2
regulatory cells
Genetically programmed by
lyp -1- mutation
3. Activation 
autoreactive cells
Environmental source: Fail-
ure of mucosal tolerance to
harmless gut antigens (e.
dietary protein)
Generated in thymus (pro-
grammed by iddm4?)
Induced experimentally by
cytotoxic anti-ART2a mAb
Induced experimentally by
immune system activator
(e.g. poly I:C , KRV)
Legend to Table 11: I postulate that at least three factors contrbute to the immunopatho-
genesis of autoimmune diabetes in BB rats. First
, autoreactive T cells are generated in the
thymus. Second, the relative number of peripheral ART2+ regulatory T cells is insuffi-
cient to prevent autoimmunity by autoreactive ARTT T cells (the "Balance Hypothe-
sis ). Third, there occurs an aberrant activation of autoreactive T cells that subsequently
initiate autoimmunity in the absence of suffcient regulation by ART2+ T cells. Listed for
both BBDP and BBDR rats are potential mechanisms for these three factors.
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ence of auto reactive cells in BBDP rats (4;146). Thymectomy prevents diabetes in BBDP
rats, suggesting fuher that autoimmunity is mediated in part by autoreactive T cells
(377). By histologic analysis
, CD4+ and CD8+ T cells are among the cells present in the
insulitic lesion (4).
That diabetes can be induced in BBDR rats following experimental manipulation
argues for the presence of autoreactive cells in these animals 
(125;164). Evidence that
autoreactive cells in BBDR rats are T cells is provided by experiments in which spleno-
cytes from diabetes-induced BBDR rats adoptively transfer disease to non-diabetic rats
(147). In addition, thymocytes from BBDR rats that are adoptively transferred to athymic
rats induce diabetes provided that recipient animals are depleted of ART2
+ T cells (151).
In both BBDP and BBDR rats
, the presence of autoreactive cells may be attbut-
able in part to an autosomal dominant diabetes-susceptibility locus
, termed iddm4 that
has recently been mapped in (WF x DP) x WF rats to chromosomes 4 (4;351;352). This
gene, which has yet to be identified
, appears to be involved with the genetic predisposi-
tion ofBB rats to autoimmunity (4).
The generation of autoreactive T cells is not unique to BB rats. 
Autoreactive T
cells appear to be responsible for experimentally induced autoimmune syndromes in PVG
and LEW rats , among others. On the other hand
, some rat strains like the WF are re-
markably resistant to autoimmune-inducing protocols (130). It is possible that such
strains lack autoreactive T cell populations entirely.
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Insufficient numbers of ART2+ regulatory T cells
A major breakhrough in the BB rat field has been the observation that the number
of peripheral AR T2+ T cells correlates inversely with expression of autoimmune diabetes
in both BBDP (118) and BBDR rats (164). Accordingly, these cells are thought to repre-
sent a population of regulatory T cells (25). The mechanism whereby these cells may
regulate immune responses is not yet known
, but potential immunoregulatory fuctions
of AR T2 were discussed in Section 4 of Chapter I.
In BBDP rats, there is a natual deficiency in peripheral ART2+ T cells attbut-
able to a homozygous mutation at the lyp gene locus (4). The lyp -l- defect in BBDP rats
results in decreased thymic export ofT cells (120) and increased intrahepatic apoptosis of
recent thymic emigrants (121). Infusion of splenocytes from non-lymphopenic histocom-
patible donors (BBDR or WF rats) prevents diabetes in BBDP rats provided that ART2
cells engraft (122; 123).
BBDR rats have normal numbers of peripheral ART2+ T cells and do not sponta-
neously develop diabetes (4). Autoimmune diabetes can be induced in :;90% 
of BBDR
rats, though, by administration of a cytotoxic anti-ART2 mAb plus an immune system
activator such as poly I:C or KRV (125;126;164). Decreased numbers of ART2+ T cells
appear permissive but not required for diabetes expression in BBDR rats, however, as
KRV infection alone induces diabetes in -30% of BBDR rats (126;378). Thus , it seems
that ART2+ regulatory T cells raise the threshold of activation required for autoimmunity.
Activation of autoreactive ARTT T cells is elaborated upon below.
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Regulatory activity has been shown for ART2+ T cells in other rat strains besides
the BB rat. Diabetes is induced in PVG-RT1 U rats by irradiation and neonatal thymec-
tomy and is associated with deficiencies in CD4+ ART2+ T cells (133). Diabetes is pre-
vented in these rats by infusion of CD4+ ART2+ T cells from unmanipulated PVG-RT1 U
rats. Administration of poly I:C or KRV also induces diabetes in PVG-RTl rats , but de-
pletion of ART2+ T cells is required for disease expression in this instance (130; 131).
Activation of autoreactive T cells
Variations of the standard diabetes inducting protocol suggest that an activation of
autoreactive T cells is required for the expression of autoimmune diabetes in BBDR rats.
Administration of high-dose poly I:C or KRV alone induces diabetes in -30% of BBDR
rats (126;378). In contrast, depletion of ART2+ T cells without poly I:C or KRV fails to
induce autoimmunity in V AF BBDR rats (156). Taken together
, these observations argue
that depletion of peripheral ART2+ T cells is not necessar for disease expression, but
activation of ARTT autoreactive T cells is required.
Unlike diabetic BBDR rats , in which immune stimulation by poly I:C or KRV
may allow for the activation of autoreactive cells, BBDP rats spontaneously develop dia-
betes between 60- 120 days of age (4). In addition, the incidence of diabetes in BBDP rats
is -90% (-:100% concordance), and diabetes onset in BBDP rats is influenced by envi-
ronmental factors, including dietary manipulation (4; 170). These data argue for the pres-
ence of one or more environmental factors that activate autoreactive cells in BBDP rats
and trgger autoimmunity.
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Chapter VI, Section 3 - Rationale for Studying Intestinal Lym-
phocytes in SS Rats: A Failure of Mucosal Tolerance Can
Have Systemic Consequences
The intestinal mucosa: Environment and the Immune System
I sought to study intestinal lymphocytes in BB rats because the proposed activa-
tion of peripheral autoreactive cells by environmental agents may occur in the intestinal
mucosa, a major site of interaction between the immune system and the environment
(185). The intestinal mucosa sees a huge antigenic load; it is estimated that 10 organ-
isms inhabit the intestine at any given time , and an individual consumes at least 2 500 kg
of food antigens durng a normal lifetime (181). Also in the gastrointestinal tract are tre-
mendous numbers of lymphocytes that must respond to infectious agents yet remain tol-
erant of antigens from tyically non-pathogenic sources (185). Intestinal lymphocytes
appear to regulate the balance between mucosal immunity and mucosal tolerance to gut
antigens.
When mucosal tolerance fails: Local consequences
In animal models and possibly in humans , the loss of normal mucosal tolerance
mechanisms is associated with several intestinal disorders, including inflammatory bowel
disease (IBD) (199;201) and celiac disease (88). In these cases , absence or failure ofmu-
cosal regulatory cells has been implicated in disease pathogenesis (199). Germ-free ani-
mals do not develop IBD (276;379-381), suggesting that an overactive immune response
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to commensal intestinal bacteria trggers IBD (185;201). In celiac disease, however, the
offending antigen is known to be gluten, a dietar protein of wheat germ, and removal of
gluten from the diets ameliorates the disease (87;88).
When mucosal tolerance fails: Systemic consequences
Mucosal tolerance is not limited to intestinal lymphocytes. Inflammatory bowel
diseases are associated systemically with ocular, joint, and skin inflammations (382). A
failure of mucosal tolerance has also been implicated in the pathogenesis of autoimmune
diabetes in NOD mice (362). Mesenteric lymph nodes from NOD mice adoptively trans-
fer disease even earlier than pancreatic lymph nodes (371;372), and the vascular endo-
thelium of acutely inflamed islets in NOD mice expresses the gut-associated adhesion
molecule MAdCAM- , a mucosal vascular addressin (383;384). Additionally, islet-
infitrating T cells in NOD mice display the a4~7 integrn tyically expressed by lamina
propria lymphocytes (385), and administration of an anti-~7 integrn prevents diabetes in
NOD mice (386).
Environment and spontaneous autoimmune diabetes in BBDP rats
Any failure of mucosal tolerance in spontaneously diabetic BBDP rats more
closely resembles celiac disease than IBD because removal of known pathogens does not
protect BBDP rats from diabetes; gnotobiotic animals spontaneously develop diabetes at
rates similar to conventionally housed animals (157). Other environmental activation
sources cannot be excluded by this study, however
, because even these gnotobiotic ani-
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mals received food; they suckled until weaning and were then maintained on germ-
free
rat chow (AI do Rossini , personal communication) (157).
Many common food antigens stimulate intestinal lymphocytes (170; 177; 181), and
diets with low antigenicity - with protein sources from hydrolyzed casein (172; 173) or
elemental amino acids (171) - decrease the incidence of spontaneous diabetes in BBDP
rats. On the other hand, gluten rich diets are diabetogenic (170; 175). It is therefore en-
tirely conceivable that BBDP rats
, which are deficient in peripheral regulatory cells
, also
lack intestinal regulatory cells and therefore lack normal mechanisms of mucosal toler-
ance to dietary antigens.
Why study intraepitheliallymphocytes in BB rats?
Intraepitheliallymphocytes are among the first cells of the immune system to en-
counter enteric antigens (8), but their role in mucosal tolerance is unown. Effector
mechanisms of mucosal tolerance were introduced in Chapter I and 
include secretory
IgA, generation of Th3 and Tr 1 cells , and generation of CD8+ suppressor cells. IELs may
contrbute to each of these processes either directly through suppression/regulation of ab-
errant mucosal immune responses (214;354;366) and/or indirectly though the mainte-
nance of epithelial permeability (247;264;265). I therefore sought to address the 
natue of
IELs in normal and BB rats with the hypothesis that defects in IEL number and/or fuc-
tion may contrbute to a failure of mucosal tolerance and spontaneous autoimmune dia-
betes in BBDP rats.
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Chapter VI, Section 4 - Review of Findings
In Chapter I, I stated that the overall objective of this disserttion was to investi-
gate whether defects in IEL number and/or fuction may contrbute to the expression of
autoimmunity in the BB rat model of tye 1 diabetes melltus. To address this issue, I
have established a new IEL isolation protocol that has enabled me to investigate the phe-
notye and function of IELs in normal WF rats. Through these studies, I identified a
population of potentially regulatory intraepithelial natual kiler cells. Importantly, the
relative number and fuction of these cells are deficient in BB rats, particularly in pre-
diabetic BBDR and BBDP rats. These data are reviewed here and discussed in the
broader context of mucosal tolerance and autoimmune diabetes.
An improved methodology for the isolation of intraepitheliallymphocytes
The role of IELs in mucosal tolerance has been difficult to study in part because
current methods for the isolation of IELs require extensive manipulation of the gut
(16;216;295;297), and IEL preparations are often contaminated with intestinal epithelial
cell that may interfere with in vitro IEL assays (296;330). I have therefore established a
new method for the isolation of rat IELs that is based on the selective removal of intesti-
nal epithelial cells under conditions that leave the basement membrane undisturbed. The
method is rapid and requires neither enzmatic digestion, nor surgical removal ofPeyer
patches, nor vigorous mechanical manipulation of the intestine. The yield of rat IELs us-
ing this method is 5- 10 fold greater and of higher purty than that reported for other
methods (216;295). Morphological and phenotyic analyses demonstrated that the puri-
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fied cell population is comprised of IELs and is not contaminated with lamina propria or
Peyer s patch lymphocytes. This methodology allows me to investigate phenotyic and
fuctional characteristics of IELs on a scale that has heretofore been unattainable.
Identification of a potentially regulatory natural kiler cell population in the
intestinal epithelium of normal rats
Using new methodology, I have identified a novel population of intraepithelial
NK cells that appear constitutively to secrete IL-4 and IFN-y. These unusual IENK cells
are similar to peripheral NK cells in morphology, in their ability to lyse NK-specific tar-
gets, and in their ability to suppress a one-way mixed lymphocyte cultue. They are
however, markedly different from peripheral NK cells in two respects. First
, IENK cells
express high levels ofCD25 and ART2 , whereas peripheral NK cells do not. Second, un-
like splenic NK cells that secrete little or no IL-4 and secrete IFN-y only in response to
stimulation (56), a substantial fraction of rat IENK cells appear to secrete IFN-y or IL-
spontaneously.
Novel function and phenotype of intraepithelial natural kiler cells
I (26) and others (54) have previously reported that cells with an NK-P1A +
CDT phenotye are present in the IE compartent of the rat intestine. My data now ex-
tend these observations by demonstrating that IENK cells appear to represent a new
, pre-
viously unrecognized subpopulation of rat NK cells. It could
, of course , be argued that
the IL-4 secretion I observed in rat IENK cell populations resulted from contamination of
the IENK cell preparation with either NK T cells or contaminating IE- T cells, both of
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which are known to secrete IL-4 (15;46;209). This is unlikely however, because my as-
says revealed that NK T and IE- T cells comprised 1 % of the purfied IENK cell prep 
rations used in my ELISpot assays. This frequency of contaminating cells is insuffcient
to account for the 1-2% frequency ofIL-4 secreting cells I observed in the purified IENK
populations. In addition, I observed that the puroseful addition of IE- T cells to the IENK
ELISpot had no effect on the number of cytokine-secreting cells.
It could also be argued that the apparently "spontaneous" secretion of IL-4 was
simply the result of the IENK cells being activated, as are nearly all IELs (8;15;209).
This is also unlikely, however, because my data show clearly that peripheral NK cells
even when activated with high levels of IL- , secrete little IL-4. The ability of freshly
isolated IENK cells to secrete IL-4 suggests that these cells may represent a new sub-
population ofNK cells that , in the IEL microenvironment, are programmed to secrete IL-
4 constitutively. It should be pointed out, however, that my data do not formally exclude
the possibility that factors other than IL-2 or IL-4 could be present in vivo in the gut, acti-
vate IENK cells, and induce them to secrete IL-4. Whether any individual IENK cells se-
crete both IFN-y and IL-4 spontaneously also cannot be determined from my data.
Consistent with the view that IENK cells comprise a distinct NK subpopulation is
my documentation that they differ phenotyically from splenic NK cells. Expression of
CD2, CD8a, CDS , CD45RC, and CD54 is lower in IE than in splenic NK cell popula-
tions. In contrast, expression of CD25 and ART2 is higher. Although the expression of
CD25 could simply reflect the constitutively activated state of IENK cells, ART2 expres-
sion on peripheral T cells is known to be downegulated in the setting of activation (150).
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Functions of IENK cells that resemble peripheral NK cells
Although the cytokine profie of rat IENK cells appears to be unique among cells
with the NK-P1A+ CDT phenotye, it is important to note that these cells do share im-
portant morphological and functional characteristics with peripheral NK cells. Both are
large and exhibit distinctive azophilic granules (209;327). I recognize that yo-TCR
IELs have been reported to have azuophilic granules (209;328), but this cell subset was
excluded from the IENK cell specimens that I analyzed. My morphological studies also
suggest that intrepithelial NK cells may be slightly larger than those in the splenic
population, consistent with their activated state (56;209). This conclusion must be re-
garded as tentative, however, as I canot exclude the possibility of artifact induced by the
cytospin method used for specimen preparation.
I also observed that, like peripheral NK cells (64;68;315;316), intraepithelial NK
cells exhibit cytotoxic activity and suppress a one-way mixed lymphocyte cultue. The
cytotoxicity data, which showed that purfied rat NK-PlA+ IELs lyse Y AC- 1 cells more
effciently than do unsorted or remixed populations, are consistent with studies performed
using mouse spleen cells (327). I recognize that NK T cells were present in my cytotox-
icity assays, but it is unlikely that they affected the outcome because, unless they are pre-
incubated in the presence of high-dose IL- , NK T cells are ineffective in lysing Y AC-
cells (46). With respect to the suppression of MLCs by rat IENK cells
, it should be
pointed out that comparable numbers of intraepithelial T cells did not result in suppres-
sion, arguing against competition for nutrents in the media as a mechanism of suppres-
sion. NK-mediated suppression of a one-way MLC is thought to occur via kiling of allo-
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geneic antigen presenting cells (64;68), a conclusion supported by my Transwell stud-
ies. These studies suggest that cell-cell contact between IENK and stimulator/responder
cells may be required for suppression, but it must be recognized that they do not formally
exclude the possibility that soluble mediators that are either short lived or present at low
concentrations could be involved.
IENK cells and regulation of intestinal immune responses
The constellation of NK-like phenotye and function, together with an unusual
cytokine profie--onstitutive expression of IL-4 and IFN-y in the local microenviron-
ment of the gut-suggests that these are specialized cells that may be sub serving a gut-
specific function. If the IENK cell population is indeed a new subpopulation of intraepi-
thelial cells, how might they influence gut immunity? I propose that IENK cells have
previously unrecognized regulatory properties. The gut is known to exhibit unique im-
mune responses that differ from those in the systemic circulation and can influence the
response of the peripheral immune system (185).
Two unique immune responses mediated by the gut are regulation of controlled or
physiologic" inflammation (185), and mediation of oral tolerance upon encounter with
exogenous antigens (8;185;362). The ability ofIENK cells to spontaneously (in essence
constitutively) secrete IL-4 implies an important role vis-a-vis these two unique functions
of the gut immune system. IL-4 is known to be a potent regulator of inflammatory proc-
esses and biases inflammation towards a "non-destrctive rather than a "pro-
inflammatory destructive" process (31 ;387;388). IL-4 has also been demonstrated to
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protect animals from inflammatory bowel disease (199), and it is required for oral toler-
ance (346). Interestingly, NK-P1 + cell populations have been implicated in the regula-
tion of a Th1-tye immune response in a mouse model of chronic colitis, but it is not
known specifically ifNK cells of gut origin subserved that function (65).
With regard to possible immunoregulatory fuction, it is intrguing to note that
ART2, an ADP-ribosyltransferase (150), and CD25 are expressed at high levels on rat
IENK cells. Expression of ART2 on peripheral rat T cells is a marker of regulatory capa-
bility (133;150), as is expression of CD25 on a population of peripheral mouse T cells
that can prevent autoimmune diabetes in NOD mice (389). It is plausible to speculate that
ART2+ CD25+ rat IENK cells could playa role in the processes that regulate the "physi-
ologic inflammation" that is characteristic of the gut (185).
The data suggest further that defects in IENK cell number or function might lead
to un-regulated inflammatory processes in the gut that result in disease. Abnormalities in
gut immunity may participate in the pathogenesis of autoimmune disorders including ce-
liac disease (88), inflammatory bowel diseases (199;201;202;312), and autoimmune tye
1 diabetes (362). With respect to diabetes , I have documented that the spontaneously dia-
betic BBDP strain of rats is severely deficient in IENK cells (Chapter IV). The diabetes
resistant BBDR rat strain is also deficient in IENK cells, as compared to the normal WF
strain rat used in the present studies. Interestingly, however, when BBDR rats are induced
to become diabetic using a standard protocol consisting of anti-ART2 mAb plus polyino-
sinic:polycytidylic acid (4), levels of IENK cells become nearly undetectable (Chapter
IV).
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There is as yet little information on the abundance and fuction of IENK cells in
species other than the rat. Some IELs in both human and mouse express NK cell surace
markers (225;390;391), and mouse IELs exhibit NK-like cytotoxic activity (225;390).
Most IELs in mice (15;209) and humans (260), however, are CD3 , and spontaneous se-
cretion of IFN-y (and IL-5) in the mouse has been associated with intraepithelial CD3+ T
cell populations (253).
Intraepithelial natural kiler cells and BB rats
With respect to diabetes, I have documented that the spontaneously diabetic
BBDP strain of rats is severely deficient in IENK cells. The diabetes resistant BBDR rat
strain is also deficient in IENK cells as compared to the normal WF strain rat. Interest-
ingly, however, when BBDR rats are induced to become diabetic using a standard proto-
col consisting of anti-ART2 mAb plus poly I:C (4), levels of IENK cells and associated
spontaneous IFN-y and IL-4 activity become nearly undetectable.
. The NK-like phenotye and fuction, together with an unusual cytokine profie-
constitutive expression ofIL-4 and IFN-y in the local microenvironment of the gut-sug-
gests that IENK cells are specialized cells that may be subserving gut-specific fuctions.
The present data suggest that one such function may relate to the expression of autoim-
mune diabetes in genetically susceptible individuals. Based on these data, I hypothesize
that BB rat diabetes is a multi-step process that starts with a deficiency of regulatory gut
NK cells. Step 1 is an abnormally regulated immune response to adventitious gut
antigens. During step 2, dysregulated gut immune cells traffc to the periphery, home to
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pancreas , and cause non-destrctive insulitis. Step 3 involves peripheral T cells that home
to the inflamed tissue and, due to genetically determined lack of regulation
, cause
destrctive insulitis. I believe that this hypothesis is deserving of additional testing.
Evidence for systemic consequences resulting from a failure of mucosal
tolerance in pre-diabetic BB rats
In preliminary experiments I have established that
, unlike BBDR and WF rats
BBDP rats are also deficient in yoTCR+ IELs that may playa role in normal mechanisms
of mucosal tolerance. Is systemic autoreactivity in BB rats initiated in the intestine? Pe-
ripheral autoreactive lymphocyte populations appear to emanate first from mesenteric
lymph nodes that drain the intestine, and such cells may initiate a tye 2 autoimmune
phenomenon drven by IL-
These findings support the argument that a failure in mucosal tolerance in BBDP
rats, perhaps secondar to deficiencies in one or more IEL subpopulations, trggers acti-
vation of autoreactive T cells peripherally and contrbutes to the immunopathogenesis of
spontaneous diabetes in BB rats. I also challenge the general applicability of the Th1-
model of autoimmune diabetes that has been the benchmark of disease pathogenesis in
the NOD mouse and question whether tye 1 diabetes in humans is trly a Thl-mediated
autoimmune disease.
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Chapter VI, Section 5 - Failure of Mucosal Tolerance in SS Rats
Triggers Autoreactivity: A Model
In Section 2 of this chapter, I proposed that three factors contrbute to the expres-
sion of autoimmune diabetes in BB rats: the presence of autoreactive T cells
, insufficient
numbers of ART2+ regulatory cells peripherally, and activation of autoreactive T cells by
environmental factors. For diabetes-induced BBDR rats, fulfillment of the third stipula-
tion may arise from experimental stimulation of the immune system by poly I:C or KRV.
Less clear is the mechanism whereby environmental agents stimulate autoreactive cells in
the spontaneously diabetic BBDP rat. To address this point, I have investigated in BB rats
one critical site where the immune system is under tremendous environmental stimula-
tion, the intestinal mucosa. My working hypothesis has been that a failure of mucosal tol-
erance in BBDP rats , and perhaps BBDR rats , contributes to the expression of autoim-
mune diabetes by allowing for the activation of autoreactive T cells peripherally. This
section of the discussion reviews and interprets data relevant to the subject of mucosal
tolerance in BB rats. I then present a model by which an activation of peripheral autore-
active cells may occur in BBDP rats.
Review and interpretation of data relevant to mucosal tolerance in BB rats
Relevant studies conducted prior to this dissertation
Prior to this dissertation, it was well established that environmental factors, par-
ticularly diet, influence the expression of autoimmune diabetes in BBDP rats (4; 170). Di-
ets comprised of hydrolyzed casein (172; 173) or elemental amino acids (171) decrease
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the incidence of spontaneous diabetes in BBDP rats
, suggesting that diets with low muco-
sal antigenicity are diabetes-protective (170). Furtermore dietary gluten proteins abro-
gate the protective effects of a hydrolyzed-casein diet (175), implying that some dietar
proteins have a greater mucosal antigenicity and contrbute to diabetes expression in BB
rats (170). Interestingly, oral insulin, which protects NOD mice from diabetes (288), fails
to prevent (289) and may even exacerbate (290) spontaneous diabetes in BBDP rats. Such
findings suggest that a failure of mucosal tolerance is a causative factor in the expression
of autoimmune diabetes in BBDP rats.
How might oral antigens trgger autoimmunity in BBDP rats? One possible
mechanism is through the direct activation of autoreactive T cells by dietary antigens.
Alternatively, spontaneous autoimmune diabetes in BBDP rats may result from "by-
stander activation" of autoreactive T cells secondary to an aberrant immune response to
one or more dietar antigens. The latter interpretation implies that a given dietary antigen
is not necessarly an auto antigen, yet it allows for the activation of autoreactive cells that
then trgger disease. At the outset of this project, I determined that a greater understand-
ing of the mechanism underlying the activation of autoreactive T cells was necessary. I
therefore investigated the role of regulatory cells in mucosal tolerance in BB rats.
Relevant data from this dissertation
I characterized in normal WF rats a population of potentially regulatory natural
killer cells in the intestinal epithelium, an important site of interaction between environ-
mental antigens and the immune system. I extended these findings to BB rats and found
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that pre-diabetic animals exhibit drastic deficiencies in IENK cell number and fuction.
In additional studies , I showed compellng yet preliminary data that BBDP rats are defi-
cient in intraepithelial yo T cells and also that pre-diabetic BB rats may have a failure of
intestinal mucosal tolerance. Given my findings in the context of what is already known
about BB rats and mucosal tolerance, I conclude that an aberrant stimulation of the im-
mune system secondary to a failure of mucosal tolerance contrbutes to the activation 
autoreactive T cells and spontaneous autoimmune diabetes in BBDP rats.
A model whereby failure of mucosal tolerance activates 
auto reactive Iym-
phocytes in SS rats
I propose a model whereby a failure of mucosal tolerance exists in pre-diabetic
BB rats and contrbutes to disease expression in these animals though the direct or indi-
rect activation of circulating autoreactive T lymphocytes (Figues 27-29). Normal muco-
sal tolerance forms the foundation of my model (Figue 6), and the first par of my model
(Figure 27) describes how IELs may contrbute to mechanisms of mucosal tolerance. The
second part of my model (Figure 28) postulates on mechanisms whereby failure of muco-
sal tolerance in BB rats is disturbed secondar to deficiencies in IEL subpopulations. The
third and final par of my model (Figue 29) proffers a mechanism whereby a failure of
mucosal tolerance in BB rats activates circulating autoreactive T cells and 
trggers sys-
temic autoimmunity.
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Figure 27: Proposed roles of IELs in mucosal tolerance. IELs (blue) may paricipate in
mucosal tolerance through two principle mechanisms: 1) the direct suppres-
sionlregulation of aberrant immune responses by potentially autoreactive lamina propria
lymphocytes (red), and 2) the maintenance of intestinal epithelial cells (violet) and
epithelial barrer function. Both allow for normal processing of gut antigens (Figue 6).
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Figure 28: Proposed mucosal consequences of IEL deficiency in BBDP rats. BBDP rats
exhibit marked deficiencies in multiple IEL subpopulations (e.g. IENK cells, yoTCR
IELs) that may interfere with mucosal tolerance at two levels: 1) the failure to suppress
aberrant immune responses by potentially autoreactive lamina propria lymphocytes (red),
and 2) the failure to maintain intestinal epithelial cells (violet) and epithelial barer fuc-
tion.

217
Figure 29: Proposed systemic consequences of a failure of mucosal tolerance in BBDP
rats. Failure of mucosal tolerance to dietar antigens secondary to Peyer s patch defi-
ciencies (step 1), poor epithelial barrer function (step 2), and decreased mucosal regula-
tion (step 2), and may allow for the activation of dendrtic cells and autoreactive T cells
in the lamina propria of BBDP rats. Activated cells then migrate to draining mesenteric
lymph nodes (step 3) and, in the absence of sufficient regulation by ART2+ T cells
propagate a systemic autoimmune response that initiates ~ cell destrction in the islets of
the pancreas (step 4).
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The role of intraepitheliallymphocytes in normal mucosal tolerance
As already shown in Chapter I (Figue 6), myrad factors contrbute to normal
mucosal tolerance including processing of antigen by Peyer s patches and intestinal
epithelial cells (185;187;280), mucosal IgA production by lamina propia plasma cells
(188), and down-regulation of aberrant immune responses locally through the activity of
specialized suppressor/regulatory lymphocyte populations (199;261). I hypothesize that
critically important to these processes is the integrty of the intestinal epithelium medi-
ated by tight junctions between intestinal epithelial cells that prevent the paracellular
transit of lumenal antigens (181;185;203;392). In normal circumstances, therefore
Peyer s patches and intestinal epithelial cells sample lumenal antigens thus allowing for
the local production of regulatory/suppressive lymphocyte populations that may contrb-
ute to oral tolerance systemically (199;278;280;285 ;291).
Intraepithelial lymphocytes appear to be in part responsible for maintenance of
epithelial integrty (8;247;264;265) and therefore mucosal tolerance (Figure 27) (181).
Cytotoxic activity, which I observed for IENK cells and has been shown for other IEL
populations as well (19;328), may delete transformed or infected intestinal epithelial cells
(IECs) thus preserving the integrty of the epithelium (8;19). Intraepithelial yo T cells
which are present in large numbers in normal rats (26), appear to support epithelial integ-
rity through the recognition of stressed IECs (247) and secretion of keratinocyte growth
factor (264;265). At least one study has also shown that yo T cells down-regulate aberrant
Th mucosal immune responses (367).
219
My data also suggests that IELs (particularly IENK cells) may also contrbute to
mucosal tolerance through the secretion of the immunoregulatory cytokines IL-4 and
IFN-y (354). IL-4 is known to be a potent regulator of inflammatory processes and biases
inflammation towards a "non-destrctive" rather than a "pro-inflammatory destrctive
process (31;387;388). IL-4 has also been demonstrated to protect animals from inflam-
matory bowel disease (199), and it is required for oral tolerance (346).
Failure of mucosal tolerance in BBDP rats
How might deficiencies in IEL number or fuction disrupt normal mechanisms of
mucosal tolerance and contrbute to systemic autoimmunity? IELs appear to playa criti-
cal role in maintaining the barer function of the intestinal epithelium (264;265), and in-
creased intestinal permeability is associated with 1) appropriate immune responses to ac-
tive infection (181;185;203;392) and 2) inappropriate immune responses to intestinal an-
tigens from tyically non-pathogenic sources. Indeed, several intestinal disorders such as
inflammatory bowel disease (201), celiac disease (87;88), and food allergy (181;203;392)
are associated with an increased intestinal epithelial permeability. Based on data pre-
sented here and elsewhere, a similar process that may parly explain the diabetogenic ef-
fects of highly antigenic diets may occur in pre-diabetic BBDP rats (Figure 28).
I have shown here that BBDP rats are severely deficient in intraepithelial yo T
cells and IENK cells, which may account for their increased intestinal permeability (370).
Thus, there may be increased paracellular and decreased transcellular trafficking of lu-
menal antigens through the intestinal epithelium in BBDP rats. Transcellular processing
220
of lumenal antigens is associated with presentation by CD 1 and generation of CD8+
regulatory/suppressor populations (185;261), whereas paracellular antigen delivery is
seen in food allergy (181;203;392). By histology, the BBDP intestine resembles allergic
hypersensitivity (204) and also appear deficient in Peyer s patch lymphocytes (unpub-
lished observation), suggesting that normal mechanisms of mucosal tolerance may be de-
fective at multiple levels in these rats. Antigen-rich diets and even oral insulin itself may
therefore trgger a cascade of events that 1) fails to generate regulatory mucosallympho-
cytes and 2) activates autoreactive circulating T cells
, leading to autoimmune diabetes in
BBDP rats.
Deficiencies in potentially immunoregulatory IENK cells in BBDP rats may also
predispose these animals to overactive (non-physiologic) mucosal inflammation due to an
absence of immunoregulatory cytokines locally. Aberrant mucosal immune responses
that might be aborted in immunocompetent animals are sustained in BBDP rats. Lamina
propria lymphocytes and dendrtic cells in these animals would therefore exist in a pro-
inflammatory environment, setting the stage for systemic spreading of mucosal inflam-
mation.
Failure of mucosal tolerance activates autoreactive lymphocytes in BB rats
Even though BBDP rats may exhibit a failure of mucosal tolerance
, it is stil nec-
essary to link that shortcoming to diabetes expression. Preliminary data presented in
Chapter V suggest that just such an association exists and beg the question of how defec-
tive mucosal tolerance contrbutes to diabetes. I propose a mechanism whereby the fail-
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ure of mucosal tolerance in BB rats recruits lamina propria dendrtic cells that then acti-
vate autoreactive T cells either directly or indirectly (Figue 29).
In this model , increased epithelial permeability and deficiencies in mucosal regu-
latory cells - defects seen in inflammatory bowel disease (201), celiac disease (87;88),
and pre-diabetic BBDP rats (370) - allow for paracellular traffcking of lumenal antigens
such that lamina propria dendrtic cells are directly exposed to unprocessed antigen in the
absence of sufficient regulation. An activation of autoreactive T cells then occurs locally
and/or in draining mesenteric lymph nodes. In the absence of suffcient regulation by
ART2+ T cells peripherally, activated autoreactive cells subsequently home to the pan-
creas and induce diabetes. It should be noted that the hyperexpression of class I antigens
that occurs in diabetic BB rats (139;393) is decreased in BB rats maintained on a diabe-
tes-protective hydrolyzed casein diet (394).
Surrisingly, the preliminary data also suggest that autoreactive lymphocytes act
via a Th2 humoral-mediated immune response. Thus, the elevated MLN IL- , elevated
serum IgE, intestinal and islet eosinophils may be down-stream consequences of defects
initiated at the intestinal epithelium. It remains to be established whether the Th2-tye
immune response in the gut contrbutes directly to beta cell destrction in the pancrease
of BB rats. The proposed Th2 model of autoimmune diabetes in BB rats is similar to
those of asthma (395;396) and food allergy (181;204). In addition
, these data challenge
the applicabilty of the Th1 model of autoimmune diabetes (established mostly in mice)
in BB rats. Such limitations must therefore be considered when one attempts to apply
animal studies to human disease.
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Chapter VI, Section 6 - Impact, Directions, and Final Comments
Applicabilty of these findings to human disease
The intestinal immune system is hypothesized to participate in the pathogenesis of
autoimmune diabetes in genetically susceptible humans, BB rats, and NOD mice (362).
The mechanisms by which gut immune responses may lead to diabetes are stil unclear in
part because evidence remains largely circumstantial. In this dissertation, I have identi-
fied potential cellular mechanisms whereby abnormal gut immune responses lead to
autoimmune diabetes in the BB rat. These data have already been discussed in detail , but
what is their applicability to tye 1 DM in humans?
Several lines of study in humans suggest that failures in mucosal regulation may
contrbute to expression of tye 1 DM in genetically susceptible individuals (362). Envi-
ronmental factors such as diet and enteromicrobial agents may participate in the initiation
of disease through mediation of the intestinal immune system (4). In particular, enterovi-
ral infections and dietary cow s milk may be associated with tye 1 DM (1). More re-
cently, an association has been identified between tye 1 DM and the intestinal disorder
celiac disease (86). These observations are particularly relevant to BB rats in which viral
infections and dietar gluten unask disease expression (4; 170).
With regards to diabetes and the intestine itself, increased levels of gut inflamma-
tion - beyond what might be deemed "physiologic" - have been observed in the intestine
of patients with tye 1 DM (369). Furtermore, an increased epithelial permeability,
reminiscent of that in BBDP rats, has been documented in the intestine of humans with
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tye 1 DM (368). Studies of IELs in patients with tye 1 DM are lacking, but humans
with celiac disease have decreased numbers of potentially regulatory NK- + CD3-
IELs (391;397;398). In the context of these human studies, it is apparent that many simi-
larities exist between autoimmune diabetes in humans and BB rats at the level of the in-
testine. Such similarities warrant continued study.
Future directions
Data presented in this dissertation broach three major avenues for futue study in
the BB rat. First, molecular mechanisms of immunoregulation should be identified for
IELs. Second, genetic and environmental factors should be evaluated in BB rats for their
influence on IELs and IENK cell number and function. Third, preliminary data presented
in Chapter V should be investigated fuher to determine if there is trly a cause-effect
relationship between the perceived lack of mucosal tolerance in BB rats and the poten-
tially Th-mediated autoimmune diabetes. Together, these lines of study should contrb-
ute to our knowledge about the immunopathogenesis of autoimmune diabetes in BB rats
and may shed additional light on human disease.
Molecular mechanisms of immunoregulation by IELs
That peripheral regulatory T cells are ART2+ suggests a role for this protein in the
immunoregulatory fuction of these cells (4;25). Interestingly, nearly all IENK cells ex-
press uniformly high levels of ART2 (26) suggesting that the potential immunoregulatory
fuction of these cells may be related to AR T2 expression. For these reasons , the role of
ART2 in immunoregulation requires fuher investigation, paricularly in IELs. Prelimi-
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nary studies in rats have already shown that IELs appear to lack crucial cell-signaling
molecules like LAT (Derrck Todd, unpublished observation). Furhermore, the tradi-
tional signaling pathways associated with ART2 in peripheral T cells are not the same in
IELs (Hans-Peter Raue, unpublished observation). Understanding these mechanisms may
unveil immunoregulatory properties of IELs and are of a high priority.
The effect of genetics and environment on IELs and epithelial permeability
I have proposed that one of the earliest defects contrbuting to the expression of
spontaneous autoimmune diabetes in BBDP rats is their dramatic deficiency in IEL (and
IENK cell) number and function. To better understand the role of genetic factors in this
process, IENK cell number and fuction should be tested in WF iddm4 congenic rats
that carr the defective BB-origin iddm4 allele. In addition, the role of environmental
factors in the disregulation of IENK cell-regulated mucosal immunity can be tested in
other rat models of inducible autoimmune diabetes (e.g. high-dose poly I:C).
According to my model , the IEL defect in BBDP rats results in an increased in-
testinal permeability that trggers a cascade of events leading to autoimmunity. Experi-
mental modalities that increase intestinal permeability (dextran sodium sulfate) should
therefore be evaluated for their ability to induce diabetes in BBDR rats when co-
administered with anti-ART2 mAb. Furhermore, epithelial permeability in diabetes-
induced BBDR rats, which may be increased, should be measured. In addition, restora-
tion of the IEL comparent of BBDP rats via BMT should theoretically restore intesti-
nal epithelial barrer function. Finally, the consequences of depleting potentially immu-
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noregulatory IEL populations should be addressed. The recent commercial availability of
an anti-CD 1 03 mAb (BD Pharmingen) may make this feasible.
Expansion of preliminary data in Chapter V
Data presented in Chapter V provide compelling data that autoimmune diabetes in
BBDP rats may result from a failure of mucosal tolerance that gives rise to Th2-mediated
autoimmunity. Given that these data directly contradict the dogma of Th1-mediated dia-
betes in NOD mice , additional experiments should be performed to confirm my prelimi-
nary observations in BB rats. Furhermore, preliminary observations can be expanded
along a number of avenues that include traffcking studies, adoptive transfer experiments
and analysis of genetically-susceptible iddm4 congenic rats. Intrguing is the possibility
that if IgE is involved in the pathogenesis of diabetes in BB rats, then perhaps identifying
the IgE-specific antigen would uncover putative autoantigens in BB rats.
Final Comments
In this chapter, I have presented a model whereby IEL defects may contrbute to
the expression of autoimmune diabetes in the BB rat. It is my sincere hope that, by de-
fining the immunopathogenesis of autoimmune diabetes in BB rats , these data may pro-
vide insight into autoimmune processes involved in human tye 1 diabetes. Curent
measures to prevent tye 1 diabetes in humans are lacking; studies using oral insulin or
nicotinamide have been largely unsuccessful in human subjects (399-401). A greater un-
derstanding of the immunopathogenesis of tye 1 diabetes melltus is necessary before
researchers can ever hope to prevent this devastating disease in humans.
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